KR20060136459A - N-(2-(Hydroxymethyl)phenyl)-1H-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials - Google Patents
N-(2-(Hydroxymethyl)phenyl)-1H-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials Download PDFInfo
- Publication number
- KR20060136459A KR20060136459A KR1020067017531A KR20067017531A KR20060136459A KR 20060136459 A KR20060136459 A KR 20060136459A KR 1020067017531 A KR1020067017531 A KR 1020067017531A KR 20067017531 A KR20067017531 A KR 20067017531A KR 20060136459 A KR20060136459 A KR 20060136459A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- chlorine
- haloalkyl
- fluorine
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 54
- 239000000463 material Substances 0.000 title description 23
- 239000004480 active ingredient Substances 0.000 title description 11
- 230000003641 microbiacidal Effects 0.000 title description 2
- YLARDGXACZHBHD-UHFFFAOYSA-N N-[2-(hydroxymethyl)phenyl]-1H-pyrazole-4-carboxamide Chemical class OCC1=CC=CC=C1NC(=O)C1=CNN=C1 YLARDGXACZHBHD-UHFFFAOYSA-N 0.000 title 1
- 244000005700 microbiome Species 0.000 claims abstract description 19
- 230000001276 controlling effect Effects 0.000 claims abstract description 7
- 239000001257 hydrogen Substances 0.000 claims description 202
- 229910052739 hydrogen Inorganic materials 0.000 claims description 202
- 239000000460 chlorine Substances 0.000 claims description 199
- 229910052801 chlorine Inorganic materials 0.000 claims description 199
- -1 methoxy, ethoxy, methylthio, ethylthio, cyclopropyl Chemical group 0.000 claims description 188
- 229910052731 fluorine Inorganic materials 0.000 claims description 187
- 239000011737 fluorine Substances 0.000 claims description 186
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 183
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 170
- 150000002431 hydrogen Chemical class 0.000 claims description 156
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 149
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 119
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 112
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 100
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 80
- 125000001246 bromo group Chemical group Br* 0.000 claims description 66
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 60
- 229910052736 halogen Inorganic materials 0.000 claims description 60
- 150000002367 halogens Chemical class 0.000 claims description 60
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 56
- 125000005843 halogen group Chemical group 0.000 claims description 56
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 47
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 46
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 claims description 43
- 239000000126 substance Substances 0.000 claims description 39
- 229910052740 iodine Inorganic materials 0.000 claims description 37
- 239000011630 iodine Substances 0.000 claims description 36
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 35
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 34
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 26
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 24
- 125000004429 atoms Chemical group 0.000 claims description 22
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 19
- 229910052717 sulfur Inorganic materials 0.000 claims description 18
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims description 17
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 16
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 15
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 15
- 239000011593 sulfur Chemical group 0.000 claims description 15
- 239000003085 diluting agent Substances 0.000 claims description 14
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 230000002194 synthesizing Effects 0.000 claims description 13
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 claims description 12
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 12
- 150000001448 anilines Chemical compound 0.000 claims description 11
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 150000001732 carboxylic acid derivatives Chemical compound 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 claims description 10
- 125000005842 heteroatoms Chemical group 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 9
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 8
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 8
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 8
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 7
- 125000004771 (C1-C4) haloalkylsulfinyl group Chemical group 0.000 claims description 7
- 238000010790 dilution Methods 0.000 claims description 7
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 7
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 6
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 claims description 6
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims description 6
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 claims description 5
- 239000004606 Fillers/Extenders Substances 0.000 claims description 5
- 125000004122 cyclic group Chemical group 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims description 4
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 4
- 125000006643 (C2-C6) haloalkenyl group Chemical group 0.000 claims description 4
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims description 4
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims description 4
- ITMCEJHCFYSIIV-UHFFFAOYSA-N Trifluoromethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000005347 halocycloalkyl group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 claims description 3
- 125000006418 4-methylphenylsulfonyl group Chemical group 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000003277 amino group Chemical compound 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- 125000001188 haloalkyl group Chemical group 0.000 claims description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 claims description 3
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
- CPPKAGUPTKIMNP-UHFFFAOYSA-N Cyanogen fluoride Chemical compound FC#N CPPKAGUPTKIMNP-UHFFFAOYSA-N 0.000 claims description 2
- PBMFSQRYOILNGV-UHFFFAOYSA-N Pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000006263 dimethyl aminosulfonyl group Chemical compound [H]C([H])([H])N(C([H])([H])[H])S(*)(=O)=O 0.000 claims description 2
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 claims description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 2
- 150000001804 chlorine Chemical compound 0.000 claims 26
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 9
- 125000003368 amide group Chemical group 0.000 claims 1
- 150000002496 iodine Chemical compound 0.000 claims 1
- XNEFVTBPCXGIRX-UHFFFAOYSA-M methanesulfinate Chemical compound CS([O-])=O XNEFVTBPCXGIRX-UHFFFAOYSA-M 0.000 claims 1
- 150000003857 carboxamides Chemical class 0.000 abstract description 36
- 238000002360 preparation method Methods 0.000 abstract description 14
- 239000000543 intermediate Substances 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 description 83
- 238000000034 method Methods 0.000 description 80
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 40
- 239000000203 mixture Substances 0.000 description 33
- 239000002904 solvent Substances 0.000 description 26
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 22
- 150000003254 radicals Chemical class 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 20
- 239000007858 starting material Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- BZKBCQXYZZXSCO-UHFFFAOYSA-N sodium hydride Chemical compound [H-].[Na+] BZKBCQXYZZXSCO-UHFFFAOYSA-N 0.000 description 18
- 230000001965 increased Effects 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 16
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 15
- 150000002828 nitro derivatives Chemical class 0.000 description 15
- 125000006414 CCl Chemical group ClC* 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- UAEPNZWRGJTJPN-UHFFFAOYSA-N Methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 14
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 14
- 150000001408 amides Chemical group 0.000 description 13
- 239000003995 emulsifying agent Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- MVPPADPHJFYWMZ-UHFFFAOYSA-N Chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 12
- FXHOOIRPVKKKFG-UHFFFAOYSA-N DMA Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 12
- 239000008079 hexane Substances 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 0 Cc1ncccc1* Chemical compound Cc1ncccc1* 0.000 description 11
- 241000233866 Fungi Species 0.000 description 11
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 238000005507 spraying Methods 0.000 description 11
- BZLVMXJERCGZMT-UHFFFAOYSA-N MeOtBu Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 150000004820 halides Chemical class 0.000 description 10
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 10
- 241000894007 species Species 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 230000000875 corresponding Effects 0.000 description 9
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 9
- 150000002170 ethers Chemical class 0.000 description 9
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 9
- 239000003112 inhibitor Substances 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- 239000003208 petroleum Substances 0.000 description 9
- 229910052938 sodium sulfate Inorganic materials 0.000 description 9
- 235000011152 sodium sulphate Nutrition 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- NFDXQGNDWIPXQL-UHFFFAOYSA-N 1-cyclooctyldiazocane Chemical compound C1CCCCCCC1N1NCCCCCC1 NFDXQGNDWIPXQL-UHFFFAOYSA-N 0.000 description 8
- WADSJYLPJPTMLN-UHFFFAOYSA-N 3-(cycloundecen-1-yl)-1,2-diazacycloundec-2-ene Chemical compound C1CCCCCCCCC=C1C1=NNCCCCCCCC1 WADSJYLPJPTMLN-UHFFFAOYSA-N 0.000 description 8
- 229920000742 Cotton Polymers 0.000 description 8
- 240000006962 Gossypium hirsutum Species 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- SCVFZCLFOSHCOH-UHFFFAOYSA-M Potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- 235000005822 corn Nutrition 0.000 description 8
- 235000005824 corn Nutrition 0.000 description 8
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 8
- SJRJJKPEHAURKC-UHFFFAOYSA-N n-methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000003638 reducing agent Substances 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 239000008096 xylene Substances 0.000 description 8
- HVZJRWJGKQPSFL-UHFFFAOYSA-N 1,1-Dimethylpropyl methyl ether Chemical compound CCC(C)(C)OC HVZJRWJGKQPSFL-UHFFFAOYSA-N 0.000 description 7
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- RDOXTESZEPMUJZ-UHFFFAOYSA-N Anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 7
- VZGDMQKNWNREIO-UHFFFAOYSA-N Carbon tetrachloride Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 7
- NNBZCPXTIHJBJL-UHFFFAOYSA-N Decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 7
- GNOIPBMMFNIUFM-UHFFFAOYSA-N Hexamethylphosphoramide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 7
- JIKUXBYRTXDNIY-UHFFFAOYSA-N N-methyl-N-phenylformamide Chemical compound O=CN(C)C1=CC=CC=C1 JIKUXBYRTXDNIY-UHFFFAOYSA-N 0.000 description 7
- 241000209149 Zea Species 0.000 description 7
- 125000002723 alicyclic group Chemical group 0.000 description 7
- 125000001931 aliphatic group Chemical group 0.000 description 7
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 7
- 229950005499 carbon tetrachloride Drugs 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 7
- XTHFKEDIFFGKHM-UHFFFAOYSA-N dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 7
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 7
- XOBKSJJDNFUZPF-UHFFFAOYSA-N methoxyethyl Chemical group CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 7
- IMNFDUFMRHMDMM-UHFFFAOYSA-N n-heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 7
- SECXISVLQFMRJM-UHFFFAOYSA-N n-methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- 241000223600 Alternaria Species 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 240000007842 Glycine max Species 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- 241000589516 Pseudomonas Species 0.000 description 6
- 125000002877 alkyl aryl group Chemical group 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000000855 fungicidal Effects 0.000 description 6
- 239000000417 fungicide Substances 0.000 description 6
- 150000008282 halocarbons Chemical class 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 150000007530 organic bases Chemical class 0.000 description 6
- 229920000151 polyglycol Polymers 0.000 description 6
- 239000010695 polyglycol Substances 0.000 description 6
- 239000001184 potassium carbonate Substances 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 235000015320 potassium carbonate Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 235000011121 sodium hydroxide Nutrition 0.000 description 6
- 239000002689 soil Substances 0.000 description 6
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-Trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 5
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-Dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 5
- 229940117389 Dichlorobenzene Drugs 0.000 description 5
- 240000008529 Triticum aestivum Species 0.000 description 5
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 5
- 150000008046 alkali metal hydrides Chemical class 0.000 description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 5
- 150000001342 alkaline earth metals Chemical class 0.000 description 5
- 230000001488 breeding Effects 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 201000009910 diseases by infectious agent Diseases 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 230000001681 protective Effects 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 235000021307 wheat Nutrition 0.000 description 5
- 239000002023 wood Substances 0.000 description 5
- BQXWCTXAXOSVLK-UHFFFAOYSA-N 1-(1-chloroethyl)-2-nitrobenzene Chemical compound CC(Cl)C1=CC=CC=C1[N+]([O-])=O BQXWCTXAXOSVLK-UHFFFAOYSA-N 0.000 description 4
- DSDBYQDNNWCLHL-UHFFFAOYSA-N 1-(2-nitrophenyl)ethanol Chemical compound CC(O)C1=CC=CC=C1[N+]([O-])=O DSDBYQDNNWCLHL-UHFFFAOYSA-N 0.000 description 4
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 4
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical class CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 4
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 4
- QDFXRVAOBHEBGJ-UHFFFAOYSA-N 3-(cyclononen-1-yl)-4,5,6,7,8,9-hexahydro-1H-diazonine Chemical compound C1CCCCCCC=C1C1=NNCCCCCC1 QDFXRVAOBHEBGJ-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- 239000005695 Ammonium acetate Substances 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- 241001465180 Botrytis Species 0.000 description 4
- VSGNNIFQASZAOI-UHFFFAOYSA-L Calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N Carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N Dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- XXBDWLFCJWSEKW-UHFFFAOYSA-N Dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 4
- 240000001047 Malus domestica Species 0.000 description 4
- OKDQKPLMQBXTNH-UHFFFAOYSA-N N,N-dimethyl-2H-pyridin-1-amine Chemical compound CN(C)N1CC=CC=C1 OKDQKPLMQBXTNH-UHFFFAOYSA-N 0.000 description 4
- DLYUQMMRRRQYAE-UHFFFAOYSA-N Phosphorus pentoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N Phosphoryl chloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M Potassium bicarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- ODZPKZBBUMBTMG-UHFFFAOYSA-N Sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 4
- QDRKDTQENPPHOJ-UHFFFAOYSA-N Sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 4
- 240000001016 Solanum tuberosum Species 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N Thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- IMFACGCPASFAPR-UHFFFAOYSA-N Tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N Trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N Triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 150000001242 acetic acid derivatives Chemical class 0.000 description 4
- 150000004703 alkoxides Chemical class 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 4
- 235000019257 ammonium acetate Nutrition 0.000 description 4
- 229940043376 ammonium acetate Drugs 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 239000000908 ammonium hydroxide Substances 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 239000001639 calcium acetate Substances 0.000 description 4
- 235000011092 calcium acetate Nutrition 0.000 description 4
- 229960005147 calcium acetate Drugs 0.000 description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 230000002140 halogenating Effects 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 150000004679 hydroxides Chemical class 0.000 description 4
- 230000001976 improved Effects 0.000 description 4
- 150000007529 inorganic bases Chemical class 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 235000011056 potassium acetate Nutrition 0.000 description 4
- 239000011736 potassium bicarbonate Substances 0.000 description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 description 4
- 229940094025 potassium bicarbonate Drugs 0.000 description 4
- 235000011118 potassium hydroxide Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 239000001187 sodium carbonate Substances 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 150000003512 tertiary amines Chemical class 0.000 description 4
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 4
- SDUNNJHULQJYOD-UHFFFAOYSA-N 1-nitro-2-(propan-2-ylsulfanylmethyl)benzene Chemical compound CC(C)SCC1=CC=CC=C1[N+]([O-])=O SDUNNJHULQJYOD-UHFFFAOYSA-N 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 3
- WTEOIRVLGSZEPR-UHFFFAOYSA-N Boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Carbodicyclohexylimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- RIFGWPKJUGCATF-UHFFFAOYSA-N Ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 3
- 241000223218 Fusarium Species 0.000 description 3
- XDDAORKBJWWYJS-UHFFFAOYSA-N Glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- 240000007119 Malus pumila Species 0.000 description 3
- QARBMVPHQWIHKH-UHFFFAOYSA-N Methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 3
- 240000008962 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 240000006394 Sorghum bicolor Species 0.000 description 3
- 231100000765 Toxin Toxicity 0.000 description 3
- 241000223259 Trichoderma Species 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000000844 anti-bacterial Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- 229910052803 cobalt Inorganic materials 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- 239000010949 copper Chemical class 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- DMJZZSLVPSMWCS-UHFFFAOYSA-N diborane Chemical compound B1[H]B[H]1 DMJZZSLVPSMWCS-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 125000006351 ethylthiomethyl group Chemical group [H]C([H])([H])C([H])([H])SC([H])([H])* 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 230000002068 genetic Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 230000002363 herbicidal Effects 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 3
- 125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 3
- 230000027756 respiratory electron transport chain Effects 0.000 description 3
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- NQHKCHWQDDWQJR-UHFFFAOYSA-M sodium;propane-2-thiolate Chemical compound [Na+].CC(C)[S-] NQHKCHWQDDWQJR-UHFFFAOYSA-M 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229910052718 tin Inorganic materials 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 108020003112 toxins Proteins 0.000 description 3
- 125000004784 trichloromethoxy group Chemical group ClC(O*)(Cl)Cl 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- RLLPVAHGXHCWKJ-HKUYNNGSSA-N (3-phenoxyphenyl)methyl (1R,3R)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-HKUYNNGSSA-N 0.000 description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 1,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- DERATCBGLUKORT-UHFFFAOYSA-N 1-nitro-2-(1-propan-2-ylsulfanylethyl)benzene Chemical compound CC(C)SC(C)C1=CC=CC=C1[N+]([O-])=O DERATCBGLUKORT-UHFFFAOYSA-N 0.000 description 2
- MBSCFAMOIHFYQM-UHFFFAOYSA-N 1-nitro-2-(propan-2-ylsulfonylmethyl)benzene Chemical compound CC(C)S(=O)(=O)CC1=CC=CC=C1[N+]([O-])=O MBSCFAMOIHFYQM-UHFFFAOYSA-N 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N 2-Butanol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- JBIWLZQJNBUFLD-UHFFFAOYSA-N 2-[1-(propan-2-ylamino)ethyl]aniline Chemical compound CC(C)NC(C)C1=CC=CC=C1N JBIWLZQJNBUFLD-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- FMKOJHQHASLBPH-OUBTZVSYSA-N 2-iodopropane Chemical compound CC([13CH3])I FMKOJHQHASLBPH-OUBTZVSYSA-N 0.000 description 2
- IBAJWKQKPIIFQU-UHFFFAOYSA-N 2-methoxypropan-2-ylcyclohexane Chemical compound COC(C)(C)C1CCCCC1 IBAJWKQKPIIFQU-UHFFFAOYSA-N 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- 239000005660 Abamectin Substances 0.000 description 2
- PRKQVKDSMLBJBJ-UHFFFAOYSA-N Ammonium carbonate Chemical compound N.N.OC(O)=O PRKQVKDSMLBJBJ-UHFFFAOYSA-N 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N Ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 229940097012 Bacillus thuringiensis Drugs 0.000 description 2
- 241000193388 Bacillus thuringiensis Species 0.000 description 2
- 241000123650 Botrytis cinerea Species 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N Bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 239000005885 Buprofezin Substances 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L Caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 229940095731 Candida albicans Drugs 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L Chromic acid Chemical compound O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- 241001600093 Coniophora Species 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L Copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- KAATUXNTWXVJKI-UHFFFAOYSA-N Cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 2
- 229960003887 Dichlorophen Drugs 0.000 description 2
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophene Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 2
- CXEGAUYXQAKHKJ-FYOMLGFFSA-N Emamectin Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@H](C)[C@@H](NC)[C@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-FYOMLGFFSA-N 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 229940093915 Gynecological Organic acids Drugs 0.000 description 2
- 229940088597 Hormone Drugs 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N Isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N Isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- PVTHJAPFENJVNC-MHRBZPPQSA-N Kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 2
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 2
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N Lindane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N Manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N Methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N Methyl iodide Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- QQPJJOXGVNMMNK-UHFFFAOYSA-N N-[1-(2-nitrophenyl)ethyl]propan-2-amine Chemical compound CC(C)NC(C)C1=CC=CC=C1[N+]([O-])=O QQPJJOXGVNMMNK-UHFFFAOYSA-N 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N Oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 241000736122 Parastagonospora nodorum Species 0.000 description 2
- 240000005158 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N Phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- IPNPIHIZVLFAFP-UHFFFAOYSA-N Phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N Phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- 241001337928 Podosphaera leucotricha Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- VZJVWSHVAAUDKD-UHFFFAOYSA-N Potassium permanganate Chemical compound [K+].[O-][Mn](=O)(=O)=O VZJVWSHVAAUDKD-UHFFFAOYSA-N 0.000 description 2
- 108010078762 Protein Precursors Proteins 0.000 description 2
- 102000014961 Protein Precursors Human genes 0.000 description 2
- 241001123569 Puccinia recondita Species 0.000 description 2
- 241000228453 Pyrenophora Species 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N Pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- JUVIOZPCNVVQFO-HBGVWJBISA-N Rotenone Natural products O([C@H](CC1=C2O3)C(C)=C)C1=CC=C2C(=O)[C@@H]1[C@H]3COC2=C1C=C(OC)C(OC)=C2 JUVIOZPCNVVQFO-HBGVWJBISA-N 0.000 description 2
- 239000005092 Ruthenium Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- HXJUTPCZVOIRIF-UHFFFAOYSA-N Sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 2
- 241000228452 Venturia inaequalis Species 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 241000222126 [Candida] glabrata Species 0.000 description 2
- 230000000895 acaricidal Effects 0.000 description 2
- 239000000642 acaricide Substances 0.000 description 2
- 102000034433 acetylcholine receptors Human genes 0.000 description 2
- 108020000715 acetylcholine receptors Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 2
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 235000012501 ammonium carbonate Nutrition 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 230000000845 anti-microbial Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 2
- 229910001863 barium hydroxide Inorganic materials 0.000 description 2
- CYKRMWNZYOIJCH-UHFFFAOYSA-N bromo(tripyrrolidin-1-yl)phosphanium;hexafluorophosphate Chemical compound F[P-](F)(F)(F)(F)F.C1CCCN1[P+](N1CCCC1)(Br)N1CCCC1 CYKRMWNZYOIJCH-UHFFFAOYSA-N 0.000 description 2
- PRLVTUNWOQKEAI-UHFFFAOYSA-N buprofezin Chemical compound O=C1N(C(C)C)C(=NC(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-UHFFFAOYSA-N 0.000 description 2
- 239000011111 cardboard Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000005068 cooling lubricant Substances 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 description 2
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N ethoxyethane;trifluoroborane Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- GKQLYSROISKDLL-UHFFFAOYSA-N ethyl 2-ethoxy-1,2-dihydro-1-quinolinecarboxylate Chemical compound C1=CC=C2N(C(=O)OCC)C(OCC)C=CC2=C1 GKQLYSROISKDLL-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 2
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 2
- 150000004675 formic acid derivatives Chemical class 0.000 description 2
- 230000002538 fungal Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- 235000009754 grape Nutrition 0.000 description 2
- 235000012333 grape Nutrition 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000749 insecticidal Effects 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- HPQVWDOOUQVBTO-UHFFFAOYSA-N lithium aluminium hydride Substances [Li+].[Al-] HPQVWDOOUQVBTO-UHFFFAOYSA-N 0.000 description 2
- OCZDCIYGECBNKL-UHFFFAOYSA-N lithium;alumanuide Chemical compound [Li+].[AlH4-] OCZDCIYGECBNKL-UHFFFAOYSA-N 0.000 description 2
- 229910052987 metal hydride Inorganic materials 0.000 description 2
- 150000004681 metal hydrides Chemical class 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 description 2
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 2
- 230000000813 microbial Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 101700054071 myo1 Proteins 0.000 description 2
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 2
- 125000006252 n-propylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 2
- 239000005645 nematicide Substances 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 230000003287 optical Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 2
- 230000010627 oxidative phosphorylation Effects 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-M phosphinothricin(1-) Chemical compound CP([O-])(=O)CCC([NH3+])C([O-])=O IAJOBQBIJHVGMQ-UHFFFAOYSA-M 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000003032 phytopathogenic Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 2
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 230000001603 reducing Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 2
- 229910052703 rhodium Inorganic materials 0.000 description 2
- 239000010948 rhodium Substances 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- YOQDYZUWIQVZSF-UHFFFAOYSA-N sodium borohydride Substances [BH4-].[Na+] YOQDYZUWIQVZSF-UHFFFAOYSA-N 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- ODGROJYWQXFQOZ-UHFFFAOYSA-N sodium;boron(1-) Chemical compound [B-].[Na+] ODGROJYWQXFQOZ-UHFFFAOYSA-N 0.000 description 2
- 210000004215 spores Anatomy 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical compound OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N t-BuOH Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 231100000730 tolerability Toxicity 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- RLLPVAHGXHCWKJ-PKOBYXMFSA-N (-)-trans-permethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-PKOBYXMFSA-N 0.000 description 1
- CXBMCYHAMVGWJQ-CABCVRRESA-N (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-CABCVRRESA-N 0.000 description 1
- VAKIESMDOCVMDV-HNNXBMFYSA-N (13aS)-2,3-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-10,11-diol Chemical compound C1C2=CC(O)=C(O)C=C2C[C@@H]2N1CCC1=C2C=C(OC)C(OC)=C1 VAKIESMDOCVMDV-HNNXBMFYSA-N 0.000 description 1
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 description 1
- YATDSXRLIUJOQN-SVRRBLITSA-N (2,3,4,5,6-pentafluorophenyl)methyl (1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=C(F)C(F)=C1F YATDSXRLIUJOQN-SVRRBLITSA-N 0.000 description 1
- AGMMRUPNXPWLGF-AATRIKPKSA-N (2,3,5,6-tetrafluoro-4-methylphenyl)methyl 2,2-dimethyl-3-[(E)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound CC1(C)C(/C=C/C)C1C(=O)OCC1=C(F)C(F)=C(C)C(F)=C1F AGMMRUPNXPWLGF-AATRIKPKSA-N 0.000 description 1
- NJGIRBISCGPRPF-KXQOOQHDSA-N (2-aminoethoxy)[(2R)-2-(icosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphinic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP(O)(=O)OCCN)COC(=O)CCCCCCCCCCCCCC NJGIRBISCGPRPF-KXQOOQHDSA-N 0.000 description 1
- LZTIMERBDGGAJD-SNAWJCMRSA-N (2E)-2-(nitromethylidene)-1,3-thiazinane Chemical compound [O-][N+](=O)\C=C1/NCCCS1 LZTIMERBDGGAJD-SNAWJCMRSA-N 0.000 description 1
- FYQGBXGJFWXIPP-UHFFFAOYSA-N (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoic acid, ethyl ester Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- SBUKOHLFHYSZNG-UHFFFAOYSA-N (2S,6S)-4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3aR,7aS)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- YSEUOPNOQRVVDY-OGEJUEGTSA-N (5-benzylfuran-3-yl)methyl (1R,3R)-3-[(E)-3-methoxy-2-methyl-3-oxoprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 YSEUOPNOQRVVDY-OGEJUEGTSA-N 0.000 description 1
- VEMKTZHHVJILDY-PMACEKPBSA-N (5-benzylfuran-3-yl)methyl (1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-PMACEKPBSA-N 0.000 description 1
- MGRRXBWTLBJEMS-UHFFFAOYSA-N (5-benzylfuran-3-yl)methyl 3-(cyclopentylidenemethyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1OC(CC=2C=CC=CC=2)=CC=1COC(=O)C1C(C)(C)C1C=C1CCCC1 MGRRXBWTLBJEMS-UHFFFAOYSA-N 0.000 description 1
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 description 1
- QTGIYXFCSKXKMO-XPSMFNQNSA-N (5R)-5-[(Z)-dec-1-enyl]oxolan-2-one Chemical compound CCCCCCCC\C=C/[C@H]1CCC(=O)O1 QTGIYXFCSKXKMO-XPSMFNQNSA-N 0.000 description 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 1
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 description 1
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 description 1
- RURQAJURNPMSSK-UHFFFAOYSA-N (±)-Flufenprox Chemical compound C1=CC(OCC)=CC=C1C(C(F)(F)F)COCC1=CC=CC(OC=2C=CC(Cl)=CC=2)=C1 RURQAJURNPMSSK-UHFFFAOYSA-N 0.000 description 1
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 description 1
- RMOGWMIKYWRTKW-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pentan-3-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)CC1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UHFFFAOYSA-N 0.000 description 1
- BXCBUWKTXLWPSB-UHFFFAOYSA-N 1-(chloromethyl)-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1CCl BXCBUWKTXLWPSB-UHFFFAOYSA-N 0.000 description 1
- JPFWJDMDPLEUBD-ITJAGOAWSA-N 1-[(2R,3R,4S,5R)-5-[(S)-[[(2S,3S,4S)-2-amino-5-carbamoyloxy-3,4-dihydroxypentanoyl]amino]-carboxymethyl]-3,4-dihydroxyoxolan-2-yl]-2,4-dioxopyrimidine-5-carboxylic acid Polymers O[C@@H]1[C@H](O)[C@@H]([C@H](NC(=O)[C@H]([C@H](O)[C@@H](O)COC(N)=O)N)C(O)=O)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 JPFWJDMDPLEUBD-ITJAGOAWSA-N 0.000 description 1
- ZZVVDIVWGXTDRQ-UHFFFAOYSA-N 1-[(4-tert-butylphenyl)methylsulfanyl]-1-butylsulfanyl-N-pyridin-3-ylmethanimine Chemical compound C=1C=CN=CC=1N=C(SCCCC)SCC1=CC=C(C(C)(C)C)C=C1 ZZVVDIVWGXTDRQ-UHFFFAOYSA-N 0.000 description 1
- RGZQIQNUMDWEKL-CMDGGOBGSA-N 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[[(E)-(3-methoxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]amino]-4-(trifluoromethylsulfanyl)pyrazole-3-carbonitrile Chemical compound C1=CC(=O)C(OC)=C\C1=C\NC1=C(SC(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl RGZQIQNUMDWEKL-CMDGGOBGSA-N 0.000 description 1
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 1
- GDZNYEZGJAFIKA-UHFFFAOYSA-N 1-[5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-methylsulfinylpyrazol-3-yl]ethanone Chemical compound NC1=C(S(C)=O)C(C(=O)C)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl GDZNYEZGJAFIKA-UHFFFAOYSA-N 0.000 description 1
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 1
- CAFAOQIVXSSFSY-UHFFFAOYSA-N 1-ethoxyethanol Chemical compound CCOC(C)O CAFAOQIVXSSFSY-UHFFFAOYSA-N 0.000 description 1
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- KFKVECZQALNWSR-UHFFFAOYSA-N 1-methyl-3-(trifluoromethyl)pyrazole-4-carbonyl chloride Chemical compound CN1C=C(C(Cl)=O)C(C(F)(F)F)=N1 KFKVECZQALNWSR-UHFFFAOYSA-N 0.000 description 1
- BAWHYOHVWHQWFQ-UHFFFAOYSA-N 1-naphthalen-1-ylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC2=CC=CC=C12 BAWHYOHVWHQWFQ-UHFFFAOYSA-N 0.000 description 1
- WDOJRYABOABOBR-UHFFFAOYSA-N 1-nitro-2-(1-propan-2-ylsulfonylethyl)benzene Chemical compound CC(C)S(=O)(=O)C(C)C1=CC=CC=C1[N+]([O-])=O WDOJRYABOABOBR-UHFFFAOYSA-N 0.000 description 1
- ZHDBTKPXEJDTTQ-UHFFFAOYSA-N 1-oxido-2-[(1-oxidopyridin-1-ium-2-yl)disulfanyl]pyridin-1-ium Chemical compound [O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-] ZHDBTKPXEJDTTQ-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-Crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- MHKBMNACOMRIAW-UHFFFAOYSA-N 2,3-dinitrophenol Chemical class OC1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O MHKBMNACOMRIAW-UHFFFAOYSA-N 0.000 description 1
- QCONQRVTJOOYNC-UHFFFAOYSA-N 2,4-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]-1,3-thiazole-5-carboxamide Chemical class CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(C)N=C(C)S1 QCONQRVTJOOYNC-UHFFFAOYSA-N 0.000 description 1
- AQCRXZYYMOXFAN-UHFFFAOYSA-N 2-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CC=N1 AQCRXZYYMOXFAN-UHFFFAOYSA-N 0.000 description 1
- BCSLXNWRBPXCKJ-UHFFFAOYSA-N 2-(1-propan-2-ylsulfanylethyl)aniline Chemical compound CC(C)SC(C)C1=CC=CC=C1N BCSLXNWRBPXCKJ-UHFFFAOYSA-N 0.000 description 1
- CPTLEMAMACVSBQ-UHFFFAOYSA-N 2-(1-propan-2-ylsulfonylethyl)aniline Chemical compound CC(C)S(=O)(=O)C(C)C1=CC=CC=C1N CPTLEMAMACVSBQ-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N 2-(2-Ethoxyethoxy)ethanol Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-Methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- OILIYWFQRJOPAI-UHFFFAOYSA-N 2-(2-chlorophenyl)-1H-benzimidazole Chemical compound ClC1=CC=CC=C1C1=NC2=CC=CC=C2N1 OILIYWFQRJOPAI-UHFFFAOYSA-N 0.000 description 1
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 1
- UGMUCBHETNRWBO-UHFFFAOYSA-N 2-(propan-2-ylsulfanylmethyl)aniline Chemical compound CC(C)SCC1=CC=CC=C1N UGMUCBHETNRWBO-UHFFFAOYSA-N 0.000 description 1
- MXIUWSYTQJLIKE-UHFFFAOYSA-N 2-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=CC=C1C(Cl)=O MXIUWSYTQJLIKE-UHFFFAOYSA-N 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-Furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- ISRUGXGCCGIOQO-UHFFFAOYSA-N 2-Isopropoxyphenyl N-methylcarbamate Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 1
- IZFZCMFMJKDHJZ-ZZFYYJJNSA-N 2-N,3-diphenyl-4-N,5-N-bis(trifluoromethyl)-1,3-thiazolidine-2,4,5-triimine Chemical compound C=1C=CC=CC=1N1\C(=N/C(F)(F)F)\C(=N/C(F)(F)F)\SC1=NC1=CC=CC=C1 IZFZCMFMJKDHJZ-ZZFYYJJNSA-N 0.000 description 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N 2-Phenylphenol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 1
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 description 1
- QKJJCZYFXJCKRX-UHFFFAOYSA-N 2-[6-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-[(2-amino-3-hydroxypropanoyl)amino]-3,6-dihydro-2H-pyran-2-yl]-5-(diaminomethylideneamino)-2,4-dihydroxypentanoic acid Chemical compound O1C(C(O)(CC(O)CN=C(N)N)C(O)=O)C(NC(=O)C(CO)N)C=CC1N1C(=O)N=C(N)C(CO)=C1 QKJJCZYFXJCKRX-UHFFFAOYSA-N 0.000 description 1
- CACOMUHPQMDEJQ-UHFFFAOYSA-N 2-amino-4-methyl-N-phenyl-1,3-thiazole-5-carboxamide Chemical compound N1=C(N)SC(C(=O)NC=2C=CC=CC=2)=C1C CACOMUHPQMDEJQ-UHFFFAOYSA-N 0.000 description 1
- KDJVKWYVUGSJQR-UHFFFAOYSA-N 2-chloro-N-(1,1,3-trimethyl-2,3-dihydroinden-4-yl)pyridine-3-carboxamide Chemical compound C=12C(C)CC(C)(C)C2=CC=CC=1NC(=O)C1=CC=CN=C1Cl KDJVKWYVUGSJQR-UHFFFAOYSA-N 0.000 description 1
- LFSAPCRASZRSKS-UHFFFAOYSA-N 2-methylcyclohexan-1-one Chemical compound CC1CCCCC1=O LFSAPCRASZRSKS-UHFFFAOYSA-N 0.000 description 1
- JTWHVBNYYWFXSI-UHFFFAOYSA-N 2-nitro-1-phenylethanone Chemical compound [O-][N+](=O)CC(=O)C1=CC=CC=C1 JTWHVBNYYWFXSI-UHFFFAOYSA-N 0.000 description 1
- 229940061334 2-phenylphenol Drugs 0.000 description 1
- AZSNMRSAGSSBNP-XPNPUAGNSA-N 22,23-dihydroavermectin B1a Chemical compound C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 AZSNMRSAGSSBNP-XPNPUAGNSA-N 0.000 description 1
- ZVOWUYIDRJPVTD-UHFFFAOYSA-N 3,4,5-trichloropyridine-2,6-dicarbonitrile Chemical compound ClC1=C(Cl)C(C#N)=NC(C#N)=C1Cl ZVOWUYIDRJPVTD-UHFFFAOYSA-N 0.000 description 1
- CVQODEWAPZVVBU-UHFFFAOYSA-N 3,5-Dimethylphenyl methylcarbamate Chemical compound CNC(=O)OC1=CC(C)=CC(C)=C1 CVQODEWAPZVVBU-UHFFFAOYSA-N 0.000 description 1
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 description 1
- LUEAXGDCTBFPAZ-UHFFFAOYSA-N 3-(5-chloropyridin-3-yl)-8-(2,2,2-trifluoroethyl)-8-azabicyclo[3.2.1]octane-3-carbonitrile Chemical compound FC(F)(F)CN1C(C2)CCC1CC2(C#N)C1=CN=CC(Cl)=C1 LUEAXGDCTBFPAZ-UHFFFAOYSA-N 0.000 description 1
- IFQAEEJSFVAQQT-UHFFFAOYSA-N 3-(difluoromethyl)-1-methyl-N-[2-(propan-2-ylsulfanylmethyl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)SCC1=CC=CC=C1NC(=O)C1=CN(C)N=C1C(F)F IFQAEEJSFVAQQT-UHFFFAOYSA-N 0.000 description 1
- RUXHWBMJNBBYNL-UHFFFAOYSA-N 3-hydroxy-1,2-dihydropyrrol-5-one Chemical compound OC1=CC(=O)NC1 RUXHWBMJNBBYNL-UHFFFAOYSA-N 0.000 description 1
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 1
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 description 1
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 1
- JKSOKTDAASTKIR-UHFFFAOYSA-N 5-fluoro-1,3-dimethylpyrazole-4-carbonyl chloride Chemical compound CC1=NN(C)C(F)=C1C(Cl)=O JKSOKTDAASTKIR-UHFFFAOYSA-N 0.000 description 1
- VSVKOUBCDZYAQY-UHFFFAOYSA-N 7-chloro-1,2-benzothiazole Chemical compound ClC1=CC=CC2=C1SN=C2 VSVKOUBCDZYAQY-UHFFFAOYSA-N 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N 8-Hydroxyquinoline Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229950008167 Abamectin Drugs 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 239000005875 Acetamiprid Substances 0.000 description 1
- WCXDHFDTOYPNIE-RIYZIHGNSA-N Acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 1
- 229960004373 Acetylcholine Drugs 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGLZXHRNAYXIBU-WEVVVXLNSA-N Aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N Alizarin Natural products C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 229940045714 Alkyl sulfonate alkylating agents Drugs 0.000 description 1
- 241000223602 Alternaria alternata Species 0.000 description 1
- 241000213004 Alternaria solani Species 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K Aluminium chloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- PPNXXZIBFHTHDM-UHFFFAOYSA-N Aluminium phosphide Chemical compound P#[Al] PPNXXZIBFHTHDM-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N Amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 1
- QGAVSDVURUSLQK-UHFFFAOYSA-N Ammonium heptamolybdate Chemical compound N.N.N.N.N.N.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Mo].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo] QGAVSDVURUSLQK-UHFFFAOYSA-N 0.000 description 1
- IMHBYKMAHXWHRP-UHFFFAOYSA-N Anilazine Chemical compound ClC1=CC=CC=C1NC1=NC(Cl)=NC(Cl)=N1 IMHBYKMAHXWHRP-UHFFFAOYSA-N 0.000 description 1
- 241000239223 Arachnida Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 229940091771 Aspergillus fumigatus Drugs 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 229950000294 Azaconazole Drugs 0.000 description 1
- 239000005878 Azadirachtin Substances 0.000 description 1
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N Azadirachtin Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 1
- 239000005730 Azoxystrobin Substances 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N Azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- XEGGRYVFLWGFHI-UHFFFAOYSA-N Bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N Benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- 239000005884 Beta-Cyfluthrin Substances 0.000 description 1
- 239000005653 Bifenazate Substances 0.000 description 1
- 239000005874 Bifenthrin Substances 0.000 description 1
- 229950002373 Bioresmethrin Drugs 0.000 description 1
- 241000190150 Bipolaris sorokiniana Species 0.000 description 1
- 241001480061 Blumeria graminis Species 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 241000233684 Bremia Species 0.000 description 1
- 241000233685 Bremia lactucae Species 0.000 description 1
- KWGUFOITWDSNQY-UHFFFAOYSA-N Bromophos-ethyl Chemical group CCOP(=S)(OCC)OC1=CC(Cl)=C(Br)C=C1Cl KWGUFOITWDSNQY-UHFFFAOYSA-N 0.000 description 1
- FOANIXZHAMJWOI-UHFFFAOYSA-N Bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 1
- 239000005741 Bromuconazole Substances 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- SLZWBCGZQRRUNG-UHFFFAOYSA-N Butacarb Chemical compound CNC(=O)OC1=CC(C(C)(C)C)=CC(C(C)(C)C)=C1 SLZWBCGZQRRUNG-UHFFFAOYSA-N 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- DNSISZSEWVHGLH-UHFFFAOYSA-N Butyramide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N Capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 229940117949 Captan Drugs 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N Carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- HSQGRXTXMXMKPQ-UHFFFAOYSA-N Cc1c(C)[s]nn1 Chemical compound Cc1c(C)[s]nn1 HSQGRXTXMXMKPQ-UHFFFAOYSA-N 0.000 description 1
- 241001157813 Cercospora Species 0.000 description 1
- 241000906476 Cercospora canescens Species 0.000 description 1
- VYLVYHXQOHJDJL-UHFFFAOYSA-K Cerium(III) chloride Chemical compound Cl[Ce](Cl)Cl VYLVYHXQOHJDJL-UHFFFAOYSA-K 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- 241001515917 Chaetomium globosum Species 0.000 description 1
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N Chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- QGTYWWGEWOBMAK-UHFFFAOYSA-N Chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 description 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 description 1
- LFHISGNCFUNFFM-UHFFFAOYSA-N Chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 1
- SBPBAQFWLVIOKP-UHFFFAOYSA-N Chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 1
- 239000005887 Chromafenozide Substances 0.000 description 1
- 241000760356 Chytridiomycetes Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241000228437 Cochliobolus Species 0.000 description 1
- 240000007170 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 239000005752 Copper oxychloride Substances 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper(II) hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- SCKHCCSZFPSHGR-UHFFFAOYSA-N Cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 1
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N Cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- 239000005946 Cypermethrin Substances 0.000 description 1
- FJDPATXIBIBRIM-UHFFFAOYSA-N Cyphenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 FJDPATXIBIBRIM-UHFFFAOYSA-N 0.000 description 1
- 239000005757 Cyproconazole Substances 0.000 description 1
- KRZUZYJEQBXUIN-UHFFFAOYSA-N Cyprofuram Chemical compound ClC1=CC=CC(N(C2C(OCC2)=O)C(=O)C2CC2)=C1 KRZUZYJEQBXUIN-UHFFFAOYSA-N 0.000 description 1
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
- NMCCNOZOBBWFMN-UHFFFAOYSA-N Davicil Chemical compound CS(=O)(=O)C1=C(Cl)C(Cl)=NC(Cl)=C1Cl NMCCNOZOBBWFMN-UHFFFAOYSA-N 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N Deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N Di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- MUMQYXACQUZOFP-UHFFFAOYSA-N Dialifor Chemical compound C1=CC=C2C(=O)N(C(CCl)SP(=S)(OCC)OCC)C(=O)C2=C1 MUMQYXACQUZOFP-UHFFFAOYSA-N 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N Diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- WURGXGVFSMYFCG-UHFFFAOYSA-N Dichlofluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=CC=C1 WURGXGVFSMYFCG-UHFFFAOYSA-N 0.000 description 1
- OEBRKCOSUFCWJD-UHFFFAOYSA-N Dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
- VEENJGZXVHKXNB-VOTSOKGWSA-N Dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- QQQYTWIFVNKMRW-UHFFFAOYSA-N Diflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C=C1 QQQYTWIFVNKMRW-UHFFFAOYSA-N 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N Dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 239000005761 Dimethomorph Substances 0.000 description 1
- YKBZOVFACRVRJN-UHFFFAOYSA-N Dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N Diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- 239000005764 Dithianon Substances 0.000 description 1
- 239000005766 Dodine Substances 0.000 description 1
- 241001465183 Drechslera Species 0.000 description 1
- 239000005894 Emamectin Substances 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N Endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241001480036 Epidermophyton floccosum Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000588694 Erwinia amylovora Species 0.000 description 1
- 241000221785 Erysiphales Species 0.000 description 1
- 241000221787 Erysiphe Species 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- RIZMRRKBZQXFOY-UHFFFAOYSA-N Ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 1
- 239000005896 Etofenprox Substances 0.000 description 1
- YREQHYQNNWYQCJ-UHFFFAOYSA-N Etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 description 1
- 229950005085 Etofenprox Drugs 0.000 description 1
- 239000005775 Fenbuconazole Substances 0.000 description 1
- 229950006668 Fenfluthrin Drugs 0.000 description 1
- HMIBKHHNXANVHR-UHFFFAOYSA-N Fenothiocarb Chemical compound CN(C)C(=O)SCCCCOC1=CC=CC=C1 HMIBKHHNXANVHR-UHFFFAOYSA-N 0.000 description 1
- 239000005899 Fipronil Substances 0.000 description 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N Fipronil Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 1
- 239000005780 Fluazinam Substances 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N Fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- 229950006719 Fluazuron Drugs 0.000 description 1
- KVKHBPGBGOVMBN-PWLVHAGJSA-N Flubenzimine Chemical compound C=1C=CC=CC=1N/1C(=N/C(F)(F)F)/S\C(=N/C(F)(F)F)\C\1=N/C1=CC=CC=C1 KVKHBPGBGOVMBN-PWLVHAGJSA-N 0.000 description 1
- 239000005784 Fluoxastrobin Substances 0.000 description 1
- 239000005785 Fluquinconazole Substances 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N Flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- 239000005787 Flutriafol Substances 0.000 description 1
- INISTDXBRIBGOC-UHFFFAOYSA-N Fluvalinate Chemical compound C=1C=CC(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C(C(C)C)NC1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-UHFFFAOYSA-N 0.000 description 1
- 239000005791 Fuberidazole Substances 0.000 description 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N Fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 239000005903 Gamma-cyhalothrin Substances 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241000250507 Gigaspora candida Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000592921 Helminthosporium Species 0.000 description 1
- FRCCEHPWNOQAEU-UHFFFAOYSA-N Heptachlor Chemical compound ClC1=C(Cl)C2(Cl)C3C=CC(Cl)C3C1(Cl)C2(Cl)Cl FRCCEHPWNOQAEU-UHFFFAOYSA-N 0.000 description 1
- CKAPSXZOOQJIBF-UHFFFAOYSA-N Hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CKAPSXZOOQJIBF-UHFFFAOYSA-N 0.000 description 1
- STMIIPIFODONDC-UHFFFAOYSA-N Hexaconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 1
- 241000342321 Hyaloperonospora brassicae Species 0.000 description 1
- IQVNEKKDSLOHHK-FNCQTZNRSA-N Hydramethylnon Chemical compound N1CC(C)(C)CNC1=NN=C(/C=C/C=1C=CC(=CC=1)C(F)(F)F)\C=C\C1=CC=C(C(F)(F)F)C=C1 IQVNEKKDSLOHHK-FNCQTZNRSA-N 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N Imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Incidol Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 239000005907 Indoxacarb Substances 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N Iodopropynyl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- 239000005867 Iprodione Substances 0.000 description 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N Iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 1
- VYFOAVADNIHPTR-UHFFFAOYSA-N Isatoic Anhydride Chemical compound NC1=CC=CC=C1CO VYFOAVADNIHPTR-UHFFFAOYSA-N 0.000 description 1
- XRHGWAGWAHHFLF-UHFFFAOYSA-N Isazofos Chemical compound CCOP(=S)(OCC)OC=1N=C(Cl)N(C(C)C)N=1 XRHGWAGWAHHFLF-UHFFFAOYSA-N 0.000 description 1
- 229960002418 Ivermectin Drugs 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000204076 Kitasatospora setae Species 0.000 description 1
- 229920000126 Latex Polymers 0.000 description 1
- 229940067606 Lecithin Drugs 0.000 description 1
- 241000222418 Lentinus Species 0.000 description 1
- 241000222451 Lentinus tigrinus Species 0.000 description 1
- 241000228456 Leptosphaeria Species 0.000 description 1
- 239000005912 Lufenuron Substances 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N Lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 241001330975 Magnaporthe oryzae Species 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N Malathion Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- 239000005802 Mancozeb Substances 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L Maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 239000005805 Mepanipyrim Substances 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N Meta-Chloroperoxybenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- AFCCDDWKHLHPDF-UHFFFAOYSA-M Metam sodium Chemical compound [Na+].CNC([S-])=S AFCCDDWKHLHPDF-UHFFFAOYSA-M 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- 239000005951 Methiocarb Substances 0.000 description 1
- YFBPRJGDJKVWAH-UHFFFAOYSA-N Methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 1
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N Methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 description 1
- 239000005917 Methoxyfenozide Substances 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- 239000005809 Metiram Substances 0.000 description 1
- 241001229889 Metis Species 0.000 description 1
- KVIZNNVXXNFLMU-AATRIKPKSA-N Metofluthrin Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1\C=C\C KVIZNNVXXNFLMU-AATRIKPKSA-N 0.000 description 1
- VOEYXMAFNDNNED-UHFFFAOYSA-N Metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N Monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- STUSTWKEFDQFFZ-UHFFFAOYSA-N N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine Chemical compound CN(C)C=NC1=CC=C(Cl)C=C1C STUSTWKEFDQFFZ-UHFFFAOYSA-N 0.000 description 1
- BLCKKNLGFULNRC-UHFFFAOYSA-L N,N-dimethylcarbamodithioate;nickel(2+) Chemical compound [Ni+2].CN(C)C([S-])=S.CN(C)C([S-])=S BLCKKNLGFULNRC-UHFFFAOYSA-L 0.000 description 1
- ICTQUFQQEYSGGJ-UHFFFAOYSA-N N,N-dimethyltrithian-5-amine;oxalic acid Chemical compound OC(=O)C(O)=O.CN(C)C1CSSSC1 ICTQUFQQEYSGGJ-UHFFFAOYSA-N 0.000 description 1
- JPLCQHHISLYGRA-UHFFFAOYSA-N N-(6-methoxypyridin-3-yl)cyclopropanecarboxamide Chemical compound C1=NC(OC)=CC=C1NC(=O)C1CC1 JPLCQHHISLYGRA-UHFFFAOYSA-N 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N N-Butylamine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- FLZOYGGRUBRZKQ-UHFFFAOYSA-N N-[2-(4,4-dimethylpentan-2-yl)phenyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxamide Chemical class CC(C)(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C FLZOYGGRUBRZKQ-UHFFFAOYSA-N 0.000 description 1
- CKCYIDSINJJPNE-UHFFFAOYSA-N N-[2-(hydroxymethyl)phenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1CO CKCYIDSINJJPNE-UHFFFAOYSA-N 0.000 description 1
- YNKFZRGTXAPYFD-UHFFFAOYSA-N N-[[2-chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1Cl YNKFZRGTXAPYFD-UHFFFAOYSA-N 0.000 description 1
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 description 1
- HRYILSDLIGTCOP-UHFFFAOYSA-N N-benzoylurea Chemical compound NC(=O)NC(=O)C1=CC=CC=C1 HRYILSDLIGTCOP-UHFFFAOYSA-N 0.000 description 1
- PCXHIHUGCCPJRV-UHFFFAOYSA-N N-butyl-8-tert-butyl-1-oxaspiro[4.5]decan-3-amine Chemical compound C1C(NCCCC)COC21CCC(C(C)(C)C)CC2 PCXHIHUGCCPJRV-UHFFFAOYSA-N 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N Natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229960003255 Natamycin Drugs 0.000 description 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Nidantin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 1
- CFRPSFYHXJZSBI-DHZHZOJOSA-N Nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- DCUJJWWUNKIJPH-UHFFFAOYSA-N Nitrapyrin Chemical compound ClC1=CC=CC(C(Cl)(Cl)Cl)=N1 DCUJJWWUNKIJPH-UHFFFAOYSA-N 0.000 description 1
- 241001668536 Oculimacula yallundae Species 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229960000625 Oxytetracycline Drugs 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N Parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241001123663 Penicillium expansum Species 0.000 description 1
- 229960000490 Permethrin Drugs 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- 241000201565 Peronospora viciae f. sp. pisi Species 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N Phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N Phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- 229940067631 Phospholipids Drugs 0.000 description 1
- WNZQDUSMALZDQF-UHFFFAOYSA-N Phthalide Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N Phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 229960005235 Piperonyl Butoxide Drugs 0.000 description 1
- 241001503460 Plasmodiophorida Species 0.000 description 1
- 241000233626 Plasmopara Species 0.000 description 1
- 241001281803 Plasmopara viticola Species 0.000 description 1
- 241000896242 Podosphaera Species 0.000 description 1
- 241000317981 Podosphaera fuliginea Species 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L Potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- DTAPQAJKAFRNJB-UHFFFAOYSA-N Promecarb Chemical compound CNC(=O)OC1=CC(C)=CC(C(C)C)=C1 DTAPQAJKAFRNJB-UHFFFAOYSA-N 0.000 description 1
- 239000005821 Propamocarb Substances 0.000 description 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N Propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 1
- 239000004146 Propane-1,2-diol Substances 0.000 description 1
- ZYHMJXZULPZUED-UHFFFAOYSA-N Propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N Propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- 239000005823 Propineb Substances 0.000 description 1
- 229960004063 Propylene glycol Drugs 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 239000005825 Prothioconazole Substances 0.000 description 1
- 229960003351 Prussian blue Drugs 0.000 description 1
- 241000682843 Pseudocercosporella Species 0.000 description 1
- 229940055023 Pseudomonas aeruginosa Drugs 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000521936 Pseudomonas amygdali pv. lachrymans Species 0.000 description 1
- 241001281802 Pseudoperonospora Species 0.000 description 1
- 241001281805 Pseudoperonospora cubensis Species 0.000 description 1
- 241000342307 Pseudoperonospora humuli Species 0.000 description 1
- 241000221300 Puccinia Species 0.000 description 1
- 239000005869 Pyraclostrobin Substances 0.000 description 1
- JOOMJVFZQRQWKR-UHFFFAOYSA-N Pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 description 1
- 241000520648 Pyrenophora teres Species 0.000 description 1
- 241000231139 Pyricularia Species 0.000 description 1
- 239000005663 Pyridaben Substances 0.000 description 1
- 239000005926 Pyridalyl Substances 0.000 description 1
- 239000005927 Pyriproxyfen Substances 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N Pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- 241000918584 Pythium ultimum Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241001633102 Rhizobiaceae Species 0.000 description 1
- 241001361634 Rhizoctonia Species 0.000 description 1
- 241000813090 Rhizoctonia solani Species 0.000 description 1
- 229940080817 Rotenone Drugs 0.000 description 1
- YGBMMMOLNODPBP-GWGZPXPZSA-N S-ethyl (2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienethioate Chemical compound CCSC(=O)\C=C(/C)\C=C\CC(C)CCCC(C)(C)OC YGBMMMOLNODPBP-GWGZPXPZSA-N 0.000 description 1
- OUNSASXJZHBGAI-UHFFFAOYSA-N Salithion Chemical compound C1=CC=C2OP(OC)(=S)OCC2=C1 OUNSASXJZHBGAI-UHFFFAOYSA-N 0.000 description 1
- 241000221662 Sclerotinia Species 0.000 description 1
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 1
- 241001533598 Septoria Species 0.000 description 1
- UTUZBCDXWYMYGA-UHFFFAOYSA-N Silafluorene Chemical compound C12=CC=CC=C2CC2=C1C=CC=[Si]2 UTUZBCDXWYMYGA-UHFFFAOYSA-N 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 102000018674 Sodium Channels Human genes 0.000 description 1
- 108010052164 Sodium Channels Proteins 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N Sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- KIEOKOFEPABQKJ-UHFFFAOYSA-N Sodium dichromate Chemical compound [Na+].[Na+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KIEOKOFEPABQKJ-UHFFFAOYSA-N 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M Sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- REHXRBDMVPYGJX-UHFFFAOYSA-H Sodium hexafluoroaluminate Chemical compound [Na+].[Na+].[Na+].F[Al-3](F)(F)(F)(F)F REHXRBDMVPYGJX-UHFFFAOYSA-H 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000579741 Sphaerotheca <fungi> Species 0.000 description 1
- 239000005930 Spinosad Substances 0.000 description 1
- 239000005664 Spirodiclofen Substances 0.000 description 1
- 239000005665 Spiromesifen Substances 0.000 description 1
- 239000005837 Spiroxamine Substances 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229940076185 Staphylococcus aureus Drugs 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000204060 Streptomycetaceae Species 0.000 description 1
- 229960005322 Streptomycin Drugs 0.000 description 1
- AKEJUJNQAAGONA-UHFFFAOYSA-N Sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 1
- 241000907561 Sydowia polyspora Species 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N Tebuconazole Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N Tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N Tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N Tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- WWJZWCUNLNYYAU-UHFFFAOYSA-N Temefos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 1
- 239000005840 Tetraconazole Substances 0.000 description 1
- QUWSDLYBOVGOCW-UHFFFAOYSA-N Tetrasul Chemical compound C1=CC(Cl)=CC=C1SC1=CC(Cl)=C(Cl)C=C1Cl QUWSDLYBOVGOCW-UHFFFAOYSA-N 0.000 description 1
- 229960004546 Thiabendazole Drugs 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N Thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N Thiomorpholine Chemical group C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 239000005842 Thiophanate-methyl Substances 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N Thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N Tiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 241000722133 Tilletia Species 0.000 description 1
- 241000722093 Tilletia caries Species 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J Titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N Tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N Triadimefon Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- AMFGTOFWMRQMEM-UHFFFAOYSA-N Triazofos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 1
- 239000005847 Triazoxide Substances 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-O Tricyclazole Chemical compound CC1=CC=CC2=C1N1C=N[NH+]=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-O 0.000 description 1
- YTOPFCCWCSOHFV-UHFFFAOYSA-N Tridemorph Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N Triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 239000005859 Triticonazole Substances 0.000 description 1
- 241000221576 Uromyces Species 0.000 description 1
- 241000221577 Uromyces appendiculatus Species 0.000 description 1
- 241000221566 Ustilago Species 0.000 description 1
- 241000514371 Ustilago avenae Species 0.000 description 1
- 241000007070 Ustilago nuda Species 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N Validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- 241000317942 Venturia <ichneumonid wasp> Species 0.000 description 1
- 241000082085 Verticillium <Phyllachorales> Species 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N Vinclozolin Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- JFLRKDZMHNBDQS-GQHNJWLYSA-N XPA88EAP6V Chemical compound C([C@@H](OC(=O)C[C@H]1[C@@H]2C=C[C@@H]3C[C@H](C[C@H]3[C@@H]2C=C1C(=O)[C@@H]1C)O[C@H]2[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O2)OC)CC)CCC1O[C@H]1CC[C@H](N(C)C)[C@@H](C)O1.C([C@@H](OC(=O)C[C@H]1[C@@H]2C=C(C)[C@@H]3C[C@H](C[C@H]3[C@@H]2C=C1C(=O)[C@@H]1C)O[C@H]2[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O2)OC)CC)CCC1O[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 JFLRKDZMHNBDQS-GQHNJWLYSA-N 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 241001272684 Xanthomonas campestris pv. oryzae Species 0.000 description 1
- BUHNCQOJJZAOMJ-UHFFFAOYSA-N ZXI 8901 Chemical compound C=1C=C(OC(F)F)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=C(Br)C=C1 BUHNCQOJJZAOMJ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- FZSVSABTBYGOQH-XFFZJAGNSA-N [(E)-(3,3-dimethyl-1-methylsulfanylbutan-2-ylidene)amino] N-methylcarbamate Chemical compound CNC(=O)O\N=C(C(C)(C)C)\CSC FZSVSABTBYGOQH-XFFZJAGNSA-N 0.000 description 1
- CFGPESLNPCIKIX-UHFFFAOYSA-N [2-[ethoxy(propylsulfanyl)phosphoryl]oxyphenyl] N-methylcarbamate Chemical compound CCCSP(=O)(OCC)OC1=CC=CC=C1OC(=O)NC CFGPESLNPCIKIX-UHFFFAOYSA-N 0.000 description 1
- VROYMKJUVCKXBU-HDTXIYAQSA-N [6-[[(2E,8E)-11,17-dihydroxy-2,10,12,20-tetramethyl-13-[4-(3-methyl-3-propanoyloxiran-2-yl)pentan-2-yl]-15-oxo-14,21-dioxabicyclo[15.3.1]henicosa-2,8,19-trien-7-yl]oxy]-3-hydroxy-2-methyloxan-4-yl] carbamate Chemical compound CCC(=O)C1(C)OC1C(C)CC(C)C1C(C)C(O)C(C)/C=C/C(OC2OC(C)C(O)C(OC(N)=O)C2)CCC/C=C(C)/C(O2)C(C)=CCC2(O)CC(=O)O1 VROYMKJUVCKXBU-HDTXIYAQSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-BWHPXCRDSA-N [cyano-(3-phenoxyphenyl)methyl] (1S,3S)-3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-BWHPXCRDSA-N 0.000 description 1
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(Z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000000996 additive Effects 0.000 description 1
- 239000000362 adenosine triphosphatase inhibitor Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005431 alkyl carboxamide group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000005466 alkylenyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- IMIDOCRTMDIQIJ-UHFFFAOYSA-N aminocarb Chemical compound CNC(=O)OC1=CC=C(N(C)C)C(C)=C1 IMIDOCRTMDIQIJ-UHFFFAOYSA-N 0.000 description 1
- 229960002587 amitraz Drugs 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003042 antagnostic Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 1
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- FYZBOYWSHKHDMT-UHFFFAOYSA-N benfuracarb Chemical compound CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 FYZBOYWSHKHDMT-UHFFFAOYSA-N 0.000 description 1
- LJOZMWRYMKECFF-UHFFFAOYSA-N benodanil Chemical compound IC1=CC=CC=C1C(=O)NC1=CC=CC=C1 LJOZMWRYMKECFF-UHFFFAOYSA-N 0.000 description 1
- YFXPPSKYMBTNAV-UHFFFAOYSA-N bensultap Chemical compound C=1C=CC=CC=1S(=O)(=O)SCC(N(C)C)CSS(=O)(=O)C1=CC=CC=C1 YFXPPSKYMBTNAV-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 230000037348 biosynthesis Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- AZWXAPCAJCYGIA-UHFFFAOYSA-N bis(2-methylpropyl)alumane Chemical compound CC(C)C[AlH]CC(C)C AZWXAPCAJCYGIA-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 229910000090 borane Inorganic materials 0.000 description 1
- CROBTXVXNQNKKO-UHFFFAOYSA-N borohydride Chemical compound [BH4-] CROBTXVXNQNKKO-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N boron Chemical class [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- NNTOJPXOCKCMKR-UHFFFAOYSA-N boron;pyridine Chemical compound [B].C1=CC=NC=C1 NNTOJPXOCKCMKR-UHFFFAOYSA-N 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- QSLZFPQJJGGNFN-UHFFFAOYSA-N calcium;sulfane Chemical compound S.[Ca+2] QSLZFPQJJGGNFN-UHFFFAOYSA-N 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229930003833 capsaicin Natural products 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003467 chloride channel stimulating agent Substances 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229940120693 copper naphthenate Drugs 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- JOXAXMBQVHFGQT-UHFFFAOYSA-J copper;manganese(2+);N-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[Cu+2].[S-]C(=S)NCCNC([S-])=S.[S-]C(=S)NCCNC([S-])=S JOXAXMBQVHFGQT-UHFFFAOYSA-J 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 229910001610 cryolite Inorganic materials 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- QQODLKZGRKWIFG-UHFFFAOYSA-N cyfluthrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-UHFFFAOYSA-N 0.000 description 1
- WCMMILVIRZAPLE-UHFFFAOYSA-M cyhexatin Chemical compound C1CCCCC1[Sn](C1CCCCC1)(O)C1CCCCC1 WCMMILVIRZAPLE-UHFFFAOYSA-M 0.000 description 1
- 229960005424 cypermethrin Drugs 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- 230000000593 degrading Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000000249 desinfective Effects 0.000 description 1
- 150000008037 diacylhydrazines Chemical class 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- CJHXCRMKMMBYJQ-UHFFFAOYSA-N dimethirimol Chemical compound CCCCC1=C(C)NC(N(C)C)=NC1=O CJHXCRMKMMBYJQ-UHFFFAOYSA-N 0.000 description 1
- KARVSHNNUWMXFO-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate Chemical compound O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Al]O[Al]=O KARVSHNNUWMXFO-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229960002345 dipyrithione Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- HZBLLTXMVMMHRJ-UHFFFAOYSA-L disodium;sulfidosulfanylmethanedithioate Chemical compound [Na+].[Na+].[S-]SC([S-])=S HZBLLTXMVMMHRJ-UHFFFAOYSA-L 0.000 description 1
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- AIGRXSNSLVJMEA-UHFFFAOYSA-N ethoxy-(4-nitrophenoxy)-phenyl-sulfanylidene-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 AIGRXSNSLVJMEA-UHFFFAOYSA-N 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- OWZFULPEVHKEKS-UHFFFAOYSA-N ethyl 2-chloro-2-oxoacetate Chemical compound CCOC(=O)C(Cl)=O OWZFULPEVHKEKS-UHFFFAOYSA-N 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-M ethyl carbonate Chemical compound CCOC([O-])=O CQDGTJPVBWZJAZ-UHFFFAOYSA-M 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N ethylene glycol monomethyl ether Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- HOXINJBQVZWYGZ-UHFFFAOYSA-N fenbutatin oxide Chemical compound C=1C=CC=CC=1C(C)(C)C[Sn](O[Sn](CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C1=CC=CC=C1 HOXINJBQVZWYGZ-UHFFFAOYSA-N 0.000 description 1
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 description 1
- WHDGWKAJBYRJJL-UHFFFAOYSA-K ferbam Chemical compound [Fe+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S WHDGWKAJBYRJJL-UHFFFAOYSA-K 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940013764 fipronil Drugs 0.000 description 1
- MXWAGQASUDSFBG-RVDMUPIBSA-N fluacrypyrim Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(OC(C)C)=N1 MXWAGQASUDSFBG-RVDMUPIBSA-N 0.000 description 1
- YOWNVPAUWYHLQX-UHFFFAOYSA-N fluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C(OC=2C(=CC(=CN=2)C(F)(F)F)Cl)=C1 YOWNVPAUWYHLQX-UHFFFAOYSA-N 0.000 description 1
- GJEREQYJIQASAW-UHFFFAOYSA-N flufenerim Chemical compound CC(F)C1=NC=NC(NCCC=2C=CC(OC(F)(F)F)=CC=2)=C1Cl GJEREQYJIQASAW-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- HAWJXYBZNNRMNO-UHFFFAOYSA-N furathiocarb Chemical compound CCCCOC(=O)N(C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 HAWJXYBZNNRMNO-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 235000003869 genetically modified organisms (GMOs) Nutrition 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- CNKHSLKYRMDDNQ-UHFFFAOYSA-N halofenozide Chemical compound C=1C=CC=CC=1C(=O)N(C(C)(C)C)NC(=O)C1=CC=C(Cl)C=C1 CNKHSLKYRMDDNQ-UHFFFAOYSA-N 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- GBAWQJNHVWMTLU-UHFFFAOYSA-N heptenophos Chemical compound C1=CCC2C(OP(=O)(OC)OC)=C(Cl)C21 GBAWQJNHVWMTLU-UHFFFAOYSA-N 0.000 description 1
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000000887 hydrating Effects 0.000 description 1
- KLGZELKXQMTEMM-UHFFFAOYSA-N hydride Chemical compound [H-] KLGZELKXQMTEMM-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229930000073 hydroprenes Natural products 0.000 description 1
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 1
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 1
- 229910000460 iron oxide Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- CAVJXSIWUWTTQE-UHFFFAOYSA-N iron(2+);oxygen(2-);titanium(2+) Chemical compound [O-2].[O-2].[Ti+2].[Fe+2] CAVJXSIWUWTTQE-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000003902 lesions Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 229960002809 lindane Drugs 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229960000521 lufenuron Drugs 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical class [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 description 1
- 230000001404 mediated Effects 0.000 description 1
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
- KZAUOCCYDRDERY-UITAMQMPSA-N methyl (1Z)-2-(dimethylamino)-N-(methylcarbamoyloxy)-2-oxoethanimidothioate Chemical compound CNC(=O)O\N=C(/SC)C(=O)N(C)C KZAUOCCYDRDERY-UITAMQMPSA-N 0.000 description 1
- LDWLDRDKNBEKMZ-UHFFFAOYSA-N methyl 3-(2,2-dimethyl-1,3-dihydroinden-1-yl)imidazole-4-carboxylate Chemical compound COC(=O)C1=CN=CN1C1C(C)(C)CC2=CC=CC=C21 LDWLDRDKNBEKMZ-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920000257 metiram Polymers 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000000051 modifying Effects 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N molybdenum Chemical class [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Chemical class 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 229940113083 morpholine Drugs 0.000 description 1
- 150000002780 morpholines Chemical group 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 150000005063 oxadiazines Chemical class 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative Effects 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- UJJLJRQIPMGXEZ-UHFFFAOYSA-M oxolane-2-carboxylate Chemical compound [O-]C(=O)C1CCCO1 UJJLJRQIPMGXEZ-UHFFFAOYSA-M 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960003536 phenothrin Drugs 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- NAYYNDKKHOIIOD-UHFFFAOYSA-N phthalamide Chemical compound NC(=O)C1=CC=CC=C1C(N)=O NAYYNDKKHOIIOD-UHFFFAOYSA-N 0.000 description 1
- 239000001007 phthalocyanine dye Substances 0.000 description 1
- 229930014565 phytoalexin Natural products 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940096992 potassium oleate Drugs 0.000 description 1
- MLICVSDCCDDWMD-KVVVOXFISA-M potassium;(Z)-octadec-9-enoate Chemical compound [K+].CCCCCCCC\C=C/CCCCCCCC([O-])=O MLICVSDCCDDWMD-KVVVOXFISA-M 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 description 1
- 230000001902 propagating Effects 0.000 description 1
- LMCBEWMQFKWHGU-UHFFFAOYSA-N propan-2-ol;titanium Chemical compound [Ti].CC(C)O LMCBEWMQFKWHGU-UHFFFAOYSA-N 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- PWYIUEFFPNVCMW-UHFFFAOYSA-N propaphos Chemical compound CCCOP(=O)(OCCC)OC1=CC=C(SC)C=C1 PWYIUEFFPNVCMW-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- 210000001938 protoplasts Anatomy 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 1
- AEHJMNVBLRLZKK-UHFFFAOYSA-N pyridalyl Chemical group N1=CC(C(F)(F)F)=CC=C1OCCCOC1=C(Cl)C=C(OCC=C(Cl)Cl)C=C1Cl AEHJMNVBLRLZKK-UHFFFAOYSA-N 0.000 description 1
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- 229910052904 quartz Inorganic materials 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 230000001850 reproductive Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000003195 sodium channel blocking agent Substances 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229940014213 spinosad Drugs 0.000 description 1
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical compound CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
- JXHJNEJVUNHLKO-UHFFFAOYSA-N sulprofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1 JXHJNEJVUNHLKO-UHFFFAOYSA-N 0.000 description 1
- 230000000153 supplemental Effects 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000005936 tau-Fluvalinate Substances 0.000 description 1
- XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 description 1
- 229960005199 tetramethrin Drugs 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- 150000003609 titanium compounds Chemical class 0.000 description 1
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 description 1
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-M valerate Chemical compound CCCCC([O-])=O NQPDZGIKBAWPEJ-UHFFFAOYSA-M 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N vinyl chloride Chemical group ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- CHNQZRKUZPNOOH-UHFFFAOYSA-J zinc;manganese(2+);N-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[Zn+2].[S-]C(=S)NCCNC([S-])=S.[S-]C(=S)NCCNC([S-])=S CHNQZRKUZPNOOH-UHFFFAOYSA-J 0.000 description 1
- FJBGIXKIXPUXBY-UHFFFAOYSA-N {2-[3-(4-chlorophenyl)propyl]-2,4,4-trimethyl-1,3-oxazolidin-3-yl}(imidazol-1-yl)methanone Chemical compound C1=CN=CN1C(=O)N1C(C)(C)COC1(C)CCCC1=CC=C(Cl)C=C1 FJBGIXKIXPUXBY-UHFFFAOYSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-GCMPRSNUSA-N γ-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 1
- OMFRMAHOUUJSGP-IRHGGOMRSA-N κ-bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 1
- INISTDXBRIBGOC-XMMISQBUSA-N τ-fluvalinate Chemical compound N([C@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-XMMISQBUSA-N 0.000 description 1
Abstract
화학식 (I)의 신규 카복사미드, 다수의 그의 제조방법, 원치않는 미생물을 구제하기 위한 그의 용도, 신규 중간체 및 그의 제조방법이 개시된다:Novel carboxamides of formula (I), a number of methods for their preparation, their use for controlling unwanted microorganisms, new intermediates and methods for their preparation are disclosed:
상기 식에서,Where
R1, M, L1, Q, L2, R 및 A는 명세서에 정의된 바와 같다.R 1 , M, L 1 , Q, L 2 , R and A are as defined in the specification.
Description
본 발명은 신규한 카복사미드, 다수의 그의 합성방법 및 원치않는 미생물을 구제하기 위한 그의 용도에 관한 것이다.The present invention relates to novel carboxamides, many methods for their synthesis and their use for controlling unwanted microorganisms.
다수의 카복사미드가 살질균 성질을 갖고 있다고 이미 공지된 바 있다(참조예: WO 03/010149, WO 02/059086, EP-A 0 824 099, EP-A 0 737 682, EP-A 0 591 699, EP-A 0 589 301, EP-A 0 545 099, DE-A 24 09 011, DE-A 20 06 472, JP-A 2001-302605, JP-A 10-251240, JP-A 8-176112, JP-A 8-92223 및 JP-A 53-72823). 즉, 알킬 부분이 비치환된 다수의 알킬 카복사미드, 예를 들어 N-알릴-N-[2-(1,3-디메틸부틸)페닐]-1-메틸-3-(트리플루오로메틸)-1H-피라졸-4-카복사미드가 WO 02/059086으로부터 공지되었고, N-[2-(1,3-디메틸부틸)페닐]-2,4-디메틸-1,3-티아졸-5-카복사미드가 EP-A 0 824 099로부터 공지되었으며, 5-플루오로-1,3-디메틸-N-[2-(1,3,3-트리메틸부틸)페닐]-1H-피라졸-4-카복사미드가 WO 03/010149로부터 공지되었다. 이들 화합물의 효과는 우수하나; 많은 경우, 예컨대 저 적용비율에서 만 족스럽지 않은 경우가 있다.Many carboxamides have already been known to have bactericidal properties (see for example WO 03/010149, WO 02/059086, EP-A 0 824 099, EP-A 0 737 682, EP-A 0 591). 699, EP-A 0 589 301, EP-A 0 545 099, DE-A 24 09 011, DE-A 20 06 472, JP-A 2001-302605, JP-A 10-251240, JP-A 8-176112 , JP-A 8-92223 and JP-A 53-72823. That is, many alkyl carboxamides with unsubstituted alkyl moieties such as N-allyl-N- [2- (1,3-dimethylbutyl) phenyl] -1-methyl-3- (trifluoromethyl) -1H-pyrazole-4-carboxamide is known from WO 02/059086, and N- [2- (1,3-dimethylbutyl) phenyl] -2,4-dimethyl-1,3-thiazole-5 Carboxamides are known from EP-A 0 824 099, 5-Fluoro-1,3-dimethyl-N- [2- (1,3,3-trimethylbutyl) phenyl] -1 H-pyrazole-4 Carboxamides are known from WO 03/010149. The effect of these compounds is excellent; In many cases, for example, it is not satisfactory at low application rates.
본 발명은 하기 화학식 (I)의 신규 카복사미드를 제공한다:The present invention provides novel carboxamides of formula (I):
상기 식에서,Where
R1은 수소, C1-C8-알킬, C1-C6-알킬설피닐, C1-C6-알킬설포닐, C1-C4-알콕시-C1-C4-알킬, C3-C8-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C6-할로알킬, C1-C4-할로알킬티오, C1-C4-할로알킬설피닐, C1-C4-할로알킬설포닐, 할로-C1-C4-알콕시-C1-C4-알킬, C3-C8-할로사이클로알킬; 포르밀, 포르밀-C1-C3-알킬, (C1-C3-알킬)카보닐-C1-C3-알킬, (C1-C3-알콕시)카보닐-C1-C3-알킬; 각 경우에 1 내지 13개의 불소, 염소 및/또는 브롬 원자를 가지는 할로-(C1-C3-알킬)카보닐-C1-C3-알킬, 할로-(C1-C3-알콕시)카보닐-C1-C3-알킬; (C1-C8-알킬)카보닐, (C1-C8-알콕시)카보닐, (C1-C4-알콕시-C1-C4-알킬)카보닐, (C3-C8-사이클로알킬)카보닐; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 (C1-C6-할로알킬)카보닐, (C1-C6-할로알콕시)카보닐, (할로-C1-C4-알콕시-C1-C4-알킬)카보닐, (C3-C8-할로사이클로알킬)카보닐; 또는 -C(=O)C(=O)R2, -CONR3R4 또는 -CH2NR5R6을 나타내고,R 1 is hydrogen, C 1 -C 8 -alkyl, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl; Having 1 to 9 fluorine, chlorine and / or bromine atoms in each case C 1 -C 6 - haloalkyl, C 1 -C 4 - haloalkylthio, C 1 -C 4 - haloalkyl sulfinyl, C 1 - C 4 -haloalkylsulfonyl, halo-C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 8 -halocycloalkyl; Formyl, formyl-C 1 -C 3 -alkyl, (C 1 -C 3 -alkyl) carbonyl-C 1 -C 3 -alkyl, (C 1 -C 3 -alkoxy) carbonyl-C 1 -C 3 -alkyl; Halo- (C 1 -C 3 -alkyl) carbonyl-C 1 -C 3 -alkyl, halo- (C 1 -C 3 -alkoxy) having 1 to 13 fluorine, chlorine and / or bromine atoms in each case Carbonyl-C 1 -C 3 -alkyl; (C 1 -C 8 -alkyl) carbonyl, (C 1 -C 8 -alkoxy) carbonyl, (C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl) carbonyl, (C 3 -C 8 -Cycloalkyl) carbonyl; (C 1 -C 6 -haloalkyl) carbonyl, (C 1 -C 6 -haloalkoxy) carbonyl, (halo-C 1 -C) having 1 to 9 fluorine, chlorine and / or bromine atoms in each case 4 -alkoxy-C 1 -C 4 -alkyl) carbonyl, (C 3 -C 8 -halocycloalkyl) carbonyl; Or -C (= 0) C (= 0) R 2 , -CONR 3 R 4 or -CH 2 NR 5 R 6 ,
R2는 수소, C1-C8-알킬, C1-C8-알콕시, C1-C4-알콕시-C1-C4-알킬, C3-C8-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C6-할로알킬, C1-C6-할로알콕시, 할로-C1-C4-알콕시-C1-C4-알킬 또는 C3-C8-할로사이클로알킬을 나타내며,R 2 is hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl; C 1 -C 6 -haloalkyl, C 1 -C 6 -haloalkoxy, halo-C 1 -C 4 -alkoxy-C 1 -C 4 with 1 to 9 fluorine, chlorine and / or bromine atoms in each case -Alkyl or C 3 -C 8 -halocycloalkyl,
R3 및 R4는 서로 독립적으로 각 경우에 수소, C1-C8-알킬, C1-C4-알콕시-C1-C4-알킬, C3-C8-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C8-할로알킬, 할로-C1-C4-알콕시-C1-C4-알킬 또는 C3-C8-할로사이클로알킬을 나타내거나,R 3 and R 4 independently of one another in each occurrence are hydrogen, C 1 -C 8 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl; C 1 -C 8 -haloalkyl, halo-C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl or C 3 -C 8 -having 1 to 9 fluorine, chlorine and / or bromine atoms in each case Halocycloalkyl, or
R3 및 R4는 또한 이들이 결합된 질소 원자와 함께, 산소, 황 및 NR7로 구성된 그룹중에서 선택되는 1 또는 2개의 추가의 비인접 헤테로원자를 가질 수 있고 할로겐 및 C1-C4-알킬로 구성된 그룹중에서 선택된 동일하거나 상이한 치환체에 의해 일- 또는 다치환된 포화된 5 내지 8 환 원자의 헤테로사이클을 나타내고,R 3 and R 4 may also, together with the nitrogen atom to which they are attached, have one or two additional nonadjacent heteroatoms selected from the group consisting of oxygen, sulfur and NR 7 and halogen and C 1 -C 4 -alkyl A heterocycle of saturated 5 to 8 ring atoms mono- or polysubstituted by the same or different substituents selected from the group consisting of
R5 및 R6은 서로 독립적으로 수소, C1-C8-알킬, C3-C8-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C8-할로알킬 또는 C3-C8-할로사이클로알킬을 나타내거나,R 5 and R 6 independently of one another are hydrogen, C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl; In each case represent C 1 -C 8 -haloalkyl or C 3 -C 8 -halocycloalkyl having 1 to 9 fluorine, chlorine and / or bromine atoms,
R5 및 R6은 또한 이들이 결합된 질소 원자와 함께, 산소, 황 및 NR7로 구성된 그룹중에서 선택되는 1 또는 2개의 추가의 비인접 헤테로원자를 가질 수 있고 할로겐 및 C1-C4-알킬로 구성된 그룹중에서 선택된 동일하거나 상이한 치환체에 의해 일- 또는 다치환된 포화된 5 내지 8 환 원자의 헤테로사이클을 나타내며,R 5 and R 6 may also, together with the nitrogen atom to which they are attached, have one or two additional nonadjacent heteroatoms selected from the group consisting of oxygen, sulfur and NR 7 and include halogen and C 1 -C 4 -alkyl A heterocycle of saturated 5 to 8 ring atoms mono- or polysubstituted by the same or different substituents selected from the group consisting of
R7은 수소 또는 C1-C6-알킬을 나타내고,R 7 represents hydrogen or C 1 -C 6 -alkyl,
M은 각 경우에 R8에 의해 일치환된 페닐, 피리딘, 피리미딘, 피리다진 또는 피라진 환을 나타내거나, R8-A에 의해 치환된 티아졸 환을 나타내며,M is represented by a substituted phenyl, pyridine, pyrimidine, pyridazine or pyrazine ring by R 8 in each case, or represents a thiazole ring substituted by R 8-A,
R8은 수소, 불소, 염소, 메틸, 이소프로필, 메틸티오 또는 트리플루오로메틸을 나타내거나,R 8 represents hydrogen, fluorine, chlorine, methyl, isopropyl, methylthio or trifluoromethyl, or
R8은 메톡시를 나타내고,R 8 represents methoxy,
R8-A는 수소, 메틸, 메틸티오 또는 트리플루오로메틸을 나타내며,R 8-A represents hydrogen, methyl, methylthio or trifluoromethyl,
L1은 C1-C10-알킬렌(알칸디일)을 나타내고,L 1 represents C 1 -C 10 -alkylene (alkanediyl),
Q는 O, S, SO, SO2 또는 NR9를 나타내며,Q represents O, S, SO, SO 2 or NR 9 ,
L2는 직접 결합, SiR10R11 또는 CO를 나타내고,L 2 represents a direct bond, SiR 10 R 11 or CO,
R은 수소, C1-C8-알킬, C1-C8-알콕시, C1-C4-알콕시-C1-C4-알킬, C1-C4-알킬티 오-C1-C4-알킬, C2-C8-알케닐, C2-C8-알키닐, C1-C6-할로알킬, C2-C6-할로알케닐, C2-C6-할로알키닐 또는 C3-C6-사이클로알킬을 나타내며,R is hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -haloalkynyl Or C 3 -C 6 -cycloalkyl,
R9는 수소, C1-C8-알킬, C1-C4-알콕시-C1-C4-알킬, C1-C4-알킬티오-C1-C4-알킬, C2-C8-알케닐, C2-C8-알키닐, C1-C6-할로알킬, C2-C6-할로알케닐, C2-C6-할로알키닐 또는 C3-C6-사이클로알킬을 나타내고,R 9 is hydrogen, C 1 -C 8 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -haloalkynyl or C 3 -C 6 -cyclo Alkyl,
R10 및 R11은 서로 독립적으로 수소, C1-C8-알킬, C1-C8-알콕시, C1-C4-알콕시-C1-C4-알킬, C1-C4-알킬티오-C1-C4-알킬 또는 C1-C6-할로알킬을 나타내며,R 10 and R 11 independently of one another are hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkyl Thio-C 1 -C 4 -alkyl or C 1 -C 6 -haloalkyl,
A는 식 (A1)의 그룹을 나타내고:A represents a group of formula (A1):
여기에서,From here,
R12는 수소, 시아노, 할로겐, 니트로, C1-C4-알킬, C1-C4-알콕시, C1-C4-알킬티오, C3-C6-사이클로알킬, 각 경우에 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬, C1-C4-할로알콕시 또는 C1-C4-할로알킬티오, 아미노카보닐 또는 아미노카보닐-C1-C4-알킬을 나타내며,R 12 is hydrogen, cyano, halogen, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkylthio, C 3 -C 6 -cycloalkyl, in each case 1 C 1 -C 4 -haloalkyl, C 1 -C 4 -haloalkoxy or C 1 -C 4 -haloalkylthio, aminocarbonyl or aminocarbonyl-C 1 -C 4 -alkyl having from 5 to 5 halogen atoms ,
R13은 수소, 할로겐, 시아노, C1-C4-알킬, C1-C4-알콕시 또는 C1-C4-알킬티오를 나타내고,R 13 represents hydrogen, halogen, cyano, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy or C 1 -C 4 -alkylthio,
R14는 수소, C1-C4-알킬, 하이드록시-C1-C4-알킬, C2-C6-알케닐, C3-C6-사이클로알킬, C1-C4-알킬티오-C1-C4-알킬, C1-C4-알콕시-C1-C4-알킬, 각 경우에 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬, C1-C4-할로알킬티오-C1-C4-알킬, C1-C4-할로알콕시-C1-C4-알킬 또는 페닐을 나타내거나, R 14 is hydrogen, C 1 -C 4 -alkyl, hydroxy-C 1 -C 4 -alkyl, C 2 -C 6 -alkenyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkylthio -C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, in each case C 1 -C 4 -haloalkyl, having 1 to 5 halogen atoms, C 1 -C 4 -Haloalkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl or phenyl
A는 식 (A2)의 그룹을 나타내며:A represents a group of formula (A2):
여기에서,From here,
R15 및 R16은 서로 독립적으로 수소, 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내고,R 15 and R 16 independently of one another represent hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
R17은 할로겐, 시아노, C1-C4-알킬, 또는 각 경우에 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬 또는 C1-C4-할로알콕시를 나타내거나,R 17 represents halogen, cyano, C 1 -C 4 -alkyl, or C 1 -C 4 -haloalkyl or C 1 -C 4 -haloalkoxy having 1 to 5 halogen atoms in each case, or
A는 식 (A3)의 그룹을 나타내며:A represents a group of formula (A3):
여기에서,From here,
R18 및 R19는 서로 독립적으로 수소, 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내고,R 18 and R 19 independently of one another represent hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
R20은 수소, 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 20 represents hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms, or
A는 식 (A4)의 그룹을 나타내며:A represents a group of formula (A4):
여기에서,From here,
R21은 수소, 할로겐, 하이드록시, 시아노, C1-C6-알킬, 또는 각 경우에 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬, C1-C4-할로알콕시 또는 C1-C4-할로알티오를 나타내거나,R 21 is hydrogen, halogen, hydroxy, cyano, C 1 -C 6 -alkyl, or C 1 -C 4 -haloalkyl, C 1 -C 4 -haloalkoxy having 1 to 5 halogen atoms in each case Or C 1 -C 4 -haloalthio,
A는 식 (A5)의 그룹을 나타내고:A represents a group of formula (A5):
여기에서,From here,
R22는 할로겐, 하이드록시, 시아노, C1-C4-알킬, C1-C4-알콕시, C1-C4-알킬티오, 각 경우에 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬, C1-C4-할로알킬티오 또는 C1-C4-할로알콕시를 나타내거나,R 22 is halogen, hydroxy, cyano, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkylthio, in each case C 1 -having 1 to 5 halogen atoms C 4 -haloalkyl, C 1 -C 4 -haloalkylthio or C 1 -C 4 -haloalkoxy, or
R23은 수소, 할로겐, 시아노, C1-C4-알킬, C1-C4-알콕시, C1-C4-알킬티오, 각 경우에 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬 또는 C1-C4-할로알콕시, 또는 C1-C4-알킬설피닐 또는 C1-C4-알킬설포닐을 나타내거나,R 23 is hydrogen, halogen, cyano, C 1 -C 4 - alkyl, C 1 -C 4 - alkoxy, C 1 -C 4 - alkylthio having 1 to 5 halogen atoms, in each case C 1 -C 4 -haloalkyl or C 1 -C 4 -haloalkoxy, or C 1 -C 4 -alkylsulfinyl or C 1 -C 4 -alkylsulfonyl, or
A는 식 (A6)의 그룹을 나타내며:A represents a group of formula (A6):
여기에서,From here,
R24는 C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내고,R 24 represents C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
R25는 C1-C4-알킬을 나타내며,R 25 represents C 1 -C 4 -alkyl,
Q1은 S(황), SO, SO2 또는 CH2를 나타내고,Q 1 represents S (sulfur), SO, SO 2 or CH 2 ,
p는 0, 1 또는 2를 나타내며, p가 2인 경우 R25는 동일하거나 상이한 그룹을 나타내거나,p represents 0, 1 or 2, and when p is 2, R 25 represents the same or different group, or
A는 식 (A7)의 그룹을 나타내고:A represents a group of formula (A7):
여기에서,From here,
R26은 C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 26 represents C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
A는 식 (A8)의 그룹을 나타내고:A represents a group of formula (A8):
여기에서,From here,
R27은 C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 27 represents C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms, or
A는 식 (A9)의 그룹을 나타내고:A represents a group of formula (A9):
여기에서,From here,
R28 및 R29는 서로 독립적으로 수소, 할로겐, 아미노, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내며,R 28 and R 29 independently of one another represent hydrogen, halogen, amino, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
R30은 수소, 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 30 represents hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms, or
A는 식 (A10)의 그룹을 나타내고:A represents a group of formula (A10):
여기에서,From here,
R31 및 R32는 서로 독립적으로 수소, 할로겐, 아미노, 니트로, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내며,R 31 and R 32 independently of one another represent hydrogen, halogen, amino, nitro, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
R33은 수소, 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 33 represents hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
A는 식 (A11)의 그룹을 나타내고:A represents a group of formula (A11):
여기에서,From here,
R34는 수소, 할로겐, 아미노, C1-C4-알킬아미노, 디-(C1-C4-알킬)아미노, 시아노, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내며,R 34 is hydrogen, halogen, amino, C 1 -C 4 -alkylamino, di- (C 1 -C 4 -alkyl) amino, cyano, C 1 -C 4 -alkyl or having 1 to 5 halogen atoms C 1 -C 4 -haloalkyl,
R35는 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 35 represents halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
A는 식 (A12)의 그룹을 나타내고:A represents a group of formula (A12):
여기에서,From here,
R36은 수소, 할로겐, 아미노, C1-C4-알킬아미노, 디-(C1-C4-알킬)아미노, 시아노, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내며,R 36 has hydrogen, halogen, amino, C 1 -C 4 -alkylamino, di- (C 1 -C 4 -alkyl) amino, cyano, C 1 -C 4 -alkyl or having 1 to 5 halogen atoms C 1 -C 4 -haloalkyl,
R37은 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 37 represents halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms, or
A는 식 (A13)의 그룹을 나타내고:A represents a group of formula (A13):
여기에서,From here,
R38은 수소, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 38 represents hydrogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
A는 식 (A14)의 그룹을 나타내고:A represents a group of formula (A14):
여기에서,From here,
R39는 수소 또는 C1-C4-알킬을 나타내며,R 39 represents hydrogen or C 1 -C 4 -alkyl,
R40은 할로겐 또는 C1-C4-알킬을 나타내거나,R 40 represents halogen or C 1 -C 4 -alkyl, or
A는 식 (A15)의 그룹을 나타내며:A represents a group of formula (A15):
여기에서,From here,
R41은 C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 41 represents C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
A는 식 (A16)의 그룹을 나타내고:A represents a group of formula (A16):
여기에서,From here,
R42는 수소, 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 42 represents hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
A는 식 (A17)의 그룹을 나타내며:A represents a group of formula (A17):
여기에서,From here,
R43은 할로겐, 하이드록시, C1-C4-알킬, C1-C4-알콕시, C1-C4-알킬티오, 각 경우에 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬, C1-C4-할로알킬티오 또는 C1-C4-할로알콕시를 나타내거나,R 43 is halogen, hydroxy, C 1 -C 4 - alkyl, C 1 -C 4 - alkoxy, C 1 -C 4 - alkylthio, in each case 1 to 5 C 1 -C 4 has a halogen atom - Haloalkyl, C 1 -C 4 -haloalkylthio or C 1 -C 4 -haloalkoxy, or
A는 식 (A18)의 그룹을 나타내고:A represents a group of formula (A18):
여기에서,From here,
R44는 수소, 시아노, C1-C4-알킬, 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬, C1-C4-알콕시-C1-C4-알킬, 하이드록시-C1-C4-알킬, C1-C4-알킬설포닐, 디(C1-C4-알킬)아미노설포닐, C1-C6-알킬카보닐 또는 각 경우에 임의로 치환된 페닐설포닐 또는 벤조일을 나타내며,R 44 is hydrogen, cyano, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, hydroxy Oxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfonyl, di (C 1 -C 4 -alkyl) aminosulfonyl, C 1 -C 6 -alkylcarbonyl or optionally substituted in each case Phenylsulfonyl or benzoyl,
R45는 수소, 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내고,R 45 represents hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
R46은 수소, 할로겐, 시아노, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내며,R 46 represents hydrogen, halogen, cyano, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
R47은 수소, 할로겐, C1-C4-알킬 또는 1 내지 5개의 할로겐 원자를 가지는 C1-C4-할로알킬을 나타내거나,R 47 represents hydrogen, halogen, C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl having 1 to 5 halogen atoms,
A는 식 (A19)의 그룹을 나타내고:A represents a group of formula (A19):
여기에서,From here,
R48은 C1-C4-알킬을 나타내나,R 48 represents C 1 -C 4 -alkyl,
단, L2가 직접 결합인 경우, R은 알콕시가 아니다.Provided that when L 2 is a direct bond, R is not alkoxy.
또한, 화학식 (I)의 카복사미드는Further, the carboxamide of formula (I)
a) 화학식 (II)의 카복실산 유도체를, 경우에 따라 촉매의 존재하, 경우에 따라 축합제의 존재하, 경우에 따라 산 결합제의 존재하 및 경우에 따라 희석제의 존재하에서 화학식 (III)의 아닐린 유도체와 반응시키거나,a) Aniline of formula (III) in the presence of a carboxylic acid derivative of formula (II), optionally in the presence of a catalyst, optionally in the presence of a condensation agent, optionally in the presence of an acid binder and optionally in the presence of a diluent React with derivatives,
b) 화학식 (IV)의 카복사미드를 염기의 존재하 및 희석 매질의 존재하에서 화학식 (V)의 화합물과 반응시키거나,b) reacting the carboxamide of formula (IV) with a compound of formula (V) in the presence of a base and in the presence of a dilution medium, or
c) 화학식 (I-a)의 카복사미드를 염기의 존재하 및 희석 매질의 존재하에서 화학식 (VI)의 할라이드와 반응시킴으로써 수득됨이 밝혀졌다:c) It has been found that the carboxamide of formula (I-a) is obtained by reacting with a halide of formula (VI) in the presence of a base and in the presence of a dilution medium:
상기 식에서,Where
A, R1, M, Q, L2 및 R은 상기 정의된 바와 같고,A, R 1 , M, Q, L 2 and R are as defined above,
X1은 할로겐 또는 하이드록시를 나타내며,X 1 represents halogen or hydroxy,
L3은 수소 또는 C1-C9-알킬을 나타내고,L 3 represents hydrogen or C 1 -C 9 -alkyl,
Y는 할로겐, 트리플레이트(트리플루오로메틸설포닐), 메실레이트(메틸설포닐) 또는 토실레이트(4-메틸페닐설포닐)을 나타내며,Y represents halogen, triflate (trifluoromethylsulfonyl), mesylate (methylsulfonyl) or tosylate (4-methylphenylsulfonyl),
X2는 염소, 브롬 또는 요오드를 나타내고,X 2 represents chlorine, bromine or iodine,
R1-A는 C1-C8-알킬, C1-C6-알킬설피닐, C1-C6-알킬설포닐, C1-C4-알콕시-C1-C4-알킬, C3-C8-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C6-할로알킬, C1-C4-할로알킬티오, C1-C4-할로알킬설피닐, C1-C4-할로알킬설포닐, 할로-C1-C4-알콕시-C1-C4-알킬 또는 C3-C8-할로사이클로알킬; 포르밀, 포르밀-C1-C3-알킬, (C1-C3-알킬)카보닐-C1-C3-알킬, (C1-C3-알콕시)카보닐-C1-C3-알킬; 각 경우에 1 내지 13개의 불소, 염소 및/또는 브롬 원자를 가지는 할로-(C1-C3-알킬)카보닐-C1-C3-알킬 또는 할로-(C1-C3-알콕시)카보닐-C1-C3-알킬; (C1-C8-알킬)카보닐, (C1-C8-알콕시)카보닐, (C1-C4-알콕시-C1-C4-알킬)카보닐, (C3-C8-사이클로알킬)카보닐; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 (C1-C6-할로알킬)카보닐, (C1-C6-할로알콕시)카보닐, (할로-C1-C4-알콕시-C1-C4-알킬)카보닐, (C3-C8-할로사이클로알킬)카보닐; 또는 -C(=O)C(=O)R2, -CONR3R4 또는 -CH2NR5R6을 나타내며,R 1 -A is C 1 -C 8 -alkyl, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl; Having 1 to 9 fluorine, chlorine and / or bromine atoms in each case C 1 -C 6 - haloalkyl, C 1 -C 4 - haloalkylthio, C 1 -C 4 - haloalkyl sulfinyl, C 1 - C 4 -haloalkylsulfonyl, halo-C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl or C 3 -C 8 -halocycloalkyl; Formyl, formyl-C 1 -C 3 -alkyl, (C 1 -C 3 -alkyl) carbonyl-C 1 -C 3 -alkyl, (C 1 -C 3 -alkoxy) carbonyl-C 1 -C 3 -alkyl; Halo- (C 1 -C 3 -alkyl) carbonyl-C 1 -C 3 -alkyl or halo- (C 1 -C 3 -alkoxy) having 1 to 13 fluorine, chlorine and / or bromine atoms in each case Carbonyl-C 1 -C 3 -alkyl; (C 1 -C 8 -alkyl) carbonyl, (C 1 -C 8 -alkoxy) carbonyl, (C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl) carbonyl, (C 3 -C 8 -Cycloalkyl) carbonyl; (C 1 -C 6 -haloalkyl) carbonyl, (C 1 -C 6 -haloalkoxy) carbonyl, (halo-C 1 -C) having 1 to 9 fluorine, chlorine and / or bromine atoms in each case 4 -alkoxy-C 1 -C 4 -alkyl) carbonyl, (C 3 -C 8 -halocycloalkyl) carbonyl; Or -C (= 0) C (= 0) R 2 , -CONR 3 R 4 or -CH 2 NR 5 R 6 ,
여기에서, R2, R3, R4, R5 및 R6은 상기 정의된 바와 같다.Wherein R 2 , R 3 , R 4 , R 5 and R 6 are as defined above.
마지막으로, 화학식 (I)의 신규 카복사미드는 매우 우수한 살미생물성을 가지며, 작물 보호 및 재료 보호 두 경우 모두에 있어서 원치않는 미생물을 구제하기 위해 사용될 수 있음이 밝혀졌다.Finally, it has been found that the novel carboxamides of formula (I) have very good bactericidal properties and can be used to control unwanted microorganisms in both crop protection and material protection.
본 발명에 따른 화합물은 여러 가능한 상이한 이성체, 특히 입체이성체 형태, 예를 들어 E 및 Z, 스레오 및 에리스로 및 또한 광학 이성체 및 경우에 따라 토토머의 혼합물로 존재할 수 있다. 본 발명에 따라 E 및 Z 이성체, 및 또한 스레오 및 에리스로이성체 및 광학 이성체, 이들 이성체의 임의 혼합물 및 가능한 토토머 형태가 모두 청구된다.The compounds according to the invention may exist in several possible different isomers, in particular stereoisomeric forms, for example E and Z, threo and erythro and also optical isomers and optionally mixtures of tautomers. According to the invention, both the E and Z isomers, and also the stereo and erythroisomers and optical isomers, any mixtures of these isomers and possible tautomeric forms are all claimed.
본 발명에 따른 카복사미드는 화학식 (I)에 의해 일반적으로 정의된다. 이하, 상기 및 이후에 언급되는 화학식의 바람직한 그룹의 정의가 주어진다. 이들 정의는 화학식 (I)의 최종 생성물 및 상응하게 모든 중간체 생성물에 적용된다.Carboxamides according to the invention are generally defined by formula (I). Hereinafter, definitions of the preferred groups of the formulas mentioned above and hereinafter are given. These definitions apply to the final product of formula (I) and correspondingly all intermediate products.
R1은 바람직하게는 수소; C1-C6-알킬, C1-C4-알킬설피닐, C1-C4-알킬설포닐, C1-C3-알콕시-C1-C3-알킬, C3-C6-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C4-할로알킬, C1-C4-할로알킬티오, C1-C4-할로알킬설피닐, C1-C4-할로알킬설포닐, 할로-C1-C3-알콕시-C1-C3-알킬 또는 C3-C8-할로사이클로알킬; 포르밀, 포르밀-C1-C3-알킬, (C1-C3-알킬)카보닐-C1-C3-알킬, (C1-C3-알콕시)카보닐-C1-C3-알킬; 각 경우에 1 내지 13개의 불소, 염소 및/또는 브롬 원자를 가지는 할로-(C1-C3-알킬)카보닐-C1-C3-알킬, 할로-(C1-C3-알콕시)카보닐-C1-C3-알킬; (C1-C6-알킬)카보닐, (C1-C4-알콕시)카보닐, (C1-C3-알콕시-C1-C3-알킬)카보닐, (C3-C6-사이클로알킬)카보닐; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 (C1-C4-할로알킬)카보닐, (C1-C4-할로알콕시)카보닐, (할로-C1-C3-알콕시-C1-C3-알킬)카보닐, (C3-C6-할로사이클로알킬)카보닐; 또는 -C(=O)C(=O)R2, -CONR3R4 또는 -CH2NR5R6을 나타낸다.R 1 is preferably hydrogen; C 1 -C 6 -alkyl, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl, C 3 -C 6- Cycloalkyl; Having 1 to 9 fluorine, chlorine and / or bromine atoms in each case C 1 -C 4 - haloalkyl, C 1 -C 4 - haloalkylthio, C 1 -C 4 - haloalkyl sulfinyl, C 1 - C 4 -haloalkylsulfonyl, halo-C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl or C 3 -C 8 -halocycloalkyl; Formyl, formyl-C 1 -C 3 -alkyl, (C 1 -C 3 -alkyl) carbonyl-C 1 -C 3 -alkyl, (C 1 -C 3 -alkoxy) carbonyl-C 1 -C 3 -alkyl; Halo- (C 1 -C 3 -alkyl) carbonyl-C 1 -C 3 -alkyl, halo- (C 1 -C 3 -alkoxy) having 1 to 13 fluorine, chlorine and / or bromine atoms in each case Carbonyl-C 1 -C 3 -alkyl; (C 1 -C 6 -alkyl) carbonyl, (C 1 -C 4 -alkoxy) carbonyl, (C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl) carbonyl, (C 3 -C 6 -Cycloalkyl) carbonyl; (C 1 -C 4 -haloalkyl) carbonyl, (C 1 -C 4 -haloalkoxy) carbonyl, (halo-C 1 -C) having 1 to 9 fluorine, chlorine and / or bromine atoms in each case 3 -alkoxy-C 1 -C 3 -alkyl) carbonyl, (C 3 -C 6 -halocycloalkyl) carbonyl; Or -C (= 0) C (= 0) R 2 , -CONR 3 R 4 or -CH 2 NR 5 R 6 .
R1은 특히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, n-, 이소-, sec- 또는 t-부틸, 펜틸, 헥실, 메틸설피닐, 에틸설피닐, n- 또는 이소프로필설피 닐, n-, 이소-, sec- 또는 t-부틸설피닐, 메틸설포닐, 에틸설포닐, n- 또는 이소프로필설포닐, n-, 이소-, sec- 또는 t-부틸설포닐, 메톡시메틸, 메톡시에틸, 에톡시메틸, 에톡시에틸, 사이클로프로필, 사이클로펜틸, 사이클로헥실, 트리플루오로메틸, 트리클로로메틸, 트리플루오로에틸, 디플루오로메틸티오, 디플루오로클로로메틸티오, 트리플루오로메틸티오, 트리플루오로메틸설피닐, 트리플루오로메틸설포닐, 트리플루오로메톡시메틸, 포르밀, -CH2-CHO, -(CH2)2-CHO, -CH2-CO-CH3, -CH2-CO-CH2CH3, -CH2-CO-CH(CH3)2, -(CH2)2-CO-CH3, -(CH2)2-CO-CH2CH3, -(CH2)2-CO-CH(CH3)2, -CH2-CO2CH3, -CH2-CO2CH2CH3, -CH2-CO2CH(CH3)2, -(CH2)2-CO2CH3, -(CH2)2-CO2CH2CH3, -(CH2)2-CO2CH(CH3)2, -CH2-CO-CF3, -CH2-CO-CCl3, -CH2-CO-CH2CF3, -CH2-CO-CH2CCl3, -(CH2)2-CO-CH2CF3, -(CH2)2-CO-CH2CCl3, -CH2-CO2CH2CF3, -CH2-CO2CF2CF3, -CH2-CO2CH2CCl3, -CH2-CO2CCl2CCl3, -(CH2)2-CO2CH2CF3, -(CH2)2-CO2CF2CF3, -(CH2)2-CO2CH2CCl3, -(CH2)2-CO2-CCl2CCl3, 메틸카보닐, 에틸카보닐, n-프로필카보닐, 이소프로필카보닐, t-부틸카보닐, 메톡시카보닐, 에톡시카보닐, t-부톡시카보닐, 사이클로프로필카보닐, 트리플루오로메틸카보닐, 트리플루오로메톡시카보닐, -C(=0)C(=0)R2, -CONR3R4 또는 -CH2NR5R6을 나타낸다.R 1 is particularly preferably hydrogen, methyl, ethyl, n- or isopropyl, n-, iso-, sec- or t-butyl, pentyl, hexyl, methylsulfinyl, ethylsulfinyl, n- or isopropylsulphi Nyl, n-, iso-, sec- or t-butylsulfinyl, methylsulfonyl, ethylsulfonyl, n- or isopropylsulfonyl, n-, iso-, sec- or t-butylsulfonyl, methoxy Methyl, methoxyethyl, ethoxymethyl, ethoxyethyl, cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethyl, trichloromethyl, trifluoroethyl, difluoromethylthio, difluorochloromethylthio, Trifluoromethylthio, trifluoromethylsulfinyl, trifluoromethylsulfonyl, trifluoromethoxymethyl, formyl, -CH 2 -CHO,-(CH 2 ) 2 -CHO, -CH 2 -CO- CH 3 , -CH 2 -CO-CH 2 CH 3 , -CH 2 -CO-CH (CH 3 ) 2 ,-(CH 2 ) 2 -CO-CH 3 ,-(CH 2 ) 2 -CO-CH 2 CH 3 ,-(CH 2 ) 2 -CO-CH (CH 3 ) 2 , -CH 2 -CO 2 CH 3 , -CH 2 -CO 2 CH 2 CH 3 ,- CH 2 -CO 2 CH (CH 3 ) 2 ,-(CH 2 ) 2 -CO 2 CH 3 ,-(CH 2 ) 2 -CO 2 CH 2 CH 3 ,-(CH 2 ) 2 -CO 2 CH (CH 3 ) 2 , -CH 2 -CO-CF 3 , -CH 2 -CO-CCl 3 , -CH 2 -CO-CH 2 CF 3 , -CH 2 -CO-CH 2 CCl 3 ,-(CH 2 ) 2 -CO-CH 2 CF 3 ,-(CH 2 ) 2 -CO-CH 2 CCl 3 , -CH 2 -CO 2 CH 2 CF 3 , -CH 2 -CO 2 CF 2 CF 3 , -CH 2 -CO 2 CH 2 CCl 3 , -CH 2 -CO 2 CCl 2 CCl 3 ,-(CH 2 ) 2 -CO 2 CH 2 CF 3 ,-(CH 2 ) 2 -CO 2 CF 2 CF 3 ,-(CH 2 ) 2 -CO 2 CH 2 CCl 3 ,-(CH 2 ) 2 -CO 2 -CCl 2 CCl 3 , methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, t-butylcarbonyl, methoxy Carbonyl, ethoxycarbonyl, t-butoxycarbonyl, cyclopropylcarbonyl, trifluoromethylcarbonyl, trifluoromethoxycarbonyl, -C (= 0) C (= 0) R 2 , -CONR 3 R 4 or —CH 2 NR 5 R 6 is represented.
R1은 가장 특히 바람직하게는 수소, 메틸, 메톡시메틸, 포르밀, -CH2-CHO, -(CH2)2-CHO, -CH2-CO-CH3, -CH2-CO-CH2CH3, -CH2-CO-CH(CH3)2, -C(=O)CHO, -C(=O)C(=O)CH3, -C(=O)C(=O)CH2OCH3, -C(=O)CO2CH3 또는 -C(=O)CO2CH2CH3를 나타낸다.R 1 is most preferably hydrogen, methyl, methoxymethyl, formyl, -CH 2 -CHO,-(CH 2 ) 2 -CHO, -CH 2 -CO-CH 3 , -CH 2 -CO-CH 2 CH 3 , -CH 2 -CO-CH (CH 3 ) 2 , -C (= O) CHO, -C (= O) C (= O) CH 3 , -C (= O) C (= O) CH 2 OCH 3 , —C (═O) CO 2 CH 3 or —C (═O) CO 2 CH 2 CH 3 .
R2는 바람직하게는 수소, C1-C6-알킬, C1-C4-알콕시, C1-C3-알콕시-C1-C3-알킬, C3-C6-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C4-할로알킬, C1-C4-할로알콕시, 할로-C1-C3-알콕시-C1-C3-알킬 또는 C3-C6-할로사이클로알킬을 나타낸다.R 2 is preferably hydrogen, C 1 -C 6 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl, C 3 -C 6 -cycloalkyl; C 1 -C 4 -haloalkyl, C 1 -C 4 -haloalkoxy, halo-C 1 -C 3 -alkoxy-C 1 -C 3 having 1 to 9 fluorine, chlorine and / or bromine atoms in each case -Alkyl or C 3 -C 6 -halocycloalkyl.
R2는 특히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, t-부틸, 메톡시, 에톡시, n- 또는 이소프로폭시, t-부톡시, 메톡시메틸, 사이클로프로필, 트리플루오로메틸 또는 트리플루오로메톡시를 나타낸다.R 2 is particularly preferably hydrogen, methyl, ethyl, n- or isopropyl, t-butyl, methoxy, ethoxy, n- or isopropoxy, t-butoxy, methoxymethyl, cyclopropyl, trifluoro Chloromethyl or trifluoromethoxy.
R3 및 R4는 서로 독립적으로 바람직하게는 수소, C1-C4-알킬, C1-C4-알콕시-C1-C4-알킬, C3-C6-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C4-할로알킬, 할로-C1-C3-알콕시-C1-C3-알킬 또는 C3-C6-할로사이클로알킬을 나타낸다.R 3 and R 4 are independently of each other preferably hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl; C 1 -C 4 -haloalkyl, halo-C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl or C 3 -C 6 -having 1 to 9 fluorine, chlorine and / or bromine atoms in each case Halocycloalkyl.
R3 및 R4는 또한 이들이 결합된 질소 원자와 함께, 바람직하게는 산소, 황 및 NR7로 구성된 그룹중에서 선택된 1 또는 2개의 추가의 비인접 헤테로 원자를 함 유할 수 있고, 할로겐 및 C1-C4-알킬로 구성된 그룹중에서 선택된 동일하거나 상이한 치환체에 의해 일- 내지 사치환되는 것이 바람직한 포화된 5 또는 6 환 원자의 헤테로사이클을 나타낸다.R 3 and R 4 together with the nitrogen atom to which they are attached may also contain one or two additional nonadjacent heteroatoms, preferably selected from the group consisting of oxygen, sulfur and NR 7 , and halogen and C 1 − It represents a heterocycle of saturated 5 or 6 ring atoms which is preferably one to tetrasubstituted by the same or different substituents selected from the group consisting of C 4 -alkyl.
R3 및 R4는 서로 독립적으로 특히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, n-, 이소-, sec- 또는 t-부틸, 메톡시메틸, 메톡시에틸, 에톡시메틸, 에톡시에틸, 사이클로프로필, 사이클로펜틸, 사이클로헥실, 트리플루오로메틸, 트리클로로메틸, 트리플루오로에틸 또는 트리플루오로메톡시메틸을 나타낸다.R 3 and R 4 independently of one another are particularly preferably hydrogen, methyl, ethyl, n- or isopropyl, n-, iso-, sec- or t-butyl, methoxymethyl, methoxyethyl, ethoxymethyl, Ethoxyethyl, cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethyl, trichloromethyl, trifluoroethyl or trifluoromethoxymethyl.
R3 및 R4는 이들이 결합된 질소 원자와 함께, 특히 바람직하게는 불소, 염소, 브롬 및 메틸로 구성된 그룹중에서 선택된 동일하거나 상이한 치환체에 의해 임의로 일- 내지 사치환되는 것이 바람직한 모르폴린, 티오모르폴린 및 피페라진으로 구성된 그룹중에서 선택된 포화 헤테로사이클을 나타내고, 여기에서 피페라진은 R9에 의해 제 2의 질소 원자에서 치환될 수 있다.R 3 and R 4 together with the nitrogen atom to which they are attached are particularly preferably one- to tetrasubstituted by the same or different substituents selected from the group consisting of fluorine, chlorine, bromine and methyl, morpholines, thiomors Saturated heterocycle selected from the group consisting of poline and piperazine, wherein piperazine may be substituted at the second nitrogen atom by R 9 .
R5 및 R6은 서로 독립적으로 바람직하게는 수소, C1-C6-알킬, C3-C6-사이클로알킬, 또는 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C4-할로알킬 또는 C3-C6-할로사이클로알킬을 나타낸다.R 5 and R 6 independently of one another preferably hydrogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, or C in each case having 1 to 9 fluorine, chlorine and / or bromine atoms 1 -C 4 -haloalkyl or C 3 -C 6 -halocycloalkyl.
R5 및 R6은 또한 이들이 결합된 질소 원자와 함께, 바람직하게는 산소, 황 및 NR7로 구성된 그룹중에서 선택된 1 또는 2개의 추가의 비인접 헤테로 원자를 함유할 수 있고, 할로겐 및 C1-C4-알킬로 구성된 그룹중에서 선택된 동일하거나 상이한 치환체에 의해 일- 내지 사치환되는 것이 바람직한 포화된 5 또는 6 환 원자의 헤테로사이클을 나타내고,R 5 and R 6 together with the nitrogen atom to which they are attached may also contain one or two additional nonadjacent heteroatoms, preferably selected from the group consisting of oxygen, sulfur and NR 7 , and halogen and C 1 − Represents a heterocycle of saturated 5 or 6 ring atoms which is preferably mono- to tetrasubstituted by the same or different substituents selected from the group consisting of C 4 -alkyl,
R5 및 R6은 서로 독립적으로 특히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, n-, 이소-, sec- 또는 t-부틸, 메톡시메틸, 메톡시에틸, 에톡시메틸, 에톡시에틸, 사이클로프로필, 사이클로펜틸, 사이클로헥실, 트리플루오로메틸, 트리클로로메틸, 트리플루오로에틸 또는 트리플루오로메톡시메틸을 나타낸다.R 5 and R 6 independently of one another are particularly preferably hydrogen, methyl, ethyl, n- or isopropyl, n-, iso-, sec- or t-butyl, methoxymethyl, methoxyethyl, ethoxymethyl, Ethoxyethyl, cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethyl, trichloromethyl, trifluoroethyl or trifluoromethoxymethyl.
R5 및 R6은 이들이 결합된 질소 원자와 함께, 특히 바람직하게는 불소, 염소, 브롬 및 메틸로 구성된 그룹중에서 선택된 동일하거나 상이한 치환체에 의해 일- 내지 사치환되는 것이 바람직한 모르폴린, 티오모르폴린 및 피페라진으로 구성된 그룹중에서 선택된 포화 헤테로사이클을 나타내고, 여기에서 피페라진은 R7에 의해 제 2의 질소 원자에서 치환될 수 있다.R 5 and R 6 together with the nitrogen atom to which they are attached are particularly preferably mono- to tetrasubstituted by the same or different substituents selected from the group consisting of fluorine, chlorine, bromine and methyl, morpholine, thiomorpholine And a saturated heterocycle selected from the group consisting of piperazine, wherein piperazine may be substituted at a second nitrogen atom by R 7 .
R7은 바람직하게는 수소 또는 C1-C4-알킬을 나타낸다.R 7 preferably represents hydrogen or C 1 -C 4 -alkyl.
R7은 특히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, n-, 이소-, sec- 또는 t-부틸을 나타낸다.R 7 particularly preferably represents hydrogen, methyl, ethyl, n- or isopropyl, n-, iso-, sec- or t-butyl.
M은 바람직하게는 하기 사이클릭중 하나를 나타내고:M preferably represents one of the following cyclics:
여기에서,From here,
*로 표시된 결합은 아미드에 결합된다. The bond marked * is attached to the amide.
M은 특히 바람직하게는 M-1, M-2, M-3, M-6, M-7, M-10 또는 M-11중에서 선택된 사이클릭을 나타낸다.M particularly preferably represents a cyclic selected from M-1, M-2, M-3, M-6, M-7, M-10 or M-11.
M은 또한 특히 바람직하게는 M-1, M-2, M-3, M-4, M-5, M-6, M-10 또는 M-11중에서 선택된 사이클릭을 나타낸다.M also particularly preferably represents a cyclic selected from M-1, M-2, M-3, M-4, M-5, M-6, M-10 or M-11.
M은 가장 바람직하게는 사이클릭 M-1을 나타낸다.M most preferably represents cyclic M-1.
M은 또한 가장 바람직하게는 헤테로사이클 M-2를 나타낸다.M also most preferably represents heterocycle M-2.
M은 또한 가장 바람직하게는 헤테로사이클 M-3를 나타낸다.M also most preferably represents heterocycle M-3.
M은 또한 가장 바람직하게는 헤테로사이클 M-6을 나타낸다.M also most preferably represents heterocycle M-6.
M은 또한 가장 바람직하게는 헤테로사이클 M-7을 나타낸다.M also most preferably represents heterocycle M-7.
M은 또한 가장 바람직하게는 헤테로사이클 M-10을 나타낸다.M also most preferably represents heterocycle M-10.
M은 또한 가장 바람직하게는 헤테로사이클 M-11을 나타낸다.M also most preferably represents heterocycle M-11.
R8은 바람직하게는 수소를 나타낸다.R 8 preferably represents hydrogen.
R8은 또한 바람직하게는 M이 M-1을 나타내는 경우, 불소, 특히 바람직하게는 4-, 5- 또는 6-위치, 가장 특히 바람직하게는 4- 또는 6-위치, 특히 4-위치에 있는 불소를 나타낸다.R 8 is also preferably fluorine when M represents M-1, particularly preferably in the 4-, 5- or 6-position, most particularly preferably in the 4- or 6-position, especially the 4-position Represents fluorine.
R8은 또한 바람직하게는 M이 M-1을 나타내는 경우, 염소, 특히 바람직하게는 4- 또는 6-위치에 있는 염소를 나타낸다.R 8 also preferably represents chlorine when M represents M-1, particularly preferably chlorine in the 4- or 6-position.
R8은 또한 바람직하게는 M이 M-1을 나타내는 경우, 메틸, 특히 바람직하게는 3-위치 및 또한 특히 바람직하게는 4-위치에 있는 메틸 그룹을 나타낸다.R 8 also preferably represents methyl, particularly when M represents M-1, methyl group in the 3-position and also particularly preferably the 4-position.
R8은 또한 바람직하게는 M이 M-1을 나타내는 경우, 메톡시, 특히 바람직하게는 4-위치에 있는 메톡시 그룹을 나타낸다.R 8 also preferably represents methoxy, particularly preferably the methoxy group in the 4-position, when M represents M-1.
R8은 또한 바람직하게는 M이 M-1을 나타내는 경우, 트리플루오로메틸, 특히 바람직하게는 4- 또는 6-위치에 있는 트리플루오로메틸 그룹을 나타낸다.R 8 also preferably represents trifluoromethyl, particularly preferably trifluoromethyl group in the 4- or 6-position when M represents M-1.
R8은 또한 바람직하게는 M이 M-2, M-3, M-4 또는 M-5를 나타내는 경우, 불소, 특히 바람직하게는 6-위치(M-2, M-3), 또는 3-위치(M-4, M-5)에 있는 불소를 나타낸다.R 8 is also preferably fluorine when M represents M-2, M-3, M-4 or M-5, particularly preferably 6-position (M-2, M-3), or 3- Fluorine in the position (M-4, M-5) is shown.
R8은 또한 바람직하게는 M이 M-2, M-3, M-4 또는 M-5를 나타내는 경우, 염소, 특히 바람직하게는 6-위치(M-2, M-3), 또는 3-위치(M-4, M-5)에 있는 염소를 나타낸다.R 8 is also preferably chlorine when M represents M-2, M-3, M-4 or M-5, particularly preferably 6-position (M-2, M-3), or 3- Chlorine at positions M-4 and M-5.
R8은 또한 바람직하게는 M이 M-2, M-3, M-4 또는 M-5를 나타내는 경우, 메틸, 특히 바람직하게는 4-위치(M-2), 또는 3-위치(M-3, M-4, M-5)에 있는 메틸 그룹을 나타낸다.R 8 is also preferably methyl when M represents M-2, M-3, M-4 or M-5, particularly preferably 4-position (M-2), or 3-position (M- 3, M-4, M-5).
R8은 또한 바람직하게는 M이 M-6을 나타내는 경우, 메틸, 특히 바람직하게는 3-위치에 있는 메틸 그룹을 나타낸다.R 8 preferably also represents methyl, particularly preferably the methyl group in the 3-position when M represents M-6.
R8은 또한 바람직하게는 M이 M-6을 나타내는 경우, 트리플루오로메틸, 특히 바람직하게는 3-위치에 있는 트리플루오로메틸 그룹을 나타낸다.R 8 also preferably represents trifluoromethyl, particularly preferably trifluoromethyl group, when M represents M-6.
R8은 또한 바람직하게는 M이 M-7, M-8 또는 M-9를 나타내는 경우, 염소, 특히 바람직하게는 5-위치(M-7, M-8), 또는 3-위치(M-9)에 있는 염소를 나타낸다.R 8 is also preferably chlorine when M represents M-7, M-8 or M-9, particularly preferably 5-position (M-7, M-8), or 3-position (M- Chlorine in 9).
R8은 또한 바람직하게는 M이 M-7, M-8 또는 M-9를 나타내는 경우, 메틸, 특히 바람직하게는 5-위치(M-7, M-8), 또는 3-위치(M-9)에 있는 메틸 그룹을 나타낸다.R 8 is also preferably methyl when M represents M-7, M-8 or M-9, particularly preferably 5-position (M-7, M-8), or 3-position (M- The methyl group in 9) is shown.
R8은 또한 바람직하게는 M이 M-12를 나타내는 경우, 메틸, 특히 바람직하게는 4-위치에 있는 메틸 그룹을 나타낸다.R 8 also preferably denotes methyl, particularly preferably the methyl group in the 4-position when M represents M-12.
R8은 또한 바람직하게는 M이 M-12를 나타내는 경우, 트리플루오로메틸, 특히 바람직하게는 4-위치에 있는 트리플루오로메틸 그룹을 나타낸다.R 8 also preferably represents trifluoromethyl, particularly preferably the trifluoromethyl group in the 4-position when M represents M-12.
R8은 또한 바람직하게는 M이 M-13을 나타내는 경우, 메틸, 특히 바람직하게는 3-위치에 있는 메틸 그룹을 나타낸다.R 8 preferably also represents methyl, particularly preferably the methyl group in the 3-position when M represents M-13.
R8은 또한 바람직하게는 M이 M-13을 나타내는 경우, 트리플루오로메틸, 특히 바람직하게는 3-위치에 있는 트리플루오로메틸 그룹을 나타낸다.R 8 also preferably represents trifluoromethyl, particularly preferably trifluoromethyl group, when M represents M-13.
R8은 또한 바람직하게는 M이 M-14를 나타내는 경우, 메틸, 특히 바람직하게는 3-위치에 있는 메틸 그룹을 나타낸다.R 8 also preferably denotes methyl, particularly preferably the methyl group at the 3-position when M represents M-14.
R8은 또한 바람직하게는 M이 M-14를 나타내는 경우, 트리플루오로메틸, 특히 바람직하게는 3-위치에 있는 트리플루오로메틸 그룹을 나타낸다.R 8 also preferably represents trifluoromethyl, particularly preferably trifluoromethyl group, when M represents M-14.
R8-A는 바람직하게는 수소를 나타낸다.R 8-A preferably represents hydrogen.
R8-A는 또한 바람직하게는 메틸을 나타낸다.R 8-A also preferably represents methyl.
R8-A는 또한 바람직하게는 트리플루오로메틸을 나타낸다.R 8-A also preferably represents trifluoromethyl.
L1은 바람직하게는 C1-C6-알킬렌(알칸디일)을 나타낸다.L 1 preferably denotes C 1 -C 6 -alkylene (alkanediyl).
L1은 특히 바람직하게는 -CH2-, -CH(CH3)- 또는 -(CH2)2C(CH3)2-를 나타낸다.L 1 particularly preferably represents —CH 2 —, —CH (CH 3 ) — or — (CH 2 ) 2 C (CH 3 ) 2 —.
L1은 또한 특히 바람직하게는 -(CH2)2-를 나타낸다.L 1 also particularly preferably represents — (CH 2 ) 2 —.
Q는 바람직하게는 O를 나타낸다.Q preferably represents O.
Q는 또한 바람직하게는 S를 나타낸다.Q also preferably represents S.
Q는 또한 바람직하게는 SO를 나타낸다.Q also preferably represents SO.
Q는 또한 바람직하게는 SO2를 나타낸다.Q also preferably represents SO 2 .
Q는 또한 바람직하게는 NR9, 특히 바람직하게는 NH를 나타낸다.Q also preferably represents NR 9 , particularly preferably NH.
L2는 바람직하게는 직접 결합을 나타낸다.L 2 preferably represents a direct bond.
L2는 또한 바람직하게는 SiR10R11을 나타낸다.L 2 also preferably denotes SiR 10 R 11 .
L2는 또한 바람직하게는 CO를 나타낸다.L 2 also preferably represents CO.
R은 바람직하게는 수소, C1-C6-알킬, C1-C6-알콕시, C1-C3-알콕시-C1-C3-알킬, C1-C3-알킬티오-C1-C3-알킬 또는 C3-C6-사이클로알킬을 나타낸다.R is preferably hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl, C 1 -C 3 -alkylthio-C 1 -C 3 -alkyl or C 3 -C 6 -cycloalkyl.
R은 또한 바람직하게는 C1-C4-할로알킬을 나타낸다.R also preferably represents C 1 -C 4 -haloalkyl.
R은 특히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, n-, 이소-, sec- 또는 t-부틸, 메톡시, 에톡시, n- 또는 이소프로폭시, n-, 이소-, sec- 또는 t-부톡시, 메톡시메틸, 에톡시메틸, 메톡시에틸, 에톡시에틸, 메틸티오메틸, 에틸티오메틸, 메틸티오에틸, 에틸티오에틸 또는 사이클로프로필을 나타낸다.R is particularly preferably hydrogen, methyl, ethyl, n- or isopropyl, n-, iso-, sec- or t-butyl, methoxy, ethoxy, n- or isopropoxy, n-, iso-, sec- or t-butoxy, methoxymethyl, ethoxymethyl, methoxyethyl, ethoxyethyl, methylthiomethyl, ethylthiomethyl, methylthioethyl, ethylthioethyl or cyclopropyl.
R은 또한 특히 바람직하게는 1-메틸부틸, 1 내지 5개의 불소, 염소 또는 브 롬 원자를 가지는 C1-C2-할로알킬, 사이클로펜틸 또는 사이클로헥실을 나타낸다.R also particularly preferably represents C 1 -C 2 -haloalkyl, cyclopentyl or cyclohexyl having 1-methylbutyl, 1 to 5 fluorine, chlorine or bromine atoms.
R은 가장 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, 이소- 또는 t-부틸, 메톡시, 이소프로폭시, 이소- 또는 t-부톡시, 메톡시메틸 또는 메틸티오메틸을 나타낸다.R most preferably represents hydrogen, methyl, ethyl, n- or isopropyl, iso- or t-butyl, methoxy, isopropoxy, iso- or t-butoxy, methoxymethyl or methylthiomethyl.
R은 또한 가장 바람직하게는 sec-부틸, 1-메틸부틸, 디클로로메틸, 사이클로프로필, 사이클로펜틸 또는 사이클로헥실을 나타낸다.R also most preferably represents sec-butyl, 1-methylbutyl, dichloromethyl, cyclopropyl, cyclopentyl or cyclohexyl.
R은 특별히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, 이소- 또는 t-부틸, 메톡시, 이소프로폭시, 이소- 또는 t-부톡시를 나타낸다.R particularly preferably represents hydrogen, methyl, ethyl, n- or isopropyl, iso- or t-butyl, methoxy, isopropoxy, iso- or t-butoxy.
R은 또한 특별히 바람직하게는 sec-부틸 또는 1-메틸부틸을 나타낸다.R also particularly preferably represents sec-butyl or 1-methylbutyl.
R9는 바람직하게는 수소, C1-C6-알킬, C1-C3-알콕시-C1-C3-알킬, C1-C3-알킬티오-C1-C3-알킬 또는 C3-C6-사이클로알킬을 나타낸다.R 9 is preferably hydrogen, C 1 -C 6 -alkyl, C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl, C 1 -C 3 -alkylthio-C 1 -C 3 -alkyl or C 3 -C 6 -cycloalkyl is represented.
R9는 특히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, n-, 이소-, sec- 또는 t-부틸, 메톡시메틸, 에톡시메틸, 메톡시에틸, 에톡시에틸, 메틸티오메틸, 에틸티오메틸, 메틸티오에틸, 에틸티오에틸 또는 사이클로프로필을 나타낸다.R 9 is particularly preferably hydrogen, methyl, ethyl, n- or isopropyl, n-, iso-, sec- or t-butyl, methoxymethyl, ethoxymethyl, methoxyethyl, ethoxyethyl, methylthio Methyl, ethylthiomethyl, methylthioethyl, ethylthioethyl or cyclopropyl.
R9는 가장 특히 바람직하게는 수소, 메틸, 에틸, n- 또는 이소프로필, 이소- 또는 t-부틸, 메톡시메틸 또는 메틸티오메틸을 나타낸다.R 9 most particularly preferably represents hydrogen, methyl, ethyl, n- or isopropyl, iso- or t-butyl, methoxymethyl or methylthiomethyl.
R9는 특별히 바람직하게는 수소 또는 메틸을 나타낸다.R 9 particularly preferably represents hydrogen or methyl.
R10 및 R11은 서로 독립적으로 바람직하게는 C1-C6-알킬, C1-C6-알콕시, C1-C3-알콕시-C1-C3-알킬 또는 C1-C3-알킬티오-C1-C3-알킬을 나타낸다.R 10 and R 11 are independently of each other preferably C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl or C 1 -C 3- Alkylthio-C 1 -C 3 -alkyl is indicated.
R10 및 R11은 서로 독립적으로 특히 바람직하게는 메틸, 에틸, 메톡시, 에톡시, 메톡시메틸, 에톡시메틸, 메톡시에틸, 에톡시에틸, 메틸티오메틸, 에틸티오메틸, 메틸티오에틸 또는 에틸티오에틸을 나타낸다.R 10 and R 11 independently of one another are particularly preferably methyl, ethyl, methoxy, ethoxy, methoxymethyl, ethoxymethyl, methoxyethyl, ethoxyethyl, methylthiomethyl, ethylthiomethyl, methylthioethyl Or ethylthioethyl.
R10 및 R11은 서로 독립적으로 가장 특히 바람직하게는 메틸, 메톡시, 메톡시메틸 또는 메틸티오메틸을 나타낸다.R 10 and R 11 independently of one another most particularly preferably represent methyl, methoxy, methoxymethyl or methylthiomethyl.
R10 및 R11은 특별히 바람직하게는 각 경우에 메틸을 나타낸다.R 10 and R 11 particularly preferably represent methyl in each case.
A는 바람직하게는 그룹 A1, A2, A3, A4, A5, A6, A9, A10, A11, A12, A17 및 A18중의 하나를 나타낸다.A preferably represents one of groups A1, A2, A3, A4, A5, A6, A9, A10, A11, A12, A17 and A18.
A는 특히 바람직하게는 그룹 A1, A2, A4, A5, A6, A9, A11, A16, A17, A18중의 하나를 나타낸다.A particularly preferably represents one of groups A1, A2, A4, A5, A6, A9, A11, A16, A17, A18.
A는 가장 특히 바람직하게는 래디칼 A1을 나타낸다.A most particularly preferably represents radical A1.
A는 또한 가장 특히 바람직하게는 래디칼 A4를 나타낸다.A also most particularly preferably represents radical A4.
A는 또한 가장 특히 바람직하게는 래디칼 A5를 나타낸다.A also most particularly preferably represents radical A5.
A는 또한 가장 특히 바람직하게는 래디칼 A6을 나타낸다.A also most particularly preferably represents radical A6.
A는 또한 가장 특히 바람직하게는 래디칼 A9를 나타낸다.A also most particularly preferably represents radical A9.
A는 또한 가장 특히 바람직하게는 래디칼 A11을 나타낸다.A also most particularly preferably represents radical A11.
A는 또한 가장 특히 바람직하게는 래디칼 A16을 나타낸다.A also most particularly preferably represents radical A16.
A는 또한 가장 특히 바람직하게는 래디칼 A18을 나타낸다.A also most particularly preferably represents radical A18.
R12는 바람직하게는 수소, 시아노, 불소, 염소, 브롬, 요오드, 메틸, 에틸, 이소프로필, 메톡시, 에톡시, 메틸티오, 에틸티오, 사이클로프로필, 각 경우에 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬, C1-C2-할로알콕시, 트리플루오로메틸티오, 디플루오로메틸티오, 아미노카보닐, 아미노카보닐메틸 또는 아미노카보닐에틸을 나타낸다.R 12 preferably is hydrogen, cyano, fluorine, chlorine, bromine, iodine, methyl, ethyl, isopropyl, methoxy, ethoxy, methylthio, ethylthio, cyclopropyl, in each case 1 to 5 fluorine, C 1 -C 2 -haloalkyl, C 1 -C 2 -haloalkoxy, trifluoromethylthio, difluoromethylthio, aminocarbonyl, aminocarbonylmethyl or aminocarbonyl having chlorine and / or bromine atoms Ethyl.
R12는 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸, 에틸, 이소프로필, 모노플루오로메틸, 모노플루오로에틸, 디플루오로메틸, 트리플루오로메틸, 디플루오로클로로메틸, 트리클로로메틸, 디클로로메틸, 사이클로프로필, 메톡시, 에톡시, 트리플루오로메톡시, 트리클로로메톡시, 메틸티오, 에틸티오, 트리플루오로메틸티오 또는 디플루오로메틸티오를 나타낸다.R 12 is particularly preferably hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, isopropyl, monofluoromethyl, monofluoroethyl, difluoromethyl, trifluoromethyl, difluorochloromethyl, Trichloromethyl, dichloromethyl, cyclopropyl, methoxy, ethoxy, trifluoromethoxy, trichloromethoxy, methylthio, ethylthio, trifluoromethylthio or difluoromethylthio.
R12는 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸, 이소프로필, 모노플루오로메틸, 모노플루오로에틸, 디플루오로메틸, 트리플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 12 is most particularly preferably hydrogen, fluorine, chlorine, bromine, iodine, methyl, isopropyl, monofluoromethyl, monofluoroethyl, difluoromethyl, trifluoromethyl, difluorochloromethyl or trichloro Romethyl.
R12는 특별히 바람직하게는 메틸, 디플루오로메틸, 트리플루오로메틸 또는 1-플루오로에틸을 나타낸다.R 12 particularly preferably represents methyl, difluoromethyl, trifluoromethyl or 1-fluoroethyl.
R13은 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸, 에틸, 메톡시, 에톡시, 메틸티오 또는 에틸티오를 나타낸다.R 13 preferably represents hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, methoxy, ethoxy, methylthio or ethylthio.
R13은 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드 또는 메틸을 나타낸다.R 13 particularly preferably represents hydrogen, fluorine, chlorine, bromine, iodine or methyl.
R13은 가장 특히 바람직하게는 수소, 불소, 염소 또는 메틸을 나타낸다.R 13 most particularly preferably represents hydrogen, fluorine, chlorine or methyl.
R14는 바람직하게는 수소, 메틸, 에틸, n-프로필, 이소프로필, 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬, 하이드록시메틸, 하이드록시에틸, 사이클로프로필, 사이클로펜틸, 사이클로헥실 또는 페닐을 나타낸다.R 14 is preferably hydrogen, methyl, ethyl, n-propyl, isopropyl, C 1 -C 2 -haloalkyl, hydroxymethyl, hydroxyethyl, having 1 to 5 fluorine, chlorine and / or bromine atoms, Cyclopropyl, cyclopentyl, cyclohexyl or phenyl.
R14는 특히 바람직하게는 수소, 메틸, 에틸, 이소프로필, 트리플루오로메틸, 디플루오로메틸, 하이드록시메틸, 하이드록시에틸 또는 페닐을 나타낸다.R 14 particularly preferably represents hydrogen, methyl, ethyl, isopropyl, trifluoromethyl, difluoromethyl, hydroxymethyl, hydroxyethyl or phenyl.
R14는 가장 특히 바람직하게는 수소, 메틸, 트리플루오로메틸 또는 페닐을 나타낸다.R 14 most particularly preferably represents hydrogen, methyl, trifluoromethyl or phenyl.
R14는 특별히 바람직하게는 메틸을 나타낸다.R 14 particularly preferably represents methyl.
R15 및 Rl6은 서로 독립적으로 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 15 and R 16 independently of one another preferably represent C 1 -C 2 -haloalkyl having hydrogen, fluorine, chlorine, bromine, methyl, ethyl or 1 to 5 fluorine, chlorine and / or bromine atoms.
R15 및 Rl6은 서로 독립적으로 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸, 디플루오로메틸, 트리플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 15 and R 16 independently of each other particularly preferably represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, difluoromethyl, trifluoromethyl, difluorochloromethyl or trichloromethyl.
R15 및 Rl6은 서로 독립적으로 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸, 디플루오로메틸, 트리플루오로메틸 또는 트리클로로메틸을 나타낸다.R 15 and R 16 independently of each other most particularly preferably represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, difluoromethyl, trifluoromethyl or trichloromethyl.
R15 및 Rl6은 특별히 바람직하게는 각 경우에 수소를 나타낸다.R 15 and R 16 particularly preferably represent hydrogen in each case.
R17은 바람직하게는 불소, 염소, 브롬, 시아노, 메틸, 에틸, 각 경우에 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬 또는 C1-C2-할로알콕시를 나타낸다.R 17 is preferably fluorine, chlorine, bromine, cyano, methyl, ethyl, in each case C 1 -C 2 -haloalkyl or C 1 -C 2 having 1 to 5 fluorine, chlorine and / or bromine atoms -Haloalkoxy.
R17은 특히 바람직하게는 불소, 염소, 브롬, 시아노, 메틸, 트리플루오로메틸, 트리플루오로메톡시, 디플루오로메톡시, 디플루오로클로로메톡시 또는 트리클로로메톡시를 나타낸다.R 17 particularly preferably represents fluorine, chlorine, bromine, cyano, methyl, trifluoromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy or trichloromethoxy.
R17은 가장 특히 바람직하게는 불소, 염소, 브롬, 요오드, 메틸, 트리플루오로메틸 또는 트리플루오로메톡시를 나타낸다.R 17 most particularly preferably represents fluorine, chlorine, bromine, iodine, methyl, trifluoromethyl or trifluoromethoxy.
R17은 특별히 바람직하게는 메틸을 나타낸다.R 17 particularly preferably represents methyl.
R18 및 Rl9는 서로 독립적으로 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 18 and R l9 is independently preferably a hydrogen, fluorine, chlorine, bromine, methyl, ethyl, or 1 to 5 fluorine, chlorine and / or C 1 -C 2 having a bromine atom - represents a haloalkyl.
R18 및 Rl9는 서로 독립적으로 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸, 디플루오로메틸, 트리플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 18 and R l9 represents a methyl, independently of each other, particularly preferably hydrogen, fluorine, chlorine, bromine, methyl, ethyl, difluoro methyl, trifluoromethyl, chloromethyl or trichloromethyl-difluoro.
R18 및 Rl9는 서로 독립적으로 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸, 디플루오로메틸, 트리플루오로메틸 또는 트리클로로메틸을 나타낸다.R 18 and R independently represents a methyl l9 most particularly preferably hydrogen, fluorine, chlorine, bromine, methyl, ethyl, difluoromethyl, methyl, methyl or trifluoromethyl trichloromethyl each other.
R18 및 Rl9는 특별히 바람직하게는 각 경우에 수소를 나타낸다.R 18 and R l9 will be particularly preferably a hydrogen in each case.
R20은 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 20 preferably denotes C 1 -C 2 -haloalkyl having hydrogen, fluorine, chlorine, bromine, methyl, ethyl or 1 to 5 fluorine, chlorine and / or bromine atoms.
R20은 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸 또는 트리플루오로메틸을 나타낸다.R 20 particularly preferably represents hydrogen, fluorine, chlorine, bromine, iodine, methyl or trifluoromethyl.
R20은 가장 특히 바람직하게는 메틸을 나타낸다.R 20 most particularly preferably represents methyl.
R21은 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 하이드록시, 시아노, C1-C4-알킬, 각 경우에 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬, C1-C2-할로알콕시 또는 C1-C2-할로알킬티오를 나타낸다.R 21 is preferably hydrogen, F, Cl, Br, I, hydroxy, cyano, C 1 -C 4 - 1 C with an alkyl, 1 to 5 fluorine, chlorine and / or bromine atoms in each case C 2 -haloalkyl, C 1 -C 2 -haloalkoxy or C 1 -C 2 -haloalkylthio.
R21은 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 하이드록시, 시아노, 메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸, sec-부틸, t-부틸, 디플루오로메틸, 트리플루오로메틸, 디플루오로클로로메틸, 트리클로로메틸, 트리플루오로메톡시, 디플루오로메톡시, 디플루오로클로로메톡시, 트리클로로메톡시, 트리플루오로메틸티오, 디플루오로메틸티오, 디플루오로클로로메틸티오 또는 트리클로로메틸티오를 나타낸다.R 21 is particularly preferably hydrogen, fluorine, chlorine, bromine, iodine, hydroxy, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, di Fluoromethyl, trifluoromethyl, difluorochloromethyl, trichloromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, trichloromethoxy, trifluoromethylthio, difluoromethyl Thio, difluorochloromethylthio or trichloromethylthio.
R21은 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸, 디플루오로메틸, 트리플루오로메틸 또는 트리클로로메틸을 나타낸다.R 21 most particularly preferably represents hydrogen, fluorine, chlorine, bromine, iodine, methyl, difluoromethyl, trifluoromethyl or trichloromethyl.
R21은 특별히 바람직하게는 요오드, 메틸, 디플루오로메틸 또는 트리플루오로메틸을 나타낸다.R 21 particularly preferably represents iodine, methyl, difluoromethyl or trifluoromethyl.
R22는 바람직하게는 불소, 염소, 브롬, 요오드, 하이드록시, 시아노, C1-C4-알킬, 메톡시, 에톡시, 메틸티오, 에틸티오, 디플루오로메틸티오, 트리플루오로메틸티오, 각 경우에 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬 또는 C1-C2-할로알콕시를 나타낸다.R 22 is preferably fluorine, chlorine, bromine, iodine, hydroxy, cyano, C 1 -C 4 -alkyl, methoxy, ethoxy, methylthio, ethylthio, difluoromethylthio, trifluoromethyl Thio, in each case C 1 -C 2 -haloalkyl or C 1 -C 2 -haloalkoxy having 1 to 5 fluorine, chlorine and / or bromine atoms.
R22는 특히 바람직하게는 불소, 염소, 브롬, 요오드, 하이드록시, 시아노, 메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸, sec-부틸, t-부틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸, 트리클로로메틸, 메톡시, 에 톡시, 메틸티오, 에틸티오, 디플루오로메틸티오, 트리플루오로메틸티오, 트리플루오로메톡시, 디플루오로메톡시, 디플루오로클로로메톡시 또는 트리클로로메톡시를 나타낸다.R 22 is particularly preferably fluorine, chlorine, bromine, iodine, hydroxy, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, trifluoro Methyl, difluoromethyl, difluorochloromethyl, trichloromethyl, methoxy, ethoxy, methylthio, ethylthio, difluoromethylthio, trifluoromethylthio, trifluoromethoxy, difluoromethoxy , Difluorochloromethoxy or trichloromethoxy.
R22는 가장 특히 바람직하게는 불소, 염소, 브롬, 요오드, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 22 most particularly preferably represents fluorine, chlorine, bromine, iodine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R23은 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 시아노, C1-C4-알킬, 메톡시, 에톡시, 메틸티오, 에틸티오, 각 경우에 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬 또는 C1-C2-할로알콕시, C1-C2-알킬설피닐 또는 C1-C2-알킬설포닐을 나타낸다.R 23 is preferably hydrogen, fluorine, chlorine, bromine, iodine, cyano, C 1 -C 4 -alkyl, methoxy, ethoxy, methylthio, ethylthio, in each case 1 to 5 fluorine, chlorine and Or C 1 -C 2 -haloalkyl or C 1 -C 2 -haloalkoxy, C 1 -C 2 -alkylsulfinyl or C 1 -C 2 -alkylsulfonyl having a bromine atom.
R23은 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 시아노, n-프로필, 이소프로필, n-부틸, 이소부틸, sec-부틸, t-부틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸, 트리클로로메틸, 메톡시, 에톡시, 메틸티오, 에틸티오, 트리플루오로메톡시, 디플루오로메톡시, 디플루오로클로로메톡시, 트리클로로메톡시, 메틸설피닐 또는 메틸설포닐을 나타낸다.R 23 is particularly preferably hydrogen, fluorine, chlorine, bromine, iodine, cyano, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, trifluoromethyl, difluoro Methyl, difluorochloromethyl, trichloromethyl, methoxy, ethoxy, methylthio, ethylthio, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, trichloromethoxy, methylsulfinyl or methyl Sulfonyl.
R23은 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, n-프로필, 이소프로필, n-부틸, 이소부틸, sec-부틸, t-부틸, 트리플루오로메틸, 디플루오로메틸, 트리클로로메틸 , 메틸설피닐 또는 메틸설포닐을 나타낸다.R 23 is most particularly preferably hydrogen, fluorine, chlorine, bromine, iodine, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, trifluoromethyl, difluoromethyl, Trichloromethyl, methylsulfinyl or methylsulfonyl.
R23은 특별히 바람직하게는 수소를 나타낸다.R 23 particularly preferably represents hydrogen.
R24는 바람직하게는 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 24 preferably represents methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R24는 특히 바람직하게는 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 24 particularly preferably represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R25는 바람직하게는 메틸 또는 에틸을 나타낸다.R 25 preferably denotes methyl or ethyl.
R25는 특히 바람직하게는 메틸을 나타낸다.R 25 particularly preferably represents methyl.
Q1은 바람직하게는 S(황), SO2 또는 CH2를 나타낸다.Q 1 preferably represents S (sulfur), SO 2 or CH 2 .
Q1은 특히 바람직하게는 S(황) 또는 CH2를 나타낸다.Q 1 particularly preferably represents S (sulfur) or CH 2 .
Q1은 가장 특히 바람직하게는 S(황)를 나타낸다.Q 1 most particularly preferably represents S (sulfur).
p는 바람직하게는 0 또는 1을 나타낸다.p preferably represents 0 or 1;
p는 특히 바람직하게는 0을 나타낸다.p particularly preferably represents 0.
R26은 바람직하게는 메틸, 에틸, 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 26 preferably represents methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R26은 특히 바람직하게는 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다. R 26 particularly preferably represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R26은 가장 특히 바람직하게는 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다. R 26 most particularly preferably represents methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R27은 바람직하게는 메틸, 에틸, 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 27 preferably denotes C 1 -C 2 -haloalkyl having methyl, ethyl or 1 to 5 fluorine, chlorine and / or bromine atoms.
R27은 특히 바람직하게는 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다. R 27 particularly preferably represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R27은 가장 특히 바람직하게는 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다. R 27 most particularly preferably represents methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R28 및 R29는 서로 독립적으로 바람직하게는 수소, 불소, 염소, 브롬, 아미노, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다. R 28 and R 29 independently of one another preferably represent hydrogen, fluorine, chlorine, bromine, amino, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms .
R28 및 R29는 서로 독립적으로 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다. R 28 and R 29 independently of one another particularly preferably represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R28 및 R29는 서로 독립적으로 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 28 and R 29 independently of one another most particularly preferably represent hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R28 및 R29는 특별히 바람직하게는 각 경우에 수소를 나타낸다.R 28 and R 29 particularly preferably represent hydrogen in each case.
R30은 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 30 preferably denotes C 1 -C 2 -haloalkyl having hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl or 1 to 5 fluorine, chlorine and / or bromine atoms.
R30은 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 30 particularly preferably represents hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R30은 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 30 most particularly preferably represents hydrogen, fluorine, chlorine, bromine, iodine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R30은 특별히 바람직하게는 메틸을 나타낸다.R 30 particularly preferably represents methyl.
R31 및 R32는 서로 독립적으로 바람직하게는 수소, 불소, 염소, 브롬, 아미노, 니트로, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 31 and R 32 are independently of each other preferably hydrogen, fluorine, chlorine, bromine, amino, nitro, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms Indicates.
R31 및 R32는 서로 독립적으로 특히 바람직하게는 수소, 불소, 염소, 브롬, 니트로, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 31 and R 32 independently of one another particularly preferably represent hydrogen, fluorine, chlorine, bromine, nitro, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R31 및 R32는 서로 독립적으로 가장 특히 바람직하게는 수소, 불소, 염소, 브 롬, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 31 and R 32 independently of one another most particularly preferably represent hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R31 및 R32는 특별히 바람직하게는 각 경우에 수소를 나타낸다.R 31 and R 32 particularly preferably represent hydrogen in each case.
R33은 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 33 preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R33은 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 33 particularly preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R33은 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 33 most particularly preferably represents hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R33은 특별히 바람직하게는 메틸을 나타낸다.R 33 particularly preferably represents methyl.
R34는 바람직하게는 수소, 불소, 염소, 브롬, 아미노, C1-C4-알킬아미노, 디(C1-C4-알킬)아미노, 시아노, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 34 is preferably hydrogen, fluorine, chlorine, bromine, amino, C 1 -C 4 -alkylamino, di (C 1 -C 4 -alkyl) amino, cyano, methyl, ethyl or 1 to 5 fluorine, C 1 -C 2 -haloalkyl having chlorine and / or bromine atoms.
R34는 특히 바람직하게는 수소, 불소, 염소, 브롬, 아미노, 메틸아미노, 디메틸아미노, 시아노, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 34 is particularly preferably hydrogen, fluorine, chlorine, bromine, amino, methylamino, dimethylamino, cyano, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl Indicates.
R34는 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 아미노, 메틸아미 노, 디메틸아미노, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 34 most particularly preferably represents hydrogen, fluorine, chlorine, bromine, amino, methylamino, dimethylamino, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R34는 특별히 바람직하게는 아미노, 메틸아미노, 디메틸아미노, 메틸 또는 트리플루오로메틸을 나타낸다.R 34 particularly preferably represents amino, methylamino, dimethylamino, methyl or trifluoromethyl.
R35는 바람직하게는 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 35 preferably represents fluorine, chlorine, bromine, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R35는 특히 바람직하게는 불소, 염소, 브롬, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 35 particularly preferably represents fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R35는 가장 특히 바람직하게는 불소, 염소, 브롬, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 35 most particularly preferably represents fluorine, chlorine, bromine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R35는 특별히 바람직하게는 메틸, 트리플루오로메틸 또는 디플루오로메틸을 나타낸다.R 35 particularly preferably represents methyl, trifluoromethyl or difluoromethyl.
R36은 바람직하게는 수소, 불소, 염소, 브롬, 아미노, C1-C4-알킬아미노, 디(C1-C4-알킬)아미노, 시아노, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 36 is preferably hydrogen, fluorine, chlorine, bromine, amino, C 1 -C 4 -alkylamino, di (C 1 -C 4 -alkyl) amino, cyano, methyl, ethyl or 1 to 5 fluorine, C 1 -C 2 -haloalkyl having chlorine and / or bromine atoms.
R36은 특히 바람직하게는 수소, 불소, 염소, 브롬, 아미노, 메틸아미노, 디 메틸아미노, 시아노, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 36 is particularly preferably hydrogen, fluorine, chlorine, bromine, amino, methylamino, dimethylamino, cyano, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl Indicates.
R36은 가장 특히 바람직하게는 수소, 불소, 염소, 브롬, 아미노, 메틸아미노, 디메틸아미노, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 36 most particularly preferably represents hydrogen, fluorine, chlorine, bromine, amino, methylamino, dimethylamino, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R36은 특별히 바람직하게는 아미노, 메틸아미노, 디메틸아미노, 메틸 또는 트리플루오로메틸을 나타낸다.R 36 particularly preferably represents amino, methylamino, dimethylamino, methyl or trifluoromethyl.
R37은 바람직하게는 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 37 preferably denotes C 1 -C 2 -haloalkyl having fluorine, chlorine, bromine, methyl, ethyl or 1 to 5 fluorine, chlorine and / or bromine atoms.
R37은 특히 바람직하게는 불소, 염소, 브롬, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 37 particularly preferably represents fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R37은 가장 특히 바람직하게는 불소, 염소, 브롬, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 37 most particularly preferably represents fluorine, chlorine, bromine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R37은 특별히 바람직하게는 메틸, 트리플루오로메틸 또는 디플루오로메틸을 나타낸다.R 37 particularly preferably represents methyl, trifluoromethyl or difluoromethyl.
R38은 바람직하게는 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 38 preferably represents fluorine, chlorine, bromine, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R38은 특히 바람직하게는 불소, 염소, 브롬, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 38 particularly preferably represents fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R38은 가장 특히 바람직하게는 불소, 염소, 브롬, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 38 most particularly preferably represents fluorine, chlorine, bromine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R39는 바람직하게는 수소, 메틸 또는 에틸을 나타낸다.R 39 preferably denotes hydrogen, methyl or ethyl.
R39는 특히 바람직하게는 메틸을 나타낸다.R 39 particularly preferably represents methyl.
R40은 바람직하게는 불소, 염소, 브롬, 메틸 또는 에틸을 나타낸다.R 40 preferably represents fluorine, chlorine, bromine, methyl or ethyl.
R40은 특히 바람직하게는 불소, 염소 또는 메틸을 나타낸다.R 40 particularly preferably represents fluorine, chlorine or methyl.
R41은 바람직하게는 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 41 preferably represents methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R41은 특히 바람직하게는 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 41 particularly preferably represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R41은 가장 특히 바람직하게는 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 41 most particularly preferably represents methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R41은 특별히 바람직하게는 메틸 또는 트리플루오로메틸을 나타낸다.R 41 particularly preferably represents methyl or trifluoromethyl.
R42는 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 42 preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R42는 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸 또는 트리플루오로메틸을 나타낸다.R 42 particularly preferably represents hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl.
R43은 바람직하게는 불소, 염소, 브롬, 요오드, 하이드록시, C1-C4-알킬, 메톡시, 에톡시, 메틸티오, 에틸티오, 디플루오로메틸티오, 트리플루오로메틸티오, 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬 또는 C1-C2-할로알콕시를 나타낸다.R 43 is preferably fluorine, chlorine, bromine, iodine, hydroxy, C 1 -C 4 -alkyl, methoxy, ethoxy, methylthio, ethylthio, difluoromethylthio, trifluoromethylthio, or C 1 -C 2 -haloalkyl or C 1 -C 2 -haloalkoxy having 1 to 5 fluorine, chlorine and / or bromine atoms.
R43은 특히 바람직하게는 불소, 염소, 브롬, 요오드, 메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸, sec-부틸, t-부틸, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸, 트리클로로메틸을 나타낸다.R 43 is particularly preferably fluorine, chlorine, bromine, iodine, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, trifluoromethyl, difluoromethyl , Difluorochloromethyl and trichloromethyl are shown.
R43은 가장 특히 바람직하게는 불소, 염소, 브롬, 요오드, 메틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 43 most particularly preferably represents fluorine, chlorine, bromine, iodine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R44는 바람직하게는 수소, 메틸, 에틸, 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬, C1-C4-알콕시-C1-C4-알킬, 하이드록시메틸, 하이드록시에틸, 메틸설포닐 또는 디메틸아미노설포닐을 나타낸다.R 44 is preferably hydrogen, methyl, ethyl, C 1 -C 2 -haloalkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl having 1 to 5 fluorine, chlorine and / or bromine atoms , Hydroxymethyl, hydroxyethyl, methylsulfonyl or dimethylaminosulfonyl.
R44는 특히 바람직하게는 수소, 메틸, 에틸, 트리플루오로메틸, 메톡시메틸, 에톡시메틸, 하이드록시메틸 또는 하이드록시에틸을 나타낸다.R 44 particularly preferably represents hydrogen, methyl, ethyl, trifluoromethyl, methoxymethyl, ethoxymethyl, hydroxymethyl or hydroxyethyl.
R44는 가장 특히 바람직하게는 메틸 또는 메톡시메틸을 나타낸다.R 44 most particularly preferably represents methyl or methoxymethyl.
R45는 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 45 preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R45는 특히 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸, 트리플루오로메틸, 디플루오로메틸 또는 트리클로로메틸을 나타낸다.R 45 particularly preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R45는 가장 특히 바람직하게는 수소 또는 메틸을 나타낸다. R 45 most particularly preferably represents hydrogen or methyl.
R46은 바람직하게는 수소, 불소, 염소, 브롬, 시아노, 메틸, 에틸, 이소프로필 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 46 preferably represents hydrogen, fluorine, chlorine, bromine, cyano, methyl, ethyl, isopropyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R46은 특히 바람직하게는 수소, 불소, 염소, 브롬, 시아노, 메틸, 에틸, 이소프로필, 트리플루오로메틸, 디플루오로메틸, 디플루오로클로로메틸 또는 트리클로로메틸을 나타낸다.R 46 particularly preferably represents hydrogen, fluorine, chlorine, bromine, cyano, methyl, ethyl, isopropyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R46은 가장 특히 바람직하게는 수소, 메틸, 디플루오로메틸 또는 트리플루오로메틸을 나타낸다.R 46 most particularly preferably represents hydrogen, methyl, difluoromethyl or trifluoromethyl.
R47은 바람직하게는 수소, 불소, 염소, 브롬, 메틸, 에틸 또는 1 내지 5개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C2-할로알킬을 나타낸다.R 47 preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5 fluorine, chlorine and / or bromine atoms.
R47은 특히 바람직하게는 수소, 불소, 염소, 브롬, 요오드, 메틸 또는 트리플루오로메틸을 나타낸다.R 47 particularly preferably represents hydrogen, fluorine, chlorine, bromine, iodine, methyl or trifluoromethyl.
R47은 가장 특히 바람직하게는 수소를 나타낸다.R 47 most particularly preferably represents hydrogen.
R48은 바람직하게는 메틸, 에틸, n-프로필 또는 이소프로필을 나타낸다.R 48 preferably denotes methyl, ethyl, n-propyl or isopropyl.
R48은 특히 바람직하게는 메틸 또는 에틸을 나타낸다.R 48 particularly preferably represents methyl or ethyl.
바람직한 구체예는 모든 그룹이 각 경우에 상기에 인용된 바람직한 의미를 가지는 화학식 (I)에 상응하는 화합물이다.Preferred embodiments are compounds corresponding to formula (I) in which all groups have in each case the preferred meaning cited above.
특히 바람직한 구체예는 모든 그룹이 각 경우에 상기에 인용된 특히 바람직한 의미를 가지는 화학식 (I)에 상응하는 화합물이다.Particularly preferred embodiments are compounds corresponding to formula (I) in which all groups have in each case the particularly preferred meaning cited above.
하기 그룹의 신규 카복사미드가 바람직하고, 각각은 상기 인용된 화학식 (I)에 상응하는 화합물의 일부로 간주된다.New carboxamides of the following groups are preferred, each of which is considered to be part of a compound corresponding to formula (I) cited above.
그룹 1: 화학식 (I-a)의 카복사미드:Group 1: carboxamide of formula (I-a):
상기 식에서,Where
M, L1, Q, L2, R 및 A는 상기 정의된 바와 같다.M, L 1 , Q, L 2 , R and A are as defined above.
그룹 2: 화학식 (I-b)의 카복사미드:Group 2: carboxamide of formula (I-b):
상기 식에서,Where
R1-A, M, L1, Q, L2, R 및 A는 상기 정의된 바와 같다.R 1 -A , M, L 1 , Q, L 2 , R and A are as defined above.
R1-A는 바람직하게는 C1-C6-알킬, C1-C4-알킬설피닐, C1-C4-알킬설포닐, C1-C3-알콕시-C1-C3-알킬, C3-C6-사이클로알킬; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 C1-C4-할로알킬, C1-C4-할로알킬티오, C1-C4-할로알킬설피닐, C1-C4-할로알킬설포닐, 할로-C1-C3-알콕시-C1-C3-알킬 또는 C3-C8-할로사이클로알킬; 포르밀, 포르밀-C1-C3-알킬, (C1-C3-알킬)카보닐-C1-C3-알킬, (C1-C3-알콕시)카보닐-C1-C3-알킬; 각 경우에 1 내지 13개의 불소, 염소 및/또는 브롬 원자를 가지는 할로-(C1-C3-알킬)카보닐-C1-C3-알킬, 할로-(C1-C3-알콕시)카보닐-C1-C3-알킬; (C1-C6-알킬)카보닐, (C1-C4-알콕시)카보닐, (C1-C3-알콕시-C1-C3-알킬)카보닐, (C3-C6-사이클로알킬)카보닐; 각 경우에 1 내지 9개의 불소, 염소 및/또는 브롬 원자를 가지는 (C1-C4-할로알킬)카보닐, (C1-C4-할로알콕시)카보닐, (할로-C1-C3-알콕시-C1-C3-알킬) 카보닐, (C3-C6-할로사이클로알킬)카보닐; 또는 -C(=O)C(=O)R2, -CONR3R4 또는 -CH2NR5R6을 나타낸다.R 1 -A is preferably C 1 -C 6 -alkyl, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 3 -alkoxy-C 1 -C 3- Alkyl, C 3 -C 6 -cycloalkyl; Having 1 to 9 fluorine, chlorine and / or bromine atoms in each case C 1 -C 4 - haloalkyl, C 1 -C 4 - haloalkylthio, C 1 -C 4 - haloalkyl sulfinyl, C 1 - C 4 -haloalkylsulfonyl, halo-C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl or C 3 -C 8 -halocycloalkyl; Formyl, formyl-C 1 -C 3 -alkyl, (C 1 -C 3 -alkyl) carbonyl-C 1 -C 3 -alkyl, (C 1 -C 3 -alkoxy) carbonyl-C 1 -C 3 -alkyl; Halo- (C 1 -C 3 -alkyl) carbonyl-C 1 -C 3 -alkyl, halo- (C 1 -C 3 -alkoxy) having 1 to 13 fluorine, chlorine and / or bromine atoms in each case Carbonyl-C 1 -C 3 -alkyl; (C 1 -C 6 -alkyl) carbonyl, (C 1 -C 4 -alkoxy) carbonyl, (C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl) carbonyl, (C 3 -C 6 -Cycloalkyl) carbonyl; (C 1 -C 4 -haloalkyl) carbonyl, (C 1 -C 4 -haloalkoxy) carbonyl, (halo-C 1 -C) having 1 to 9 fluorine, chlorine and / or bromine atoms in each case 3 -alkoxy-C 1 -C 3 -alkyl) carbonyl, (C 3 -C 6 -halocycloalkyl) carbonyl; Or -C (= 0) C (= 0) R 2 , -CONR 3 R 4 or -CH 2 NR 5 R 6 .
R1-A는 특히 바람직하게는 메틸, 에틸, n- 또는 이소프로필, n-, 이소-, sec- 또는 t-부틸, 펜틸, 헥실, 메틸설피닐, 에틸설피닐, n- 또는 이소프로필설피닐, n-, 이소-, sec- 또는 t-부틸설피닐, 메틸설포닐, 에틸설포닐, n- 또는 이소프로필설포닐, n-, 이소-, sec- 또는 t-부틸설포닐, 메톡시메틸, 메톡시에틸, 에톡시메틸, 에톡시에틸, 사이클로프로필, 사이클로펜틸, 사이클로헥실, 트리플루오로메틸, 트리클로로메틸, 트리플루오로에틸, 디플루오로메틸티오, 디플루오로클로로메틸티오, 트리플루오로메틸티오, 트리플루오로메틸설피닐, 트리플루오로메틸설포닐, 트리플루오로메톡시메틸, 포르밀, -CH2-CHO, -(CH2)2-CHO, -CH2-CO-CH3, -CH2-CO-CH2CH3, -CH2-CO-CH(CH3)2, -(CH2)2-CO-CH3, -(CH2)2-CO-CH2CH3, -(CH2)2-CO-CH(CH3)2, -CH2-CO2CH3, -CH2-CO2CH2CH3, -CH2-CO2CH(CH3)2, -(CH2)2-CO2CH3, -(CH2)2-CO2CH2CH3, -(CH2)2-CO2CH(CH3)2, -CH2-CO-CF3, -CH2-CO-CCl3, -CH2-CO-CH2CF3, -CH2-CO-CH2CCl3, -(CH2)2-CO-CH2CF3, -(CH2)2-CO-CH2CCl3, -CH2-CO2CH2CF3, -CH2-CO2CF2CF3, -CH2-CO2CH2CCl3, -CH2-CO2CCl2CCl3, -(CH2)2-CO2CH2CF3, -(CH2)2-CO2CF2CF3, -(CH2)2-CO2CH2CCl3, -(CH2)2-CO2-CCl2CCl3, 메틸카보닐, 에틸카보닐, n-프로필카보닐, 이소프 로필카보닐, t-부틸카보닐, 메톡시카보닐, 에톡시카보닐, t-부톡시카보닐, 사이클로프로필카보닐, 트리플루오로메틸카보닐, 트리플루오로메톡시카보닐, -C(=0)C(=0)R2, -CONR3R4 또는 -CH2NR5R6을 나타낸다.R 1-A is particularly preferably methyl, ethyl, n- or isopropyl, n-, iso-, sec- or t-butyl, pentyl, hexyl, methylsulfinyl, ethylsulfinyl, n- or isopropylsulphi Nyl, n-, iso-, sec- or t-butylsulfinyl, methylsulfonyl, ethylsulfonyl, n- or isopropylsulfonyl, n-, iso-, sec- or t-butylsulfonyl, methoxy Methyl, methoxyethyl, ethoxymethyl, ethoxyethyl, cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethyl, trichloromethyl, trifluoroethyl, difluoromethylthio, difluorochloromethylthio, Trifluoromethylthio, trifluoromethylsulfinyl, trifluoromethylsulfonyl, trifluoromethoxymethyl, formyl, -CH 2 -CHO,-(CH 2 ) 2 -CHO, -CH 2 -CO- CH 3 , -CH 2 -CO-CH 2 CH 3 , -CH 2 -CO-CH (CH 3 ) 2 ,-(CH 2 ) 2 -CO-CH 3 ,-(CH 2 ) 2 -CO-CH 2 CH 3 ,-(CH 2 ) 2 -CO-CH (CH 3 ) 2 , -CH 2 -CO 2 CH 3 , -CH 2 -CO 2 CH 2 CH 3 , -CH 2 -C O 2 CH (CH 3 ) 2 ,-(CH 2 ) 2 -CO 2 CH 3 ,-(CH 2 ) 2 -CO 2 CH 2 CH 3 ,-(CH 2 ) 2 -CO 2 CH (CH 3 ) 2 , -CH 2 -CO-CF 3 , -CH 2 -CO-CCl 3 , -CH 2 -CO-CH 2 CF 3 , -CH 2 -CO-CH 2 CCl 3 ,-(CH 2 ) 2 -CO- CH 2 CF 3 ,-(CH 2 ) 2 -CO-CH 2 CCl 3 , -CH 2 -CO 2 CH 2 CF 3 , -CH 2 -CO 2 CF 2 CF 3 , -CH 2 -CO 2 CH 2 CCl 3 , -CH 2 -CO 2 CCl 2 CCl 3 ,-(CH 2 ) 2 -CO 2 CH 2 CF 3 ,-(CH 2 ) 2 -CO 2 CF 2 CF 3 ,-(CH 2 ) 2 -CO 2 CH 2 CCl 3 ,-(CH 2 ) 2 -CO 2 -CCl 2 CCl 3 , methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, t-butylcarbonyl, methoxycarbonyl, Ethoxycarbonyl, t-butoxycarbonyl, cyclopropylcarbonyl, trifluoromethylcarbonyl, trifluoromethoxycarbonyl, -C (= 0) C (= 0) R 2 , -CONR 3 R 4 Or -CH 2 NR 5 R 6 .
R1-A는 가장 특히 바람직하게는 메틸, 메톡시메틸, 포르밀, -CH2-CHO, -(CH2)2-CHO, -CH2-CO-CH3, -CH2-CO-CH2CH3, -CH2-CO-CH(CH3)2, -C(=O)CHO, -C(=O)C(=O)CH3, -C(=O)C(=O)CH2OCH3, -C(=O)CO2CH3 또는 -C(=O)CO2CH2CH3를 나타낸다. R 1-A is most particularly preferably methyl, methoxymethyl, formyl, -CH 2 -CHO,-(CH 2 ) 2 -CHO, -CH 2 -CO-CH 3 , -CH 2 -CO-CH 2 CH 3 , -CH 2 -CO-CH (CH 3 ) 2 , -C (= O) CHO, -C (= O) C (= O) CH 3 , -C (= O) C (= O) CH 2 OCH 3 , —C (═O) CO 2 CH 3 or —C (═O) CO 2 CH 2 CH 3 .
그룹 3: 화학식 (I-c)의 카복사미드:Group 3: carboxamide of formula (I-c):
상기 식에서,Where
R1, R8, L1, Q, L2, R 및 A는 상기 정의된 바와 같다.R 1 , R 8 , L 1 , Q, L 2 , R and A are as defined above.
바람직한 구체예는 R1이 수소를 나타내는 화학식 (I-c)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ic) in which R 1 represents hydrogen.
바람직한 구체예는 R8이 수소를 나타내는 화학식 (I-c)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ic) in which R 8 represents hydrogen.
바람직한 구체예는 R1 및 R8이 각각 수소를 나타내는 화학식 (I-c)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ic) in which R 1 and R 8 each represent hydrogen.
그룹 4: 화학식 (I-d)의 카복사미드:Group 4: carboxamide of formula (I-d):
상기 식에서,Where
R1, R8, L1, Q, L2, R 및 A는 상기 정의된 바와 같다.R 1 , R 8 , L 1 , Q, L 2 , R and A are as defined above.
바람직한 구체예는 R1이 수소를 나타내는 화학식 (I-d)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Id) wherein R 1 represents hydrogen.
바람직한 구체예는 R8이 수소를 나타내는 화학식 (I-d)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Id) wherein R 8 represents hydrogen.
바람직한 구체예는 R1 및 R8이 각각 수소를 나타내는 화학식 (I-d)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Id) in which R 1 and R 8 each represent hydrogen.
그룹 5: 화학식 (I-e)의 카복사미드:Group 5: carboxamide of formula (I-e):
상기 식에서,Where
R1, R8, L1, Q, L2, R 및 A는 상기 정의된 바와 같다.R 1 , R 8 , L 1 , Q, L 2 , R and A are as defined above.
바람직한 구체예는 R1이 수소를 나타내는 화학식 (I-e)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ie) in which R 1 represents hydrogen.
바람직한 구체예는 R8이 수소를 나타내는 화학식 (I-e)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ie) in which R 8 represents hydrogen.
바람직한 구체예는 R1 및 R8이 각각 수소를 나타내는 화학식 (I-e)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ie) in which R 1 and R 8 each represent hydrogen.
그룹 6: 화학식 (I-f)의 카복사미드:Group 6: carboxamide of formula (I-f):
상기 식에서,Where
R1, R8, L1, Q, L2, R 및 A는 상기 정의된 바와 같다.R 1 , R 8 , L 1 , Q, L 2 , R and A are as defined above.
바람직한 구체예는 R1이 수소를 나타내는 화학식 (I-f)의 카복사미드이다.Preferred embodiments are carboxamides of formula (If) wherein R 1 represents hydrogen.
바람직한 구체예는 R8이 수소를 나타내는 화학식 (I-f)의 카복사미드이다.Preferred embodiments are carboxamides of formula (If) in which R 8 represents hydrogen.
바람직한 구체예는 R1 및 R8이 각각 수소를 나타내는 화학식 (I-f)의 카복사미드이다.Preferred embodiments are carboxamides of formula (If) in which R 1 and R 8 each represent hydrogen.
그룹 7: 화학식 (I-g)의 카복사미드:Group 7: carboxamide of formula (I-g):
상기 식에서,Where
R1, R8, L1, Q, L2, R 및 A는 상기 정의된 바와 같다.R 1 , R 8 , L 1 , Q, L 2 , R and A are as defined above.
바람직한 구체예는 R1이 수소를 나타내는 화학식 (I-g)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ig) in which R 1 represents hydrogen.
바람직한 구체예는 R8이 수소를 나타내는 화학식 (I-g)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ig) wherein R 8 represents hydrogen.
바람직한 구체예는 R1 및 R8이 각각 수소를 나타내는 화학식 (I-g)의 카복사미드이다.Preferred embodiments are carboxamides of formula (Ig) in which R 1 and R 8 each represent hydrogen.
R1이 수소를 나타내는 화학식 (I)의 화합물(및 그룹 1 내지 7)이 강조된다.Emphasis is given to compounds of formula (I) in which R 1 represents hydrogen (and groups 1 to 7).
R1이 포르밀을 나타내는 화학식 (I)의 화합물(및 그룹 1 내지 7)이 강조된다.Emphasis is given to compounds of formula (I) in which R 1 represents formyl (and groups 1 to 7).
R1이 -C(=O)C(=O)R2를 나타내고, R2는 상기 정의된 바와 같은 화학식 (I)의 화합물(및 그룹 1 내지 7)이 강조된다.R 1 represents —C (═O) C (═O) R 2 , with R 2 accentuating the compounds of formula (I) as defined above (and groups 1 to 7).
예를 들어, 알콕시에서와 같이 헤테로 원자와 결합된 것을 포함하여 알킬 또는 알케닐과 같은 포화 또는 불포화된 탄화수소 래디칼은 가능한 한, 각 경우에 직쇄 또는 측쇄일 수 있다. 마찬가지로, 알킬렌(알칸디일)과 같은 이중결합의 탄화수소 그룹은 가능한 한, 각 경우에 직쇄 또는 측쇄일 수 있다.For example, saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl can be as straight or branched as possible in each case, including those bonded with heteroatoms such as in alkoxy. Likewise, double bond hydrocarbon groups, such as alkylene (alkanediyl), can in each case be as straight or branched as possible.
임의로 치환된 래디칼은 일- 또는 다치환될 수 있으며, 다치환된 경우 치환체는 동일하거나 상이할 수 있다. 따라서, 정의 "디알킬아미노"는 또한 비대칭적으로 치환된 아미노 그룹, 예를 들어 메틸에틸아미노를 포함한다.The optionally substituted radical may be mono- or polysubstituted, and when polysubstituted, the substituents may be the same or different. Thus, the definition "dialkylamino" also includes asymmetrically substituted amino groups, such as methylethylamino.
예를 들어 할로알킬과 같이 할로겐-치환된 래디칼은 모노- 또는 폴리할로겐화된다. 폴리할로겐화된 경우, 할로겐 원자는 동일하거나 상이할 수 있다. 여기에서, 할로겐은 불소, 염소, 브롬 및 요오드, 특히 불소, 염소 및 브롬을 나타낸다.Halogen-substituted radicals, such as for example haloalkyl, are mono- or polyhalogenated. In the case of polyhalogenated halogen atoms may be the same or different. Here, halogen represents fluorine, chlorine, bromine and iodine, in particular fluorine, chlorine and bromine.
그러나, 상기에 주어진 일반적이거나 바람직한 래디칼의 정의 및/또는 설명은 필요에 따라 각각의 범위와 바람직한 범위 사이에서 서로 조합될 수 있다. 이들 정의는 최종 생성물 및, 상응하게 전구체 및 중간체 모두에 적용된다. 특히, 그룹 1 내지 6에 언급된 정의들은 일반적이거나, 바람직하거나 특히 바람직한 것 등의 정의와 함께 조합될 수 있으며, 여기에서는 바람직한 영역의 모든 조합이 각 경우에 가능하다.However, the definitions and / or descriptions of the general or preferred radicals given above may be combined with one another between each range and the preferred range as necessary. These definitions apply to both the final product and, correspondingly, to precursors and intermediates. In particular, the definitions mentioned in groups 1 to 6 may be combined with definitions such as general, preferred or particularly preferred, where all combinations of preferred regions are possible in each case.
화학식 (I)의 헥실카복스아닐리드 및 중간체 생성물을 합성하기 위한 본 발명에 따른 방법의 설명Description of the process according to the invention for synthesizing hexylcarboxanilide and intermediate products of formula (I)
방법 (a)Method (a)
출발물질로 2-트리플루오로메틸벤조일 클로라이드 및 {2-[1-(이소프로필설포닐)에틸]페닐}아민을 사용하는 경우, 본 발명에 따른 방법 (a)의 과정은 하기 반응식으로 나타내어질 수 있다:When using 2-trifluoromethylbenzoyl chloride and {2- [1- (isopropylsulfonyl) ethyl] phenyl} amine as starting materials, the process of the method (a) according to the present invention can be represented by the following scheme. Can:
본 발명에 따른 방법 (a)를 수행하는데 출발물질로 필요한 카복실산 유도체는 화학식 (II)에 의해 일반적으로 정의된다. 이 화학식 (II)에서, A는 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I)의 화합물의 설명과 관련하여 A에 대해 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다. X1은 바람직하게는 염소, 브롬 또는 하이드록시를 나타낸다.Carboxylic acid derivatives required as starting materials for carrying out process (a) according to the invention are generally defined by formula (II). In this formula (II), A is preferably, particularly preferably or most particularly preferably mentioned above as preferred, particularly preferred or very particularly preferred for A with respect to the description of the compounds of formula (I) according to the invention. Has a meaning. X 1 preferably represents chlorine, bromine or hydroxy.
대부분의 화학식 (II)의 카복실산 유도체는 공지되었고/되었거나 공지된 방법에 의해 합성될 수 있다(참조: WO 93/11117, EP-A 0 545 099, EP-A 0 589 301 및 EP-A 0 589 313).Most of the carboxylic acid derivatives of formula (II) are known and / or can be synthesized by known methods (see WO 93/11117, EP-A 0 545 099, EP-A 0 589 301 and EP-A 0 589). 313).
본 발명에 따른 방법 (a)를 수행하는데 출발물질로 또한 필요한 아닐린 유도체는 화학식 (III)에 의해 일반적으로 정의된다. 이 화학식 (III)에서, R1, M, Q, L2 및 R은 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다. L3은 바람직하게는 수소 또는 C1-C5-알킬, 특히 바람직하게는 수소 또는 메틸을 나타낸다.Aniline derivatives which are also necessary as starting materials for carrying out process (a) according to the invention are generally defined by formula (III). In this formula (III), R 1 , M, Q, L 2 and R are preferably, particularly preferably or most particularly preferably for these radicals in connection with the description of the compounds of formula (I) according to the invention. Each has the meanings mentioned above as being preferred, particularly preferred or very particularly preferred. L 3 preferably denotes hydrogen or C 1 -C 5 -alkyl, particularly preferably hydrogen or methyl.
화학식 (III)의 아닐린 유도체는 신규하다.The aniline derivatives of formula (III) are novel.
화학식 (III-a)의 아닐린 유도체는Aniline derivatives of formula (III-a)
d) 화학식 (III-b)의 아닐린 유도체를 염기의 존재하 및 경우에 따라 희석 매질의 존재하에서 화학식 (VI)의 할라이드와 반응시킴으로써 수득됨이 밝혀졌다:d) It has been found that the aniline derivatives of formula (III-b) are obtained by reacting with a halide of formula (VI) in the presence of a base and optionally in the presence of a dilution medium:
상기 식에서,Where
R1-A, M, Q, L2, R, L3 및 X2는 상기 정의된 바와 같다.R 1 -A , M, Q, L 2 , R, L 3 and X 2 are as defined above.
화학식 (III-b)의 아닐린 유도체는Aniline derivatives of formula (III-b)
e) 화학식 (VII)의 니트로 화합물을 금속 및 환원제의 존재하, 경우에 따라 희석제의 존재하 및 경우에 따라 반응 매질의 존재하에서 반응시킴으로써 수득됨이 밝혀졌다:e) It has been found that the nitro compound of formula (VII) is obtained by reacting in the presence of a metal and a reducing agent, optionally in the presence of a diluent and optionally in the presence of a reaction medium:
상기 식에서,Where
M, Q, L2, R 및 L3은 상기 정의된 바와 같다.M, Q, L 2 , R and L 3 are as defined above.
발명에 따른 방법 (e)를 수행하는데 출발물질로 필요한 니트로 화합물은 화학식 (VII)에 의해 일반적으로 정의된다. 이 화학식 (VII)에서, M, Q, L2, R 및 L3은 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I) 또는 (III)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다.Nitro compounds required as starting materials for carrying out process (e) according to the invention are generally defined by formula (VII). In this formula (VII), M, Q, L 2 , R and L 3 are preferably, particularly preferably or most particularly preferably with reference to the description of the compounds of formula (I) or (III) according to the invention Each of these radicals has the meanings mentioned above as being preferred, particularly preferred or very particularly preferred.
화학식 (VII)의 니트로 화합물은The nitro compound of formula (VII) is
f) 하기 화학식 (VII)의 니트로 화합물을 염기의 존재하 및 경우에 따라 희석 매질의 존재하에서 화학식 (IX)의 화합물과 반응시킴으로써 수득됨이 밝혀졌다:f) It has been found that the nitro compound of formula (VII) is obtained by reaction with a compound of formula (IX) in the presence of a base and optionally in the presence of a dilution medium:
상기 식에서,Where
M, Q, L2, R 및 L3는 상기 정의된 바와 같고,M, Q, L 2 , R and L 3 are as defined above,
X는 염소, 브롬 또는 요오드를 나타낸다.X represents chlorine, bromine or iodine.
발명에 따른 방법 (f)를 수행하는데 출발물질로 필요한 니트로 화합물은 화학식 (VII)에 의해 일반적으로 정의된다. 이 화학식 (VII)에서, M 및 L3은 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I) 또는 (III)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다. X는 바람직하게는 염소를 나타낸다.Nitro compounds required as starting materials for carrying out process (f) according to the invention are generally defined by formula (VII). In this formula (VII), M and L 3 are preferably, particularly preferably or most particularly preferably respectively preferred for these radicals in connection with the description of the compounds of formula (I) or (III) according to the invention It has the meaning mentioned above as particularly preferred or very particularly preferred. X preferably represents chlorine.
본 발명에 따른 방법 (f)를 수행하는데 출발물질로 필요한 화합물은 화학식 (IX)에 의해 일반적으로 정의된다. 이 화학식 (IX)에서, Q, L2 및 R은 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I) 또는 (III)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다.Compounds required as starting materials for carrying out process (f) according to the invention are generally defined by formula (IX). In this formula (IX), Q, L 2 and R are preferably, particularly preferably or most particularly preferably for these radicals in connection with the description of the compounds of formula (I) or (III) according to the invention, respectively. It has the meaning mentioned above as being preferred, particularly preferred or very particularly preferred.
화학식 (IX)의 화합물은 공지되었거나, 공지 방법에 따라 수득할 수 있다.Compounds of formula (IX) are known or may be obtained according to known methods.
화학식 (VII-a)의 니트로 화합물은The nitro compound of formula (VII-a)
g) 화학식 (VII-b)의 니트로 화합물을 산화제의 존재하, 경우에 따라 희석제의 존재하 및 경우에 따라 반응 매질의 존재하에서 반응시킴으로써 수득됨이 밝혀졌다:g) It has been found that the nitro compound of formula (VII-b) is obtained by reacting in the presence of an oxidizing agent, optionally in the presence of a diluent and optionally in the presence of a reaction medium:
상기 식에서,Where
M, L2, R 및 L3은 상기 정의된 바와 같고,M, L 2 , R and L 3 are as defined above,
n은 1 또는 2를 나타낸다.n represents 1 or 2.
화학식 (VII-c)의 니트로 화합물은The nitro compound of formula (VII-c) is
h) 화학식 (VII-d)의 니트로 화합물을 염기의 존재하 및 희석 매질의 존재하에서 반응시킴으로써 수득됨이 밝혀졌다:h) It was found that the nitro compound of formula (VII-d) is obtained by reacting in the presence of a base and in the presence of a dilution medium:
상기 식에서,Where
M, L2, R 및 n은 상기 정의된 바와 같고,M, L 2 , R and n are as defined above,
L4는 C1-C9-알킬, 특히 C1-C5-알킬, 특히 바람직하게는 메틸을 나타낸다.L 4 represents C 1 -C 9 -alkyl, in particular C 1 -C 5 -alkyl, particularly preferably methyl.
화학식 (X)의 할라이드는 공지되었다.Halides of formula (X) are known.
화학식 (VII-a), (VII-b), (VII-c) 및 (VII-d)의 화합물은 화학식 (VII)의 니트로 화합물의 서브그룹이며, 이들 화합물의 일반적인 설명에 포함된다. 따라서, 바람직하거나, 특히 바람직하거나 매우 특히 바람직한 것 등의 정의가 적용된 다.Compounds of formula (VII-a), (VII-b), (VII-c) and (VII-d) are subgroups of nitro compounds of formula (VII) and are included in the general description of these compounds. Thus, definitions such as preferred, particularly preferred or very particularly preferred apply.
화학식 (VII)의 니트로 화합물은The nitro compound of formula (VII) is
j) 화학식 (XI)의 하이드록시 유도체를, 경우에 따라 희석제의 존재하, 경우에 따라 산수용체의 존재하 및 경우에 따라 촉매의 존재하에서 할로겐화시킴으로써 수득됨이 밝혀졌다:j) It has been found that the hydroxy derivatives of formula (XI) are obtained by halogenating, optionally in the presence of diluents, optionally in the presence of acid acceptors and optionally in the presence of catalysts:
상기 식에서,Where
M 및 L3은 상기 정의된 바와 같다.M and L 3 are as defined above.
본 발명에 따른 방법 (j)를 수행하는데 출발물질로 필요한 하이드록시 유도체는 화학식 (XI)에 의해 일반적으로 정의된다. 이 화학식 (XI)에서, M 및 L3은 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I) 또는 (III)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다.The hydroxy derivatives required as starting materials for carrying out process (j) according to the invention are generally defined by formula (XI). In this formula (XI), M and L 3 are preferably, particularly preferably or most particularly preferably respectively preferred for these radicals in connection with the description of the compounds of the formula (I) or (III) according to the invention It has the meaning mentioned above as particularly preferred or very particularly preferred.
화학식 (XI)의 하이드록시 유도체는 Hydroxy derivatives of formula (XI)
k) 화학식 (XII)의 아실화 방향족을 환원제의 존재하, 경우에 따라 희석제의 존재하, 경우에 따라 산의 존재하 및 경우에 따라 촉매의 존재하에서 반응시킴으로써 수득됨이 밝혀졌다:k) It has been found that the acylated aromatics of formula (XII) are obtained by reacting in the presence of a reducing agent, optionally in the presence of a diluent, optionally in the presence of an acid and optionally in the presence of a catalyst:
상기 식에서,Where
M 및 L3은 상기 정의된 바와 같다.M and L 3 are as defined above.
화학식 (III)의 아닐린 유도체는 또한 공지 방법과 유사한 방식으로 수득할 수 있다(참조: EP-A 0 737 682).Aniline derivatives of formula (III) can also be obtained in a manner analogous to known methods (see EP-A 0 737 682).
방법 (b)Method (b)
출발물질로 N-[2-(하이드록시메틸)페닐]-1-메틸-3-(트리플루오로메틸)-1H-피라졸-4-카복사미드 및 2-요오도프로판을 사용하는 경우, 본 발명에 따른 방법 (b)의 과정은 하기 반응식으로 나타내어질 수 있다:When using N- [2- (hydroxymethyl) phenyl] -1-methyl-3- (trifluoromethyl) -1H-pyrazole-4-carboxamide and 2-iodopropane as starting materials, The process of process (b) according to the invention can be represented by the following scheme:
본 발명에 따른 방법 (b)를 수행하는데 출발물질로 필요한 카복사미드는 화학식 (IV)에 의해 일반적으로 정의된다. 이 화학식 (IV)에서, M2, L1, Q 및 A는 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다.Carboxamides required as starting materials for carrying out process (b) according to the invention are generally defined by formula (IV). In this formula (IV), M 2 , L 1 , Q and A are each preferably preferred for these radicals in connection with the description of the compounds of formula (I) according to the invention, particularly preferably or most particularly preferably. Or particularly as preferred or very particularly preferred.
본 발명에 따른 방법 (b)를 수행하는데 출발물질로 필요한 화합물은 화학식 (V)에 의해 일반적으로 정의된다. 이 화학식 (V)에서, L2 및 R은 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다. Y는 바람직하게는 염소, 브롬, 요오드, 트리플레이트(트리플루오로메틸설포닐), 메실레이트(메틸설포닐) 또는 토실레이트(4-메틸페닐설포닐), 특히 바람직하게는 브롬, 요오드 또는 트리플레이트(트리플루오로메틸설포닐)를 나타낸다.Compounds required as starting materials for carrying out process (b) according to the invention are generally defined by formula (V). In this formula (V), L 2 and R are preferably, particularly preferably or most particularly preferably respectively preferred, particularly preferred or very preferred for these radicals in connection with the description of the compounds of formula (I) according to the invention. As particularly preferred, they have the meanings mentioned above. Y is preferably chlorine, bromine, iodine, triflate (trifluoromethylsulfonyl), mesylate (methylsulfonyl) or tosylate (4-methylphenylsulfonyl), particularly preferably bromine, iodine or triflate (Trifluoromethylsulfonyl) is shown.
화학식 (V)의 화합물은 공지되었거나, 공지 방법에 따라 수득할 수 있다. 화학식 (IV)의 카복사미드는 신규하다. 이들은Compounds of formula (V) are known or may be obtained according to known methods. Carboxamides of formula (IV) are novel. These are
m) 화학식 (II)의 카복실산 유도체를, 경우에 따라 촉매의 존재하, 경우에 따라 축합제의 존재하, 경우에 따라 산 결합제의 존재하 및 경우에 따라 희석제의 존재하에서 화학식 (XIII)의 아닐린 유도체와 반응시킴으로써 수득됨이 밝혀졌다:m) Aniline of formula (XIII) in which the carboxylic acid derivative of formula (II) is optionally in the presence of a catalyst, optionally in the presence of a condensation agent, optionally in the presence of an acid binder and optionally in the presence of a diluent It has been found that it is obtained by reacting with a derivative:
상기 식에서,Where
A, M, L1 및 Q는 상기 정의된 바와 같고,A, M, L 1 and Q are as defined above,
X1은 할로겐 또는 하이드록시를 나타낸다.X 1 represents halogen or hydroxy.
본 발명에 따른 방법 (m)을 수행하는데 출발물질로 필요한 화학식 (II)의 카복실산 유도체는 본 발명에 따른 방법 (a)와 관련하여 상술되었다.Carboxylic acid derivatives of formula (II) which are necessary as starting materials for carrying out process (m) according to the invention have been described above in connection with process (a) according to the invention.
본 발명에 따른 방법 (m)을 수행하는데 출발물질로 필요한 아닐린 유도체는 화학식 (XIII)에 의해 일반적으로 정의된다. 이 화학식 (XIII)에서, M, L1 및 Q는 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다.Aniline derivatives required as starting materials for carrying out process (m) according to the invention are generally defined by formula (XIII). In this formula (XIII), M, L 1 and Q are preferably, particularly preferably or most particularly preferably respectively preferred or particularly preferred for these radicals in connection with the description of the compounds of formula (I) according to the invention. Or very particularly preferred as mentioned above.
화학식 (XIII)의 아닐린 유도체는 공지되었거나, 공지 방법에 따라 수득할 수 있다. Aniline derivatives of formula (XIII) are known or may be obtained according to known methods.
방법 (c)Method (c)
출발물질로 3-(디플루오로메틸)-N-{2-[(이소프로필티오)메틸]페닐}-1-메틸-1H-피라졸-4-카복사미드 및 에틸클로로(옥소)아세테이트를 사용하는 경우, 본 발명에 따른 방법 (c)의 과정은 하기 반응식으로 나타내어질 수 있다:As starting materials 3- (difluoromethyl) -N- {2-[(isopropylthio) methyl] phenyl} -1-methyl-1H-pyrazole-4-carboxamide and ethylchloro (oxo) acetate If used, the process of process (c) according to the invention can be represented by the following scheme:
본 발명에 따른 방법 (c)를 수행하는데 출발물질로 필요한 헥실카복스아닐리 드는 화학식 (I-a)에 의해 일반적으로 정의된다. 이 화학식 (I-a)에서, M, L1, Q, L2, R 및 A는 바람직하게, 특히 바람직하게 또는 가장 특히 바람직하게는 본 발명에 따른 화학식 (I)의 화합물의 설명과 관련하여 이들 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다.Hexylcarboxanilides required as starting materials for carrying out process (c) according to the invention are generally defined by formula (la). In this formula (Ia), M, L 1 , Q, L 2 , R and A are preferably, particularly preferably or most particularly preferably these radicals in connection with the description of the compounds of formula (I) according to the invention Each have the meanings mentioned above as being preferred, particularly preferred or very particularly preferred.
화학식 (I-a)의 헥실카복스아닐리드는 또한 본 발명에 따른 화합물이며, 본 출원의 특허대상이다. 이들은 본 발명에 따른 방법 (a)에 의해 수득될 수 있다(R1=수소).Hexylcarboxanilides of formula (Ia) are also compounds according to the invention and are subject to patents of the present application. These can be obtained by process (a) according to the invention (R 1 = hydrogen).
본 발명에 따른 방법 (c)를 수행하는데 출발물질로 필요한 할라이드는 화학식 (VI)에 의해 일반적으로 정의된다. 이 화학식 (VI)에서, R1-A는 바람직하게, 특히 바람직하게 및 가장 특히 바람직하게는 본 발명에 따른 화학식 (I-b)의 화합물의 설명과 관련하여 이 래디칼에 대해 각각 바람직하거나 특히 바람직하거나 매우 특히 바람직한 것으로서 상기 언급된 의미를 갖는다. X2는 바람직하게는 염소 또는 브롬을 나타낸다.The halides required as starting materials for carrying out process (c) according to the invention are generally defined by formula (VI). In this formula (VI), R 1-A is preferably, particularly preferably and most particularly preferably respectively preferred, particularly preferred or very preferred for this radical in connection with the description of the compound of formula (Ib) according to the invention. As particularly preferred, they have the meanings mentioned above. X 2 preferably represents chlorine or bromine.
화학식 (VI)의 할라이드는 공지되었다.Halides of formula (VI) are known.
반응 조건Reaction conditions
모든 불활성 유기 용매가 본 발명에 따른 방법 (a) 및 (m)을 수행하는데 희석제로 고려될 수 있다. 이들에는 바람직하게는 지방족, 지환식 또는 방향족 탄화 수소, 예컨대 석유 에테르, 헥산, 헵탄, 사이클로헥산, 메틸사이클로헥산, 벤젠, 톨루엔, 크실렌 또는 데칼린; 할로겐화 탄화수소, 예컨대 클로로벤젠, 디클로로벤젠, 디클로로메탄, 클로로포름, 테트라클로로메탄, 디클로로에탄 또는 트리클로로에탄; 에테르, 예컨대 디에틸 에테르, 디이소프로필 에테르, 메틸 t-부틸 에테르, 메틸 t-아밀 에테르, 디옥산, 테트라하이드로푸란, 1,2-디메톡시에탄, 1,2-디에톡시에탄 또는 아니솔; 아미드, 예컨대 N,N-디메틸포름아미드, N,N-디메틸아세트아미드, N-메틸포름아닐리드, N-메틸피롤리돈 또는 헥사메틸포스포릭 트리아미드가 포함된다.All inert organic solvents can be considered as diluents for carrying out the processes (a) and (m) according to the invention. These preferably include aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Halogenated hydrocarbons such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane or trichloroethane; Ethers such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide.
본 발명에 따른 방법 (a) 및 (m)은 경우에 따라 적합한 산 수용체의 존재하에서 수행된다. 통상적인 모든 무기 또는 유기 염기가 그 자체로 사용될 수 있다. 이들에는 바람직하게는 알칼리 토금속 또는 알칼리 금속 수소화물, 수산화물, 아미드, 알콕사이드, 아세테이트, 탄산염 또는 중탄산염, 예를 들어 수소화나트륨, 소듐 아미드, 소듐 메틸레이트, 소듐 에틸레이트, 포타슘 t-부틸레이트, 수산화나트륨, 수산화칼륨, 수산화암모늄, 소듐 아세테이트, 포타슘 아세테이트, 칼슘 아세테이트, 암모늄 아세테이트, 탄산나트륨, 탄산칼륨, 중탄산칼륨, 중탄산나트륨 또는 탄산암모늄, 및 또한 삼급 아민, 예를 들어 트리메틸아민, 트리에틸아민, 트리부틸아민, N,N-디메틸아닐린, N,N-디메틸벤질아민, 피리딘, N-메틸피페리딘, N-메틸모르폴린, N,N-디메틸아미노피리딘, 디아자비사이클로옥탄(DABCO), 디아자비사이클로노넨(DBN) 또는 디아자비사이클로운데센(DBU)이 포함된다.Processes (a) and (m) according to the invention are optionally carried out in the presence of a suitable acid acceptor. All conventional inorganic or organic bases can be used by themselves. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates or bicarbonates such as sodium hydride, sodium amide, sodium methylate, sodium ethylate, potassium t-butylate, sodium hydroxide , Potassium hydroxide, ammonium hydroxide, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or ammonium carbonate, and also tertiary amines such as trimethylamine, triethylamine, tributyl Amine, N, N-dimethylaniline, N, N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabi Cyclononene (DBN) or diazabicycloundecene (DBU).
본 발명에 따른 방법 (a) 및 (m)은 경우에 따라 적합한 축합제의 존재하에서 수행된다. 적합한 축합제는 이러한 아미드화 반응에 통상적으로 사용되는 모든 축합제이다. 이들의 예로 산 할라이드 형성제, 예를 들어 포스겐, 삼브롬화인, 삼염화인, 오염화인, 옥시염화인, 옥살릴 클로라이드 또는 티오닐 클로라이드; 무수물 형성제, 예를 들어 클로로포름산 에틸 에스테르, 클로로포름산 에틸 에스테르, 클로로포포름산 메틸 에스테르, 클로로포포름산 이소프로필 에스테르, 클로로포포름산 이소부틸 에스테르 또는 메탄설포닐 클로라이드; 카보디이미드, 예를 들어 N,N'-디사이클로헥실카보디이미드(DCC), 또는 다른 통상의 축합제, 예를 들어 오산화인, 폴리인산, N,N'-카보닐디이미다졸, 2-에톡시-N-에톡시카보닐-1,2-디하이드로퀴놀린(EEDQ), 트리페닐포스핀/테트라클로로메탄 또는 브로모트리피롤리디노포스포늄 헥사플루오로포스페이트가 언급될 수 있다.Processes (a) and (m) according to the invention are optionally carried out in the presence of a suitable condensing agent. Suitable condensing agents are all condensing agents conventionally used for such amidation reactions. Examples thereof include acid halide formers such as phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride, oxalyl chloride or thionyl chloride; Anhydride formers such as chloroformic acid ethyl ester, chloroformic acid ethyl ester, chloroformic acid methyl ester, chloroformic acid isopropyl ester, chloroformic acid isobutyl ester or methanesulfonyl chloride; Carbodiimides such as N, N'-dicyclohexylcarbodiimide (DCC), or other conventional condensing agents such as phosphorus pentoxide, polyphosphoric acid, N, N'-carbonyldiimidazole, 2- Ethoxy-N-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ), triphenylphosphine / tetrachloromethane or bromotripyrrolidinophosphonium hexafluorophosphate may be mentioned.
방법 (a) 및 (m)은 경우에 따라 촉매의 존재하에 수행된다. 이들의 예로는 4-디메틸아미노피리딘, 1-하이드록시벤조트리아졸 또는 디메틸포름아미드가 언급될 수 있다.Processes (a) and (m) are optionally carried out in the presence of a catalyst. Examples thereof may be mentioned 4-dimethylaminopyridine, 1-hydroxybenzotriazole or dimethylformamide.
본 발명에 따른 방법 (a) 및 (m)을 수행하는 경우, 반응 온도는 넓은 범위에서 변화될 수 있다. 일반적으로, 이들 방법은 0 내지 150 ℃, 바람직하게는 0 내지 80 ℃의 온도에서 수행된다.When carrying out the processes (a) and (m) according to the invention, the reaction temperature can be varied in a wide range. In general, these processes are carried out at temperatures of 0 to 150 ° C, preferably 0 to 80 ° C.
화학식 (I)의 화합물을 제조하기 위한 본 발명에 따른 방법 (a)를 수행하는 경우, 화학식 (II)의 카복실산 유도체 1 몰당 일반적으로 0.2 내지 5 몰, 바람직하게는 0.5 내지 2 몰의 화학식 (III)의 아닐린 유도체가 사용된다.When carrying out process (a) according to the invention for the preparation of compounds of formula (I), generally 0.2 to 5 moles, preferably 0.5 to 2 moles of formula (III) per mole of carboxylic acid derivative of formula (II) Aniline derivatives) are used.
화학식 (IV)의 화합물을 제조하기 위한 본 발명에 따른 방법 (m)을 수행하는 경우, 화학식 (II)의 카복실산 유도체 1 몰당 일반적으로 0.2 내지 5 몰, 바람직하게는 0.5 내지 2 몰의 화학식 (XIII)의 아닐린 유도체가 사용된다.When carrying out process (m) according to the invention for the preparation of compounds of formula (IV), generally 0.2 to 5 moles, preferably 0.5 to 2 moles of formula (XIII) per mole of carboxylic acid derivative of formula (II) Aniline derivatives).
모든 불활성 유기 용매가 본 발명에 따른 방법 (b), (c), (d) 및 (h)를 수행하는데 희석제로 고려될 수 있다. 이들에는 바람직하게는 지방족, 지환식 또는 방향족 탄화수소, 예컨대 석유 에테르, 헥산, 헵탄, 사이클로헥산, 메틸사이클로헥산, 벤젠, 톨루엔, 크실렌 또는 데칼린; 할로겐화 탄화수소, 예컨대 클로로벤젠, 디클로로벤젠, 디클로로메탄, 클로로포름, 테트라클로로메탄, 디클로로에탄 또는 트리클로로에탄; 에테르, 예컨대 디에틸 에테르, 디이소프로필 에테르, 메틸 t-부틸 에테르, 메틸 t-아밀 에테르, 디옥산, 테트라하이드로푸란, 1,2-디메톡시에탄, 1,2-디에톡시에탄 또는 아니솔; 아미드, 예컨대 N,N-디메틸포름아미드, N,N-디메틸아세트아미드, N-메틸포름아닐리드, N-메틸피롤리돈 또는 헥사메틸포스포릭 트리아미드가 포함된다.All inert organic solvents can be considered as diluents for carrying out the processes (b), (c), (d) and (h) according to the invention. These preferably include aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Halogenated hydrocarbons such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane or trichloroethane; Ethers such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide.
본 발명에 따른 방법 방법 (b), (c), (d) 및 (h)는 염기의 존재하에서 수행된다. 통상적인 모든 무기 또는 유기 염기가 사용될 수 있다. 이들에는 바람직하게는 알칼리 토금속 또는 알칼리 금속 수소화물, 수산화물, 아미드, 알콕사이드, 아세테이트, 탄산염 또는 중탄산염, 예를 들어 수소화나트륨, 소듐 아미드, 소듐 메틸레이트, 소듐 에틸레이트, 포타슘 t-부틸레이트, 수산화나트륨, 수산화칼륨, 수산화암모늄, 소듐 아세테이트, 포타슘 아세테이트, 칼슘 아세테이트, 암모늄 아세테이트, 탄산나트륨, 탄산칼륨, 중탄산칼륨, 중탄산나트륨 또는 탄산세슘, 및 또한 삼급 아민, 예를 들어 트리메틸아민, 트리에틸아민, 트리부틸아민, N,N-디메틸 아닐린, N,N-디메틸벤질아민, 피리딘, N-메틸피페리딘, N-메틸모르폴린, N,N-디메틸아미노피리딘, 디아자비사이클로옥탄(DABCO), 디아자비사이클로노넨(DBN) 또는 디아자비사이클로운데센(DBU)이 포함된다.Processes according to the invention Processes (b), (c), (d) and (h) are carried out in the presence of a base. All conventional inorganic or organic bases can be used. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates or bicarbonates such as sodium hydride, sodium amide, sodium methylate, sodium ethylate, potassium t-butylate, sodium hydroxide , Potassium hydroxide, ammonium hydroxide, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or cesium carbonate, and also tertiary amines such as trimethylamine, triethylamine, tributyl Amine, N, N-dimethyl aniline, N, N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabi Cyclononene (DBN) or diazabicycloundecene (DBU).
본 발명에 따른 방법 방법 (b), (c), (d) 및 (h)를 수행하는 경우, 반응 온도는 넓은 범위에서 변화될 수 있다. 일반적으로, 이들 방법은 0 내지 150 ℃, 바람직하게는 20 내지 110 ℃의 온도에서 수행된다.Process according to the invention When carrying out the processes (b), (c), (d) and (h), the reaction temperature can be varied in a wide range. In general, these processes are carried out at temperatures of 0 to 150 ° C, preferably 20 to 110 ° C.
화학식 (I)의 화합물을 제조하기 위한 본 발명에 따른 방법 (b)를 수행하는 경우, 화학식 (IV)의 카복사미드 1 몰당 일반적으로 0.2 내지 5 몰, 바람직하게는 0.5 내지 2 몰의 화학식 (V)의 화합물이 사용된다.When carrying out process (b) according to the invention for the preparation of compounds of formula (I), generally 0.2 to 5 moles, preferably 0.5 to 2 moles of the formula (1) per mole of carboxamide of formula (IV) The compound of V) is used.
화학식 (I)의 화합물을 제조하기 위한 본 발명에 따른 방법 (c)를 수행하는 경우, 화학식 (I-a)의 헥실카복스아닐리드 1 몰당 일반적으로 0.2 내지 5 몰, 바람직하게는 0.5 내지 2 몰의 화학식 (VI)의 할라이드가 사용된다.When carrying out process (c) according to the invention for preparing compounds of formula (I), generally 0.2 to 5 moles, preferably 0.5 to 2 moles per mole of hexylcarboxanilide of formula (Ia) The halide of (VI) is used.
화학식 (III-a)의 화합물을 제조하기 위한 본 발명에 따른 방법 (d)를 수행하는 경우, 화학식 (III-b)의 아닐린 유도체 1 몰당 일반적으로 0.2 내지 5 몰, 바람직하게는 0.5 내지 2 몰의 화학식 (VI)의 할라이드가 사용된다.When carrying out process (d) according to the invention for the preparation of compounds of formula (III-a), generally 0.2 to 5 moles, preferably 0.5 to 2 moles per mole of aniline derivatives of formula (III-b) Halides of formula (VI) are used.
화학식 (VII-c)의 화합물을 제조하기 위한 본 발명에 따른 방법 (h)를 수행하는 경우, 화학식 (VII-d)의 니트로 화합물 1 몰당 일반적으로 0.2 내지 5 몰, 바람직하게는 0.5 내지 2 몰의 화학식 (X)의 할라이드가 사용된다.When carrying out process (h) according to the invention for the preparation of compounds of formula (VII-c), generally 0.2 to 5 moles, preferably 0.5 to 2 moles per mole of nitro compound of formula (VII-d) Halides of formula (X) are used.
모든 불활성 유기 용매가 본 발명에 따른 방법 (e)를 수행하는데 희석제로 고려될 수 있다. 이들에는 바람직하게는 지방족, 지환식 또는 방향족 탄화수소, 예컨대 석유 에테르, 헥산, 헵탄, 사이클로헥산, 메틸사이클로헥산, 벤젠, 톨루엔, 크실렌 또는 데칼린; 에테르, 예컨대 디에틸 에테르, 디이소프로필 에테르, 메틸 t-부틸 에테르, 메틸 t-아밀 에테르, 디옥산, 테트라하이드로푸란, 1,2-디메톡시에탄, 1,2-디에톡시에탄 또는 아니솔; 아미드, 예컨대 N,N-디메틸포름아미드, N,N-디메틸아세트아미드, N-메틸포름아닐리드, N-메틸피롤리돈 또는 헥사메틸포스포릭 트리아미드; 설폭사이드, 예컨대 디메틸 설폭사이드; 설폰, 예컨대 설폴란; 알콜, 예컨대 메탄올, 에탄올, n- 또는 이소프로판올, n-, 이소-, sec- 또는 t-부탄올, 에탄디올, 프로판-1,2-디올, 에톡시에탄올, 메톡시에탄올, 디에틸렌 글리콜 모노메틸 에테르, 디에틸렌 글리콜 모노에틸 에테르, 트리에틸렌 글리콜, 이들과 물과의 혼합물 또는 순수한 물이 포함된다.All inert organic solvents can be considered as diluents for carrying out process (e) according to the invention. These preferably include aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Ethers such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide; Sulfoxides such as dimethyl sulfoxide; Sulfones such as sulfolane; Alcohols such as methanol, ethanol, n- or isopropanol, n-, iso-, sec- or t-butanol, ethanediol, propane-1,2-diol, ethoxyethanol, methoxyethanol, diethylene glycol monomethyl ether , Diethylene glycol monoethyl ether, triethylene glycol, mixtures thereof with water or pure water.
본 발명에 따른 방법 (e)는 금속의 존재하에서 수행된다. 이들로 전이 금속, 예를 들어 팔라듐, 백금, 로듐, 니켈(라니 니켈), 철, 코발트, 루테늄, 이리듐, 아연 또는 오스뮴이 바람직하다. 금속은 필요에 따라 기질, 예컨대 탄소, 수지, 제올라이트, 알칼리 또는 알칼리 토류 설페이트에 결합될 수 있다.Process (e) according to the invention is carried out in the presence of a metal. Preferred among them are transition metals such as palladium, platinum, rhodium, nickel (Rani nickel), iron, cobalt, ruthenium, iridium, zinc or osmium. The metal may be bonded to a substrate, such as carbon, resin, zeolite, alkali or alkaline earth sulfate, as desired.
본 발명에 따른 방법 (e)는 환원제의 존재하에서 수행된다. 이들로 바람직한 물질은 수소 원소, 포르메이트 염, 바람직하게는 알칼리 포르메이트 염, 예컨대 소듐 포르메이트, 암모늄 포르메이트 또는 금속 수소화물 또는 금속 착수소화물, 예컨대 리튬 알루미늄 하이드라이드 및 소듐 보로하이드라이드이다.Process (e) according to the invention is carried out in the presence of a reducing agent. Preferred materials for these are elemental hydrogen, formate salts, preferably alkali formate salts such as sodium formate, ammonium formate or metal hydrides or metal hydrides such as lithium aluminum hydride and sodium borohydride.
본 발명에 따른 방법 (e)는 산의 존재하에서 수행될 수 있다. 이들로 바람직한 물질은 유기산, 예컨대 포름산, 아세트산, 아스코르브산, 무기산, 예컨대 염 산 또는 황산이다.Process (e) according to the invention can be carried out in the presence of an acid. Preferred materials for these are organic acids such as formic acid, acetic acid, ascorbic acid, inorganic acids such as hydrochloric acid or sulfuric acid.
본 발명에 따른 방법 (e)는 염기의 존재하에서 수행될 수 있다. 이들로 바람직한 물질은 유기 염기, 예컨대 피리딘, 알칼리 또는 알칼리 토금속 수산화물의 수용액, 예컨대 수산화나트륨 또는 수산화바륨이다.Process (e) according to the invention can be carried out in the presence of a base. Preferred materials for these are organic bases such as aqueous solutions of pyridine, alkali or alkaline earth metal hydroxides such as sodium or barium hydroxide.
본 발명에 따른 방법 (e)를 수행하는 경우, 반응 온도는 넓은 범위에서 변화될 수 있다. 일반적으로, 이 방법은 -80 내지 300 ℃, 바람직하게는 0 내지 200 ℃의 온도에서 수행된다.When carrying out process (e) according to the invention, the reaction temperature can be varied in a wide range. In general, this process is carried out at temperatures of -80 to 300 ° C, preferably 0 to 200 ° C.
수소 원소를 사용하는 경우, 본 발명에 따른 방법 (e)는 0.5 내지 200 바, 바람직하게는 1 내지 100 바의 수소 압력하에 수행된다.When using elemental hydrogen, process (e) according to the invention is carried out under hydrogen pressure of 0.5 to 200 bar, preferably 1 to 100 bar.
화학식 (III-b)의 화합물을 제조하기 위한 본 발명에 따른 방법 (e)를 수행하는 경우, 화학식 (VII)의 니트로 화합물 1 몰당 일반적으로 0.8 내지 1000 몰, 바람직하게는 1 내지 500 몰의 환원제(암모늄 포르메이트, 수소화물 등)가 사용된다.When carrying out process (e) according to the invention for the preparation of compounds of formula (III-b), generally 0.8 to 1000 moles, preferably 1 to 500 moles of reducing agent per mole of nitro compound of formula (VII) (Ammonium formate, hydride, etc.) are used.
모든 불활성 유기 용매가 본 발명에 따른 방법 (f)를 수행하는데 희석제로 고려될 수 있다. 이들에는 바람직하게는 지방족, 지환식 또는 방향족 탄화수소, 예컨대 석유 에테르, 헥산, 헵탄, 사이클로헥산, 메틸사이클로헥산, 벤젠, 톨루엔, 크실렌 또는 데칼린; 할로겐화 탄화수소, 예컨대 클로로벤젠, 디클로로벤젠, 디클로로메탄, 클로로포름, 테트라클로로메탄, 디클로로에탄 또는 트리클로로에탄; 에테르, 예컨대 디에틸 에테르, 디이소프로필 에테르, 메틸 t-부틸 에테르, 메틸 t-아밀 에테르, 디옥산, 테트라하이드로푸란, 1,2-디메톡시에탄, 1,2-디에톡시에탄 또는 아니솔; 아미드, 예컨대 N,N-디메틸포름아미드, N,N-디메틸아세트아미드, N-메틸포름아닐리드, N-메틸피롤리돈 또는 헥사메틸포스포릭 트리아미드가 포함된다.All inert organic solvents can be considered as diluents for carrying out process (f) according to the invention. These preferably include aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Halogenated hydrocarbons such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane or trichloroethane; Ethers such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide.
본 발명에 따른 방법 방법 (f)는 염기의 존재하에서 수행된다. 통상적인 모든 무기 또는 유기 염기가 사용될 수 있다. 이들에는 바람직하게는 알칼리 토금속 또는 알칼리 금속 수소화물, 수산화물, 아미드, 알콕사이드, 아세테이트, 탄산염 또는 중탄산염, 예를 들어 수소화나트륨, 소듐 아미드, 소듐 메틸레이트, 소듐 에틸레이트, 포타슘 t-부틸레이트, 수산화나트륨, 수산화칼륨, 수산화암모늄, 소듐 아세테이트, 포타슘 아세테이트, 칼슘 아세테이트, 암모늄 아세테이트, 탄산나트륨, 탄산칼륨, 중탄산칼륨, 중탄산나트륨 또는 탄산세슘, 및 또한 삼급 아민, 예를 들어 트리메틸아민, 트리에틸아민, 트리부틸아민, N,N-디메틸아닐린, N,N-디메틸벤질아민, 피리딘, N-메틸피페리딘, N-메틸모르폴린, N,N-디메틸아미노피리딘, 디아자비사이클로옥탄(DABCO), 디아자비사이클로노넨(DBN) 또는 디아자비사이클로운데센(DBU)이 포함된다.Process according to the invention Process (f) is carried out in the presence of a base. All conventional inorganic or organic bases can be used. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates or bicarbonates such as sodium hydride, sodium amide, sodium methylate, sodium ethylate, potassium t-butylate, sodium hydroxide , Potassium hydroxide, ammonium hydroxide, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or cesium carbonate, and also tertiary amines such as trimethylamine, triethylamine, tributyl Amine, N, N-dimethylaniline, N, N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabi Cyclononene (DBN) or diazabicycloundecene (DBU).
본 발명에 따른 방법 방법 (f)를 수행하는 경우, 반응 온도는 넓은 범위에서 변화될 수 있다. 일반적으로, 이 방법은 0 내지 200 ℃, 바람직하게는 20 내지 150 ℃의 온도에서 수행된다.When carrying out process (f) according to the invention, the reaction temperature can be varied in a wide range. In general, this process is carried out at temperatures of 0 to 200 ° C, preferably 20 to 150 ° C.
화학식 (VII)의 화합물을 제조하기 위한 본 발명에 따른 방법 (f)를 수행하는 경우, 화학식 (VII)의 니트로 화합물 1 몰당 일반적으로 0.2 내지 5 몰, 바람직하게는 0.5 내지 2 몰의 화학식 (IX)의 화합물이 사용된다.When carrying out process (f) according to the invention for preparing compounds of formula (VII), generally 0.2 to 5 moles, preferably 0.5 to 2 moles of formula (IX) per mole of nitro compound of formula (VII) ) Compounds are used.
모든 불활성 유기 용매가 본 발명에 따른 방법 (g)를 수행하는데 희석제로 고려될 수 있다. 이들에는 바람직하게는 지방족, 지환식 또는 방향족 탄화수소, 예컨대 석유 에테르, 헥산, 헵탄, 사이클로헥산, 메틸사이클로헥산, 벤젠, 톨루엔, 크실렌 또는 데칼린; 에테르, 예컨대 디에틸 에테르, 디이소프로필 에테르, 메틸 t-부틸 에테르, 메틸 t-아밀 에테르, 디옥산, 테트라하이드로푸란, 1,2-디메톡시에탄, 1,2-디에톡시에탄 또는 아니솔; 아미드, 예컨대 N,N-디메틸포름아미드, N,N-디메틸아세트아미드, N-메틸포름아닐리드, N-메틸피롤리돈 또는 헥사메틸포스포릭 트리아미드; 설폭사이드, 예컨대 디메틸 설폭사이드; 설폰, 예컨대 설폴란이 포함된다.All inert organic solvents can be considered as diluents for carrying out process (g) according to the invention. These preferably include aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Ethers such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide; Sulfoxides such as dimethyl sulfoxide; Sulfones such as sulfolane.
본 발명에 따른 방법 방법 (g)는 산화제의 존재하에서 수행된다. 모든 유기 및 무기 산화제, 바람직하게는 산소 원소, 오존, 퍼옥사이드, 이를테면 과산화수소, m-클로로퍼벤조산, 벤조일 퍼옥사이드, t-부틸 퍼옥사이드; 소듐 하이포클로라이트; 크롬염, 예를 들어 산화크롬(VI), 크롬산, 소듐 디크로메이트, 피리디늄 클로로크로메이트; 망간염, 예컨대 과망간산칼륨, 이산화망간; 이산화셀레늄; 이오데이트 및 퍼이오데이트; 포타슘 퍼옥소디설페이트가 사용될 수 있다.Process according to the invention Process (g) is carried out in the presence of an oxidizing agent. All organic and inorganic oxidizing agents, preferably oxygen elements, ozone, peroxides such as hydrogen peroxide, m-chloroperbenzoic acid, benzoyl peroxide, t-butyl peroxide; Sodium hypochlorite; Chromium salts such as chromium oxide (VI), chromic acid, sodium dichromate, pyridinium chlorochromate; Manganese salts such as potassium permanganate, manganese dioxide; Selenium dioxide; Iodate and puriodate; Potassium peroxodisulfate can be used.
본 발명에 따른 방법 방법 (g)는 산의 존재하에서 수행된다. 이들로 바람직한 물질은 유기산, 예컨대 포름산, 아세트산, 아스코르브산, 무기산, 예컨대 염산 또는 황산이다.Process (g) according to the invention is carried out in the presence of an acid. Preferred materials for these are organic acids such as formic acid, acetic acid, ascorbic acid, inorganic acids such as hydrochloric acid or sulfuric acid.
본 발명에 따른 방법 (g)는 염기의 존재하에서 수행될 수 있다. 이들로 바람직한 물질은 유기 염기, 예컨대 피리딘, 알칼리 또는 알칼리 토금속 수산화물의 수용액, 예컨대 수산화나트륨 또는 수산화바륨이다.Process (g) according to the invention can be carried out in the presence of a base. Preferred materials for these are organic bases such as aqueous solutions of pyridine, alkali or alkaline earth metal hydroxides such as sodium or barium hydroxide.
본 발명에 따른 방법 (g)를 수행하는 경우, 반응 온도는 넓은 범위에서 변화될 수 있다. 일반적으로, 이 방법은 -80 내지 300 ℃, 바람직하게는 0 내지 200 ℃의 온도에서 수행된다.When carrying out process (g) according to the invention, the reaction temperature can be varied in a wide range. In general, this process is carried out at temperatures of -80 to 300 ° C, preferably 0 to 200 ° C.
화학식 (VII-a)의 화합물을 제조하기 위한 본 발명에 따른 방법 (g)를 수행하는 경우, 화학식 (VII-b)의 니트로 화합물 1 몰당 일반적으로 0.6 내지 10 몰, 바람직하게는 0.8 내지 5 몰의 산화제가 사용된다.When carrying out process (g) according to the invention for preparing compounds of formula (VII-a), it is generally from 0.6 to 10 moles, preferably from 0.8 to 5 moles per mole of nitro compound of formula (VII-b) Oxidant is used.
모든 불활성 유기 용매가 본 발명에 따른 방법 (j)를 수행하는데 희석제로 고려될 수 있다. 이들에는 바람직하게는 지방족, 지환식 또는 방향족 탄화수소, 예컨대 석유 에테르, 헥산, 헵탄, 사이클로헥산, 메틸사이클로헥산, 벤젠, 톨루엔, 크실렌 또는 데칼린; 할로겐화 탄화수소, 예컨대 클로로벤젠, 디클로로벤젠, 디클로로메탄, 클로로포름, 테트라클로로메탄, 디클로로에탄 또는 트리클로로에탄; 에테르, 예컨대 디에틸 에테르, 디이소프로필 에테르, 메틸 t-부틸 에테르, 메틸 t-아밀 에테르, 디옥산, 테트라하이드로푸란, 1,2-디메톡시에탄, 1,2-디에톡시에탄 또는 아니솔; 아미드, 예컨대 N,N-디메틸포름아미드, N,N-디메틸아세트아미드, N-메틸포름아닐리드, N-메틸피롤리돈 또는 헥사메틸포스포릭 트리아미드가 포함된다.All inert organic solvents can be considered as diluents for carrying out process (j) according to the invention. These preferably include aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Halogenated hydrocarbons such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane or trichloroethane; Ethers such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide.
본 발명에 따른 방법 (j)는 경우에 따라 적합한 산 수용체의 존재하에서 수행된다. 통상적인 모든 무기 또는 유기 염기가 사용될 수 있다. 이들에는 바람직하게는 알칼리 토금속 또는 알칼리 금속 수소화물, 수산화물, 아미드, 알콕사이드, 아세테이트, 탄산염 또는 중탄산염, 예를 들어 수소화나트륨, 소듐 아미드, 소듐 메틸레이트, 소듐 에틸레이트, 포타슘 t-부틸레이트, 수산화나트륨, 수산화칼륨, 수산화암모늄, 소듐 아세테이트, 포타슘 아세테이트, 칼슘 아세테이트, 암모늄 아세테이트, 탄산나트륨, 탄산칼륨, 중탄산칼륨, 중탄산나트륨 또는 탄산암모늄, 및 또한 삼급 아민, 예를 들어 트리메틸아민, 트리에틸아민, 트리부틸아민, N,N-디메틸아닐린, N,N-디메틸벤질아민, 피리딘, N-메틸피페리딘, N-메틸모르폴린, N,N-디메틸아미노피리딘, 디아자비사이클로옥탄(DABCO), 디아자비사이클로노넨(DBN) 또는 디아자비사이클로운데센(DBU)이 포함된다.Process (j) according to the invention is optionally carried out in the presence of a suitable acid acceptor. All conventional inorganic or organic bases can be used. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates or bicarbonates such as sodium hydride, sodium amide, sodium methylate, sodium ethylate, potassium t-butylate, sodium hydroxide , Potassium hydroxide, ammonium hydroxide, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or ammonium carbonate, and also tertiary amines such as trimethylamine, triethylamine, tributyl Amine, N, N-dimethylaniline, N, N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabi Cyclononene (DBN) or diazabicycloundecene (DBU).
본 발명에 따른 방법 (j)는 경우에 따라 적합한 할로겐화제의 존재하에서 수행된다. 할로겐화제로는 이러한 할로겐화 반응에 통상적으로 사용되는 것이 고려될 수 있다. 이들의 예로 할라이드 형성제, 예를 들어 포스겐, 삼브롬화인, 삼염화인, 오염화인, 옥시염화인 또는 티오닐 클로라이드; 무수물 형성제, 예를 들어 클로로포름산 에틸 에스테르, 클로로포포름산 메틸 에스테르, 클로로포포름산 이소프로필 에스테르, 클로로포포름산 이소부틸 에스테르 또는 메탄설포닐 클로라이드; 또는 다른 통상의 축합제, 예를 들어 오산화인, 폴리인산, N,N'-카보닐디이미다졸, 2-에톡시-N-에톡시카보닐-1,2-디하이드로퀴놀린(EEDQ), 트리페닐포스핀/테트라클로로메탄 또는 브로모트리피롤리디노포스포늄 헥사플루오로포스페이트가 언급될 수 있다.Process (j) according to the invention is optionally carried out in the presence of a suitable halogenating agent. As the halogenating agent, those conventionally used for such halogenation reactions can be considered. Examples thereof include halide formers such as phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride or thionyl chloride; Anhydride formers such as chloroformic acid ethyl ester, chloroformic acid methyl ester, chloroformic acid isopropyl ester, chloroformic acid isobutyl ester or methanesulfonyl chloride; Or other conventional condensing agents such as phosphorus pentoxide, polyphosphoric acid, N, N'-carbonyldiimidazole, 2-ethoxy-N-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ), tri Phenylphosphine / tetrachloromethane or bromotripyrrolidinophosphonium hexafluorophosphate may be mentioned.
방법 (j)는 경우에 따라 촉매의 존재하에 수행된다. 이들의 예로는 4-디메틸아미노피리딘, 1-하이드록시벤조트리아졸 또는 디메틸포름아미드가 언급될 수 있다.Process (j) is optionally carried out in the presence of a catalyst. Examples thereof may be mentioned 4-dimethylaminopyridine, 1-hydroxybenzotriazole or dimethylformamide.
본 발명에 따른 방법 (j)를 수행하는 경우, 반응 온도는 넓은 범위에서 변화 될 수 있다. 일반적으로, 이 방법은 0 내지 200 ℃, 바람직하게는 0 내지 150 ℃의 온도에서 수행된다.When carrying out process (j) according to the invention, the reaction temperature can be varied in a wide range. In general, this process is carried out at temperatures of 0 to 200 ° C, preferably 0 to 150 ° C.
화학식 (VII)의 화합물을 제조하기 위한 본 발명에 따른 방법 (g)를 수행하는 경우, 화학식 (XI)의 하이드록시 유도체 1 몰당 일반적으로 0.2 내지 10 몰, 바람직하게는 0.5 내지 5 몰의 할로겐화제가 사용된다.When carrying out process (g) according to the invention for preparing compounds of formula (VII), generally 0.2 to 10 moles, preferably 0.5 to 5 moles of halogenating agent per mole of hydroxy derivative of formula (XI) Used.
모든 불활성 유기 용매가 본 발명에 따른 방법 (k)를 수행하는데 희석제로 고려될 수 있다. 이들에는 바람직하게는 지방족, 지환식 또는 방향족 탄화수소, 예컨대 석유 에테르, 헥산, 헵탄, 사이클로헥산, 메틸사이클로헥산, 벤젠, 톨루엔, 크실렌 또는 데칼린; 할로겐화 탄화수소, 예컨대 클로로벤젠, 디클로로벤젠, 디클로로메탄, 클로로포름, 테트라클로로메탄, 디클로로에탄 또는 트리클로로에탄; 에테르, 예컨대 디에틸 에테르, 디이소프로필 에테르, 메틸 t-부틸 에테르, 메틸 t-아밀 에테르, 디옥산, 테트라하이드로푸란, 1,2-디메톡시에탄, 1,2-디에톡시에탄 또는 아니솔; 아미드, 예컨대 N,N-디메틸포름아미드, N,N-디메틸아세트아미드, N-메틸포름아닐리드, N-메틸피롤리돈 또는 헥사메틸포스포릭 트리아미드; 알콜, 예컨대 메탄올, 에탄올, 이소프로판올이 포함된다.All inert organic solvents can be considered as diluents for carrying out process (k) according to the invention. These preferably include aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Halogenated hydrocarbons such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane or trichloroethane; Ethers such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide; Alcohols such as methanol, ethanol, isopropanol.
본 발명에 따른 방법 방법 (k)는 적합한 환원제의 존재하에서 수행된다. 이를 위해, 모든 통상의 무기 또는 유기 환원제가 사용될 수 있다. 이들에는 바람직하게는 알칼리 토금속 또는 알칼리 금속 수소화물, 예컨대 수소화나트륨 또는 착수소화물, 예컨대 리튬 알루미늄 하이드라이드, 소듐 보로하이드라이드, 소듐 시아노 보로하이드라이드, 디이소부틸 알루미늄 하이드라이드, 보란, 디보란 또는 보란 복합물, 예컨대 보란-피리딘, 실란, 예컨대 트리에틸실란, 금속, 예컨대 소듐, 리튬, 아연, 철 또는 수소가 포함된다.Process according to the invention Process (k) is carried out in the presence of a suitable reducing agent. For this purpose, all conventional inorganic or organic reducing agents can be used. These preferably include alkaline earth metal or alkali metal hydrides such as sodium hydride or complex hydrides such as lithium aluminum hydride, sodium borohydride, sodium cyano borohydride, diisobutyl aluminum hydride, borane, diborane or Borane complexes such as borane-pyridine, silanes such as triethylsilane, metals such as sodium, lithium, zinc, iron or hydrogen.
본 발명에 따른 방법 (k)는 적합한 산 또는 루이스산의 존재하에서 수행된다. 산/루이스산-매개 환원에 사용되는 모든 전형적인 산/루이스산이 사용될 수 있다. 예로서 염산, 아세트산, 트리플루오로아세트산, 삼불화붕소 또는 삼불화붕소 복합물, 예컨대 삼불화붕소 에테레이트, 삼염화알루미늄, 삼염화세륨, 무기 또는 유기 티탄 화합물, 예컨대 사염화티탄, 티탄 테트라이소프로필레이트가 언급된다.Process (k) according to the invention is carried out in the presence of a suitable acid or Lewis acid. All typical acids / Lewis acids used for acid / Lewis acid-mediated reduction can be used. Examples include hydrochloric acid, acetic acid, trifluoroacetic acid, boron trifluoride or boron trifluoride complexes such as boron trifluoride etherate, aluminum trichloride, cerium trichloride, inorganic or organic titanium compounds such as titanium tetrachloride, titanium tetraisopropylate do.
본 발명에 따른 방법 (k)는 경우에 따라 촉매의 존재하에서 수행된다. 이들로 금속 또는 금속염, 특히 전이 금속, 예를 들어 백금, 팔라듐, 니켈(라니 니켈), 이리듐, 로듐, 오스뮴, 철, 루테늄, 코발트가 예로 언급된다. 이들 금속 또는 금속염은 또한 기질 또는 표면 또는 기질 물질(예컨대 탄소)에 결합 또는 적용될 수 있다.Process (k) according to the invention is optionally carried out in the presence of a catalyst. These are mentioned by way of example of metals or metal salts, in particular transition metals such as platinum, palladium, nickel (Rani nickel), iridium, rhodium, osmium, iron, ruthenium, cobalt. These metals or metal salts may also be bound or applied to a substrate or surface or substrate material such as carbon.
본 발명에 따른 방법 (k)를 수행하는 경우, 반응 온도는 넓은 범위에서 변화될 수 있다. 일반적으로, 이 방법은 0 내지 200 ℃, 바람직하게는 0 내지 150 ℃의 온도에서 수행된다.When carrying out process (k) according to the invention, the reaction temperature can be varied in a wide range. In general, this process is carried out at temperatures of 0 to 200 ° C, preferably 0 to 150 ° C.
본 발명에 따른 방법 (k)에서 수소 원소가 환원제로 사용되는 경우, 압력은 넓은 범위내에서 변화될 수 있다. 일반적으로, 1 내지 300 바, 바람직하게는 1 내지 100 바의 압력하에 수행된다.When elemental hydrogen is used as reducing agent in the process (k) according to the invention, the pressure can be varied within a wide range. In general, it is carried out under a pressure of 1 to 300 bar, preferably 1 to 100 bar.
화학식 (XI)의 화합물을 제조하기 위한 본 발명에 따른 방법 (k)를 수행하는 경우, 화학식 (XII)의 아실화 방향족 1 몰당 일반적으로 0.2 내지 10 몰, 바람직하게는 0.5 내지 5 몰의 환원제가 사용된다.When carrying out process (k) according to the invention for the preparation of compounds of formula (XI), generally 0.2 to 10 moles, preferably 0.5 to 5 moles of reducing agent per mole of acylated aromatics of formula (XII) Used.
달리 언급이 없으면, 본 발명에 따른 모든 방법은 일반적으로 대기압하에서 수행된다. 그러나, 각 경우에 승압 또는 감압 - 일반적으로 0.1 내지 10 바하에 수행하는 것이 또한 가능하다.Unless stated otherwise, all the processes according to the invention are generally carried out at atmospheric pressure. However, it is also possible in each case to carry out under elevated or reduced pressure-generally 0.1 to 10 bar.
본 발명에 따른 물질은 강력한 살미생물 활성을 나타내며, 작물 보호 및 재료 보호시 원치않는 미생물, 예를 들어 진균 및 박테리아를 구제하기 위해 사용될 수 있다.The materials according to the invention exhibit strong microbicidal activity and can be used to control unwanted microorganisms, for example fungi and bacteria, in crop protection and material protection.
살진균제는 작물 보호에 있어서 플라스모디오포로마이세테스 (Plasmodiophoromycetes), 오오마이세테스(Oomycetes), 키트리디오마이세테스 (Chytridiomycetes), 지고마이세테스(Zygomycetes), 아스코마이세테스 (Ascomycetes), 바시디오마이세테스(Basidiomycetes) 및 듀테로마이세테스 (Deuteromycetes)를 구제하기 위해 사용될 수 있다.Fungicides include Plasmodiophoromycetes , Oomycetes , Chytridiomycetes , Zygomycetes and Ascomycetes in crop protection. , Basidiomycetes and Deuteromycetes can be used to rescue.
살균제는 작물 보호에 있어서 슈도모노아다세아(Pseudomonoadaceae), 리조비아세아(Rhizobiaceae), 엔테로박테리아세아(Enterobacteriaceae), 코리네박테리아세아(Corynebacteriaceae) 및 스트렙토마이세타세아(Streptomycetaceae)를 구제하기 위해 사용될 수 있다.Fungicides may be used to remedy the pseudo mono Ada years old child (Pseudomonoadaceae), Li Jovi Asia (Rhizobiaceae), Enterobacter bacteria years old child (Enterobacteriaceae), Corey four bacteria years old child (Corynebacteriaceae) and Streptomyces setae years old child (Streptomycetaceae) in crop protection .
상기 속명의 진균 및 박테리아 질병을 야기하는 몇가지 병원균의 예를 하기에 언급하지만, 이에 한정되지는 않는다:Some examples of pathogens that cause fungal and bacterial diseases of the genus above are mentioned below, but not limited to:
크산토모나스(Xanthomonas)종, 예를 들어 크산토모나스 캄페스트리스 피브 이. 오리자에(Xanthomonas campestris pv. oryzae); Xanthomonas species, for example Xanthomonas campestris fib. Orissa ( Xanthomonas campestris pv. Oryzae );
슈도모나스(Pseudomonas)종, 예를 들어 슈도모나스 시링가에 피브이. 라크리만스(Pseudomonas syringae pv. lachrymans);Pseudomonas (Pseudomonas) species, such as blood V Pseudomonas when Manly. Lacrymans ( Pseudomonas syringae pv. Lachrymans );
에르위니아(Erwinia)종, 예를 들어 에르위니아 아밀로보라(Erwinia amylovora); Erwinia species, for example Erwinia amylovora ;
피티움(Pythium)종, 예를 들어 피티움 울티뭄(Pythium ultimum); Pythium species, for example Pythium ultimum ;
피토프토라(Phytophthora)종, 예를 들어 피토프토라 인페스탄스 (Phytophthora infestans); Phytophthora species, for example Phytophthora infestans ;
슈도페로노스포라(Pseudoperonospora)종, 예를 들어 슈도페로노스포라 후물리(Pseudoperonospora humuli) 또는 슈도페로노스포라 쿠벤시스(Pseudoperonospora cubensis); Pseudoperonospora species, for example Pseudoperonospora humuli or Pseudoperonospora cubensis ;
플라스모파라(Plasmopara)종, 예를 들어 플라스모파라 비티콜라(Plasmopara viticola); Plasmopara species, for example Plasmopara viticola ;
브레미아(Bremia)종, 예를 들어 브레미아 락투카에(Bremia lactucae) Bremia species, for example Bremia lactucae
페로노스포라(Peronospora)종, 예를 들어 페로노스포라 피시(Peronospora pisi) 또는 페로노스포라 브라시카에(Peronospora brassicae); Peronospora species, for example Peronospora pisi or Peronospora brassicae ;
에리시페(Erysiphe)종, 예를 들어 에리시페 그라미니스(Erysiphe graminis); Erysiphe species, for example Erysiphe graminis ;
스파에로테카(Sphaerotheca)종, 예를 들어 스파에로테카 풀리기네아 (Sphaerotheca fuliginea); Sphaerotheca species, for example Sphaerotheca fuliginea ;
포도스파에라(Podosphaera)종, 예를 들어 포도스파에라 류코트리차 (Podosphaera leucotricha); Podosphaera species, for example Podosphaera leucotricha ;
벤투리아(Venturia)종, 예를 들어 벤투리아 이내쿠알리스(Venturia inaequalis); Venturia species, for example Venturia inaequalis ;
피레노포라(Pyrenophora)종, 예를 들어 피레노포라 테레스(Pyrenophora teres) 또는 피레노포라 그라미니아(Pyrenophora gr아민a)(분생자 형태: 드레쉬슬레라(Drechslera), 동형: 헬민토스포리움(Helminthosporium));Avoid Leno Fora (Pyrenophora) species, for example, blood Reno Fora Te Les (Pyrenophora teres) or blood Reno Fora Gras Minya (Pyrenophora gr amines a) (min living person Type: Dre rest sled LA (Drechslera), homozygous: Hell Minto Helminthosporium );
코클리오볼루스(Cochliobolus)종, 예를 들어 코클리오볼루스 사티부스 (Cochliobolus sativus)(분생자 형태: 드레쉬슬레라, 동형: 헬민토스포리움); Cochliobolus species, for example Cochliobolus sativus (conidia form: Dresslera, isoform: Helmintosporium);
우로마이세스(Uromyces)종, 예를 들어 우로마이세스 아펜디쿨라투스 (Uromyces appendiculatus); Uromyces species, for example Uromyces appendiculatus ;
푸키니아(Puccinia)종, 예를 들어 푸키니아 레콘디타(Puccinia recondita); Puccinia species, for example Puccinia recondita ;
스클레로티니아(Sclerotinia)종, 예를 들어 스클레로티니아 스클레로티오룸 (Sclerotinia sclerotiorum); Sclerotinia species, for example Sclerotinia sclerotiorum ;
틸레티아(Tilletia)종, 예를 들어 틸레티아 카리에스(Tilletia caries); Tilletia species, for example Tilletia caries ;
우스틸라고(Ustilago)종, 예를 들어 우스틸라고 누다(Ustilago nuda) 또는 우스틸라고 아베나에(Ustilago avenae); Ustilago species, for example Ustilago nuda or Ustilago avenae ;
펠리쿨라리아(Pellicularia)종, 예를 들어 펠리쿨라리아 사사키이 (Pellicularia sasakii); Pellicularia species, for example Pellicularia sasakii ;
피리쿨라리아(Pyricularia)종, 예를 들어 피리쿨라리아 오리자에 (Pyricularia oryzae); Pyricularia species, for example Pyricularia oryzae ;
푸사리움(Fusarium)종, 예를 들어 푸사리움 쿨모룸(Fusarium culmorum);Fusarium (Fusarium) species, such as Fusarium cool morum (Fusarium culmorum);
보트리티스(Botrytis)종, 예를 들어 보트리티스 시네레아(Botrytis cinerea); Botrytis species, for example Botrytis cinerea ;
셉토리아(Septoria)종, 예를 들어 셉토리아 노도룸(Septoria nodorum); Septoria species, for example Septoria nodorum ;
렙토스패리아(Leptosphaeria)종, 예를 들어 렙토스패리아 노도룸 (Leptosphaeria nodorum); Leptosphaeria species, for example Leptosphaeria nodorum ;
세르코스포라(Cercospora)종, 예를 들어 세르코스포라 카네센스(Cercospora canescens); Cercospora species, for example Cercospora canescens ;
알테르나리아(Alternaria)종, 예를 들어 알테르나리아 브라시카에 (Alternaria brassica) 및 Alternaria species, for example Alternaria brassica and
슈도세르코스포렐라(Pseudocercosporella)종, 예를 들어 슈도세르코스포렐라 헤르포트리코이데스(Pseudocercosporella herpotrichoides); Pseudocercosporella species, for example Pseudocercosporella herpotrichoides ;
리족토니아(Rhizoctonia) 종, 예를 들어 리족토니아 솔라니(Rhizoctonia solani). Rhizoctonia species, for example Rhizoctonia solani .
본 발명에 따른 활성 물질은 또한 식물에서 매우 우수한 강화 작용을 나타낸다. 따라서, 이들은 원치않는 미생물에 의한 공격에 대해 식물의 방어력을 부여하기 위해 사용될 수 있다.The active substances according to the invention also show very good strengthening action in plants. Thus, they can be used to confer plant protection against attack by unwanted microorganisms.
여기에서, 식물 강화(저항성-유도) 화합물이란, 처리 식물에 원치않는 미생물을 접종하였을 때 식물에 이들 미생물에 대해 상당한 저항성이 생기도록 식물의 방어 시스템을 자극할 수 있는 물질을 의미하는 것으로 이해되어야 한다.Here, a plant fortifying (resistance-inducing) compound should be understood to mean a substance capable of stimulating a plant's defense system so that when plants are inoculated with unwanted microorganisms, the plant is significantly resistant to these microorganisms. do.
이 경우, 원치않는 미생물이란 식물병원성 진균, 박테리아 및 바이러스를 의미하는 것으로 이해되어야 한다. 따라서, 본 발명에 따른 화합물은 식물을 처리후 일정 기간동안 상기 언급된 병원균에 의한 침습으로부터 보호하기 위해 사용될 수 있다. 보호 기간은 식물을 활성 물질로 처리한 후 일반적으로 1 내지 10일, 바람직하게는 1 내지 7일간이다.In this case, unwanted microorganisms should be understood to mean phytopathogenic fungi, bacteria and viruses. Thus, the compounds according to the invention can be used to protect plants from invasion by the aforementioned pathogens for a period of time after treatment. The period of protection is generally 1 to 10 days, preferably 1 to 7 days after treatment of the plant with the active substance.
식물 질병을 구제하는데 필요한 농도에서 식물이 활성 물질에 대해 내약성을 갖기 때문에 식물의 지상부, 번식 줄기 및 종자, 및 토양의 처리가 가능하다.The plants are tolerated to the active substance at the concentrations necessary to control plant diseases, thus allowing the treatment of the plant's ground, breeding stems and seeds, and soil.
이 경우, 본 발명에 따른 활성 물질은 곡물 질병, 예를 들어 푸키니아 종, 및 포도, 과일 및 야채 재배시에 나타나는 질병, 예를 들어 보트리티스, 벤투리아 또는 알터나리아 종을 구제하기 위해 사용되는 경우 특히 성공적으로 사용될 수 있다.In this case, the active substances according to the invention are used for the control of grain diseases, for example Puchinia species, and diseases that appear in the cultivation of grapes, fruits and vegetables, for example Botrytis, Venturi or Alternaria species. If used, it can be used particularly successfully.
본 발명에 따른 활성 물질은 또한 작물 수확량을 증산시키기 위해 사용될 수 있다. 또한, 이들은 저독성이며, 우수한 식물 상용성을 나타낸다.The active substances according to the invention can also be used to increase crop yields. In addition, they are low toxicity and exhibit excellent plant compatibility.
경우에 따라, 본 발명에 따른 활성 물질은 특정 농도 및 적용 비율에서 또한 제초제로서, 식물 성장을 조절하기 위해서나, 동물 해충을 구제하기 위해 사용될 수 있다. 경우에 따라, 이들은 또한 다른 활성 물질을 합성하기 위한 중간체 또는 전구체로도 사용될 수 있다.If desired, the active substances according to the invention can also be used at certain concentrations and application rates and also as herbicides, for controlling plant growth or for controlling animal pests. If desired, they can also be used as intermediates or precursors for synthesizing other active substances.
본 발명에 따라 모든 식물 및 식물 부분이 처리될 수 있다. 여기에서 식물이란 원하거나 원치않는 야생 식물(잡초) 또는 작물(자연 발생 작물 포함)과 같은 모든 식물 및 식물 집단을 의미하는 것으로 이해되어야 한다. 작물은 식물 육종권 자의 보증에 의해 보호될 수 있거나 보호될 수 없는 식물 재배종 및 형질전환(transgenic) 식물을 포함하여, 통상적인 육종 및 최적화 방법에 의해, 생명공학 및 유전자공학 방법에 의해 또는 이들 방법을 조합하여 얻을 수 있는 식물일 수 있다. 식물의 일부는 식물의 모든 지상 및 지하 부분 및 기관, 예를 들어 싹, 잎, 꽃 및 뿌리를 의미하는 것으로 이해되어야 하며, 이들의 예로 잎, 침엽(needles), 자루(stalk), 줄기(stem), 꽃, 과실체, 과일, 종자, 뿌리, 괴경 및 뿌리 줄기가 언급될 수 있다. 식물의 일부는 또한 수확 물질, 및 영양 및 생식 번식 물질, 예를 들어 묘목, 괴경, 뿌리 줄기, 삽목 및 종자를 포함한다.All plants and plant parts can be treated according to the invention. Plant is to be understood here as meaning all plants and plant populations, such as desired or unwanted wild plants (weeds) or crops (including naturally occurring crops). Crops include plant cultivars and transgenic plants, which may or may not be protected by plant breeder's endorsement, by conventional breeding and optimization methods, by biotechnology and genetic engineering methods, or by these methods It may be a plant obtained by combining. Some of the plants are to be understood as meaning all the above-ground and underground parts and organs of the plant, for example, shoots, leaves, flowers and roots, examples of which are leaves, needles, stalks, stems. ), Flowers, fruits, fruits, seeds, roots, tubers and rhizomes may be mentioned. Some of the plants also include harvesting materials, and nutritional and reproductive materials, such as seedlings, tubers, rhizomes, cuttings and seeds.
본 발명에 따라 활성 물질로 식물 및 식물의 일부를 처리하는 것은 통상의 처리 방법에 의해, 예를 들어 침지, 분무, 증발 노출, 분사, 살포, 뿌리기에 의해서 및, 전파 물질, 특히 종자의 경우에는 또한 일 또는 다중 코팅을 적용하여 직접, 또는 그의 환경, 서식지 또는 저장 공간에 작용시킴으로써 수행된다.Treatment of plants and parts of plants with active substances according to the invention is carried out by conventional treatment methods, for example by dipping, spraying, evaporating exposure, spraying, spraying, spraying, and in the case of propagating materials, in particular seed It is also carried out by applying one or multiple coatings to act directly or on its environment, habitat or storage space.
본 발명에 따른 화합물은 재료를 보호하는데 있어 공업용 물질이 원치 않는 미생물에 의해 감염 및 파괴되는 것으로부터 보호하기 위해 사용될 수 있다.The compounds according to the invention can be used to protect the material from being infected and destroyed by unwanted microorganisms.
여기에서 공업용 물질이란 산업적 용도로 제조된 무생 물질을 의미하는 것으로 이해되어야 한다. 예를 들어, 미생물에 의한 변화 또는 파괴로 부터 본 발명에 따른 활성 물질에 의해 보호받고자 하는 공업용 물질은 접착제, 아교, 종이, 판지(cardboard), 직물, 가죽, 목재, 페인트, 플라스틱 제품, 냉각 윤활제 및 미생물에 의해 감염되거나 파괴될 수 있는 기타 물질일 수 있다. 보호되는 물질의 범위내에 포함되는 것으로는 또한 미생물의 증식에 의해 손상될 수 있는 생산 설비의 일부, 예를 들어 냉각수 회로가 언급될 수 있다. 본 발명의 범주내에서 언급될 수 있는 공업용 물질은 바람직하게는 접착제, 아교, 종이, 판지, 가죽, 목재, 페인트, 냉각 윤활제 및 열전달 유체, 특히 바람직하게는 목재이다.Industrial materials here are to be understood as meaning non-living materials prepared for industrial use. For example, industrial materials intended to be protected by the active substances according to the invention from changes or destruction by microorganisms are adhesives, glues, paper, cardboard, textiles, leather, wood, paints, plastic products, cooling lubricants. And other substances that can be infected or destroyed by microorganisms. Within the scope of the material to be protected, mention may also be made of parts of the production equipment, such as cooling water circuits, which may be damaged by the growth of microorganisms. Industrial materials that may be mentioned within the scope of the present invention are preferably adhesives, glues, paper, cardboard, leather, wood, paints, cooling lubricants and heat transfer fluids, particularly preferably wood.
공업용 물질을 분해 또는 변화시킬 수 있는 미생물로는 예를 들어, 박테리아, 진균, 이스트, 조류(algae) 및 변형(slime) 유기체가 언급될 수 있다. 본 발명에 따른 활성 물질은 바람직하게는 진균, 특히 사상균, 목재 변색 및 목재 파괴 진균(바시디오마이세테스) 및 변형 유기체 및 조류에 작용한다.Microorganisms capable of degrading or changing industrial materials can be mentioned, for example, bacteria, fungi, yeast, algae and slime organisms. The active substances according to the invention preferably act on fungi, in particular filamentous fungi, wood discoloration and wood destruction fungi (vasidiomycetes) and on modified organisms and algae.
하기 속의 미생물이 예로 언급될 수 있다:Microorganisms of the following genus may be mentioned by way of example:
알터나리아(Alternaria), 예를 들어 알터나리아 테누이스(Alternaria tenuis) Alternaria , for example Alternaria tenuis
아스퍼길루스(Aspergillus), 예를 들어 아스퍼길루스 니거(Aspergillus niger) Aspergillus , for example Aspergillus niger
캐토미움(Chaetomium), 예를 들어 캐토미움 글로보숨(Chaetomium globosum),Kaeto hate (Chaetomium), for example kaeto hatred Globo breath (Chaetomium globosum),
코니오포라(Coniophora), 예를 들어 코니오포라 푸에타나(Coniophora puetana), Coniophora , for example Coniophora puetana ,
렌티누스(Lentinus), 예를 들어 렌티누스 티그리누스(Lentinus tigrinus), Lentinus , for example Lentinus tigrinus ,
페니실리움(Penicillium), 예를 들어 페니실리움 글라우쿰(Penicillium glaucum), Penicillium , for example Penicillium glaucum ,
폴리포루스(Polyporus), 예를 들어, 폴리포루스 버시컬러(Polyporus versicolor), Polyporus , for example Polyporus versicolor ,
아우레오바시디움(Aureobasidium), 예를 들어 아우레오바시디움 풀루란스 (Aureobasidium pullulans), Aureobasidium , for example Aureobasidium pullulans ,
스클레오포마(Sclerophoma), 예를 들어 스클레오포마 피타이오필라 (Sclerophoma pityophila),'S nucleoside poma (Sclerophoma), for example, scan nucleoside poma pita EO pillar (Sclerophoma pityophila),
트리코더마(trichoderma), 예를 들어 트리코더마 비리데(Trichoderma viride),Trichoderma (trichoderma), for example, to irregularities in Trichoderma (Trichoderma viride),
에스케리키아(Escherichia), 예를 들어 에스케리키아 콜리(Escherichia coli), Escherichia , for example Escherichia coli ,
슈도모나스(Pseudomonas), 예를 들어 슈도모나스 아에루기노사(Pseudomonas aeruginosa) 및Pseudomonas (Pseudomonas), for example Pseudomonas rugi ah industrial (Pseudomonas aeruginosa) and
스타필로코쿠스(Staphylococcus), 예를 들어 스타필로코쿠스 아우레우스 (Staphylococcus aureus). Staphylococcus , for example Staphylococcus aureus .
활성 물질은 그의 특별한 물리적 및/또는 화학적 성질에 따라 용액제, 유제, 현탁제, 산제, 포움제, 페이스트, 과립제, 에어로졸, 및 중합물질 및 종자용 코팅 조성물중의 마이크로캅셀제와 같은 통상의 제제 및 극소 부피 냉무제 및 온무제로 전환시킬 수 있다.The active substances may be prepared according to their particular physical and / or chemical properties, such as conventional formulations such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols and microcapsules in polymeric and seed coating compositions. It can be converted to very small volume coolants and warmers.
이들 제제는 공지된 방법으로, 예를 들어, 임의로 계면활성제, 즉 유화제 및/또는 분산제 및/또는 포움 형성제를 사용하여 활성 물질을 증량제, 즉 액상 용매, 가압 액화가스 및/또는 고형 담체 물질과 혼합하여 제조된다. 사용된 증량제가 물인 경우에는, 예를 들어 유기 용매가 또한 보조 용매로 사용될 수 있다. 적합한 액상 용매는, 주로 크실렌, 톨루엔 또는 알킬나프탈렌과 같은 방향족 화합물; 클로로벤젠, 클로로에틸렌 또는 메틸렌 클로라이드와 같은 염소화 방향족 또는 염소화 지방족 탄화수소; 사이클로헥산 또는 파라핀, 예를 들어, 석유 분획과 같은 지방족 탄화수소; 부탄올 또는 글리콜과 같은 알콜 및 그들의 에테르 및 에스테르; 아세톤, 메틸 에틸 케톤, 메틸 이소부틸 케톤 또는 사이클로헥사논과 같은 케톤; 디메틸포름아미드 또는 디메틸설폭사이드와 같은 강한 극성 용매, 또는 물이다. 액화가스 증량제 또는 담체란 상온 및 상압하에서 가스 상태인 액체를 의미하며, 예를 들어 할로겐화 탄화수소 및 또한 부탄, 프로판, 질소 및 이산화탄소와 같은 에어로졸 추진제이다. 적합한 고형 담체는 예를 들어 카올린, 점토, 활석, 백악, 석영, 아타펄기트, 몬모릴로나이트 또는 규조토와 같은 분쇄된 천연 광물, 및 미분 실리카, 알루미나 및 실리케이트와 같은 분쇄된 합성 광물이다. 적합한 과립제용 고형 담체는 예를 들어 방해석, 대리석, 경석, 해포석 및 백운석과 같은 분쇄 및 분류된 천연 암석, 또는 무기 및 유기가루의 합성과립, 및 톱밥, 코코넛 껍질, 옥수수 속대 및 담배줄기와 같은 유기물질의 과립이다. 적합한 유화제 및/또는 포움 형성제는 예를 들어 비이온성 및 음이온성 유화제, 예를 들어 폴리옥시에틸렌 지방산 에스테르, 폴리옥시에틸렌 지방 알콜 에테르, 예를 들어 알킬아릴 폴리글리콜 에테르, 알킬설포네이트, 알킬설페이트, 아릴설포네이트 또는 단백질 가수분해물이다. 리그닌, 설파이트 폐액 및 메틸셀룰로오즈가 분산제로 고려될 수 있다.These formulations are known methods, for example, using surfactants, ie emulsifiers and / or dispersants and / or foam formers, to extend the active material with extenders, ie liquid solvents, pressurized liquefied gases and / or solid carrier materials. It is prepared by mixing. If the extender used is water, for example organic solvents can also be used as auxiliary solvents. Suitable liquid solvents are mainly aromatic compounds such as xylene, toluene or alkylnaphthalene; Chlorinated aromatic or chlorinated aliphatic hydrocarbons such as chlorobenzene, chloroethylene or methylene chloride; Aliphatic hydrocarbons such as cyclohexane or paraffins such as petroleum fractions; Alcohols such as butanol or glycols and their ethers and esters; Ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone; Strong polar solvents such as dimethylformamide or dimethylsulfoxide, or water. Liquefied gaseous extenders or carriers mean liquids which are gaseous at room temperature and atmospheric pressure, for example halogenated hydrocarbons and also aerosol propellants such as butane, propane, nitrogen and carbon dioxide. Suitable solid carriers are, for example, ground natural minerals such as kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals such as finely divided silica, alumina and silicates. Suitable granular solid carriers are, for example, pulverized and classified natural rocks such as calcite, marble, pumice, calcite and dolomite, or synthetic granules of inorganic and organic powders, and organic such as sawdust, coconut husks, corn cobs and tobacco stems. Granules of matter. Suitable emulsifiers and / or foam formers are for example nonionic and anionic emulsifiers, for example polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulfonates, alkylsulfates , Arylsulfonates or protein hydrolysates. Lignin, sulfite waste liquor and methylcellulose can be considered as dispersants.
제제는 또한 점착제, 예를 들어 카복시메틸셀룰로오즈, 및 아라비아고무, 폴리비닐 알콜 및 폴리비닐 아세테이트와 같은 분말, 과립 또는 라텍스 형태의 천연 및 합성 중합체, 또는 세팔린 및 레시틴과 같은 천연 인지질 및 합성 인지질을 포함한다. 그밖의 첨가제는 광유 및 식물유일 수 있다.The formulations also contain adhesives such as carboxymethylcellulose, and natural and synthetic polymers in the form of powders, granules or latex, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or natural and synthetic phospholipids such as cephalin and lecithin. Include. Other additives may be mineral and vegetable oils.
착색제, 예를 들어 산화철, 산화티탄 및 프루시안 블루와 같은 무기안료, 및 알리자린 염료, 아조염료 및 금속 프탈로시아닌 염료와 같은 유기 안료, 및 철, 망간, 붕소, 구리, 코발트, 몰리브덴 및 아연의 염과 같은 미량 영양소가 사용될 수도 있다.Colorants such as inorganic pigments such as iron oxide, titanium oxide and prussian blue, and organic pigments such as alizarin dyes, azo dyes and metal phthalocyanine dyes, and salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc; The same micronutrients may be used.
제제는 일반적으로 0.1 내지 95 중량%, 바람직하게는 0.5 내지 90 중량%의 활성 물질을 함유한다.The formulations generally contain 0.1 to 95% by weight, preferably 0.5 to 90% by weight of active substance.
본 발명에 따른 활성 물질은 또한, 그 자체로, 또는 그의 제제중에서 예를 들어 활성 스펙트럼을 넓히거나 내성이 생기는 것을 방지하기 위하여 공지된 살진균제, 살균제, 살비제, 살선충제 또는 살충제와의 혼합물로서 존재할 수 있다. 많은 경우 상승 효과가 얻어지며, 즉, 혼합물의 효과는 개별 성분들의 효과를 능가한다.The active substance according to the invention can also be used on its own or as a mixture with known fungicides, fungicides, acaricides, nematicides or insecticides, for example in order to prevent broadening or developing resistance in the activity spectrum. May exist. In many cases a synergistic effect is obtained, ie the effect of the mixture exceeds the effect of the individual components.
보충 제제 성분의 예에 다음과 같은 화합물이 있다:Examples of supplemental formulation ingredients include the following compounds:
살진균제:Fungicides:
2-페닐페놀, 8-하이드록시퀴놀린 설페이트,2-phenylphenol, 8-hydroxyquinoline sulfate,
아시벤졸라-S-메틸, 알디모르프, 아미도플루메트, 암프로필포스, 암프로필포스-포타슘, 안도프림, 아닐라진, 아자코나졸, 아족시스트로빈,Acibenzola-S-methyl, Aldimorph, Amidoflumet, Ampropyl force, Ampropyl force-potassium, Andoprim, Anilazin, Azaconazole, Azoxystrobin,
베날락실, 베날락실-M, 베노다닐, 베노밀, 벤티아발리카브-이소프로필, 벤자마크릴, 벤자마크릴-이소부틸, 빌라나포스, 비나파크릴, 비페닐, 비터탄올, 블라스 티시딘-S, 브로무코나졸, 부피리메이트, 부티오베이트, 부틸아민,Benalacyl, Benalacyl-M, Benodanil, Benomyl, Ventiavalicab-Isopropyl, Benzamacryl, Benzamacryl-Isobutyl, Villanaphos, Vinapacryl, Biphenyl, Vitertanol, Blastisidin- S, bromuconazole, burimate, butiobate, butylamine,
칼슘-폴리설파이드, 캅시마이신, 캅타폴, 캅탄, 카벤다짐, 카복신, 카프로파미드, 카르본, 퀴노메티오네이트, 클로벤티아존, 클로르페나졸, 클로로네브, 클로로탈로닐, 클로졸리네이트, 클로질라콘, 사이아조파미드, 사이플루페나미드, 사이목사닐, 사이프로코나졸, 사이프로디닐, 사이프로푸람,Calcium-polysulfide, capsaicin, captapol, captan, carbendazim, carboxycin, capropamide, carbon, quinomethionate, clobenthiazone, chlorfenazole, chloroneb, chlorotalonyl, clozolinate , Clozilacon, cyazopamide, cyflufenamide, cymoxanyl, cyproconazole, cyprodinyl, cyprofuram,
Dagger G, 데바카브, 디클로플루아니드, 디클론, 디클로로펜, 디클로사이메트, 디클로메진, 디클로란, 디에토펜카브, 디페노코나졸, 디플루메토림, 디메티리몰, 디메토모르프, 디목시스트로빈, 디니코나졸, 디니코나졸-M, 디노캅, 디페닐아민, 디피리티온, 디탈림포스, 디티아논, 도딘, 드라족솔론,Dagger G, devacarb, diclofluanide, diclones, dichlorophene, diclocemet, diclomezin, dichloran, dietofencarb, difenokazole, diflumethorim, dimethirimol, dimetho Morph, Dimoxistrobin, Diconazole, Diconazole-M, Dinocap, Diphenylamine, Dipyrithione, Ditalimfoss, Dithianon, Dodine, Dragoxolone,
에디펜포스, 에폭시코나졸, 에타복삼, 에티리몰, 에트리디아졸,Edifene Force, Epoxyconazole, Ethaboxam, Ethirimole, Etridazole,
파목사돈, 페나미돈, 페나파닐, 페나리몰, 펜부코나졸, 펜푸람, 펜헥사미드, 페니트로판, 페녹사닐, 펜피클로닐, 펜프로피딘, 펜프로피모르프, 페르밤, 플루아지남, 플루벤지민, 플루디옥소닐, 플루메토버, 플루모르프, 플루오로미드, 플루옥사스트로빈, 플루퀸코나졸, 플루프리미돌, 플루실라졸, 플루설파미드, 플루톨라닐, 플루트리아폴, 폴펫, 포세틸-Al, 포세틸-소듐, 푸베리다졸, 푸랄락실, 푸라메트피르, 푸르카바닐, 푸르메사이클록스,Soxaxadon, phenamidone, phenananil, phenarimol, fenbuconazole, fenfuram, phenhexamide, phenytropan, phenoxanyl, fenpiclonyl, phenpropidine, phenpropimod, ferbam, Fluazinam, Flubenzimin, Fludioxonyl, Flumetober, Flumorph, Fluoromid, Fluoxastrobin, Fluquinconazole, Fluprimidol, Flusilazole, Flusulfamid, Flutolanil , Flutriafol, polpet, pocetyl-Al, pocetyl-sodium, fuberidazole, furalacyl, furametpyr, purcarbanyl, purmecyclolox,
구아자틴,Guazatin,
헥사클로로벤젠, 헥사코나졸, 하이멕사졸,Hexachlorobenzene, hexaconazole, hymexazole,
이마잘릴, 이미벤코나졸, 이미녹타딘 트리아세테이트, 이미녹타딘 알베실레이트, 요오도카브, 이프코나졸, 이프로벤포스, 이프로디온, 이프로발리카브, 이루 마마이신, 이소프로티올란, 이소발레디온,Imazalyl, imibenconazole, iminottadine triacetate, iminottadine albesylate, iodocarb, ifconazole, iprobenfos, iprodione, iprovalicab, irumamycin, isoprothiolane, isovale Dion,
카수가마이신, 크레속심-메틸,Kasugamycin, Cresoxime-Methyl,
만코제브, 마네브, 메페림존, 메파니피림, 메프로닐, 메탈락실, 메탈락실-M, 메트코나졸, 메타설포카브, 메트푸록삼, 메티람, 메토미노스트로빈, 메트설포박스, 밀디오마이신, 마이클로부타닐, 마이클로졸린,Mancozeb, maneb, meperimzone, mepanipyrim, mepronil, metallaxyl, metallaxyl-M, metconazole, metasulfocarb, metfuroxam, metiram, metomistrobin, metsulfobox, Mildiomycin, Michael Robutanil, Michael Rozoline,
나타마이신, 니코비펜, 니트로탈-이소프로필, 노비플루무론, 누아리몰,Natamycin, nicobifen, nitrotal-isopropyl, nobiflumuron, noarimol,
오푸라스, 오리사스트로빈, 옥사딕실, 옥솔린산, 옥스포코나졸, 옥시카복신, 옥시펜티인,Opuras, orissastrobin, oxadixyl, oxolinic acid, oxpoconazole, oxycarboxycin, oxypentetiin,
파클로부트라졸, 페푸라조에이트, 펜코나졸, 펜시쿠론, 포스디펜, 프탈리드, 피콕시스트로빈, 피페랄린, 폴리옥신, 폴리옥소림, 프로베나졸, 프로클로라즈, 프로사이미돈, 프로파모카브, 프로파노신-소듐, 프로피코나졸, 프로피네브, 프로퀴나지드, 프로티오코나졸, 피라클로스트로빈, 피라조포스, 피리페녹스, 피리메타닐, 피로퀼론, 피록시푸르, 피롤니트린,Paclobutrazole, pepurazoate, fenconazole, pensicuron, phosphodiphene, phthalide, picoxistrobin, piperaline, polyoxine, polyoxorim, provenazole, prochloraz, procymidone, pro Pamocarb, propanosine-sodium, propiconazole, propineb, proquinazide, prothioconazole, pyraclostrobin, pyrazophos, pyriphenox, pyrimethanyl, pyroquilon, pyroxipur Pyrronitrin,
퀸코나졸, 퀴녹시펜, 퀸토젠,Quinconazole, quinoxifen, quintogen,
시메코나졸, 스피록사민, 황,Cymeconazole, spiroxamine, sulfur,
테부코나졸, 테클로프탈람, 테크나젠, 테트사이클라시스, 테트라코나졸, 티아벤다졸, 티사이오펜, 티플루자미드, 티오파네이트-메틸, 티람, 티옥시미드, 톨클로포스-메틸, 톨릴플루아니드, 트리아디메폰, 트리아디메놀, 트리아즈부틸, 트리아족사이드, 트리사이클라미드, 트리사이클라졸, 트리데모르프, 트리플록시스트로빈, 트리플루미졸, 트리포린, 트리티코나졸,Tebuconazole, Teclophthalam, Tecnazen, Tecyclcyclase, Tetraconazole, Thiabendazole, Tiothiophene, Tifluzamide, Thiophanate-methyl, Thiram, Thioxymide, Tollclofos-methyl , Tolylufluoride, triadimefon, triadimenol, triazbutyl, triazoxide, tricyclamide, tricyclazole, tridemorph, trixystrobin, triflumizol, tripolin, tri Ticonazole,
유니코나졸,Uniconazole,
발리다마이신 A, 빈클로졸린,Validamycin A, vinclozoline,
지네브, 지람, 족사미드,Geneb, Zeram, Joksamid,
(2S)-N-[2-[4-[[3-(4-클로로페닐)-2-프로피닐]옥시]-3-메톡시페닐]에틸]-3-메틸-2-[(메틸설포닐)아미노]부탄아미드,(2S) -N- [2- [4-[[3- (4-chlorophenyl) -2-propynyl] oxy] -3-methoxyphenyl] ethyl] -3-methyl-2-[(methylsul Phonyl) amino] butanamide,
1-(1-나프탈레닐)-1H-피롤-2,5-디온,1- (1-naphthalenyl) -1H-pyrrole-2,5-dione,
2,3,5,6-테트라클로로-4-(메틸설포닐)피리딘,2,3,5,6-tetrachloro-4- (methylsulfonyl) pyridine,
2-아미노-4-메틸-N-페닐-5-티아졸카복사미드,2-amino-4-methyl-N-phenyl-5-thiazolecarboxamide,
2-클로로-N-(2,3-디하이드로-1,1,3-트리메틸-1H-인덴-4-일)-3-피리딘카복사미드,2-chloro-N- (2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl) -3-pyridinecarboxamide,
3,4,5-트리클로로-2,6-피리딘 디카보니트릴,3,4,5-trichloro-2,6-pyridine dicarbonitrile,
액티노베이트,Actinate,
시스-1-(4-클로로페닐)-2-(1H-1,2,4-트리아졸-1-일)사이클로헵탄올,Cis-1- (4-chlorophenyl) -2- (1H-1,2,4-triazol-1-yl) cycloheptanol,
메틸 1-(2,3-디하이드로-2,2-디메틸-1H-인덴-1-일)-1H-이미다졸-5-카복실레이트,Methyl 1- (2,3-dihydro-2,2-dimethyl-1H-inden-1-yl) -1H-imidazole-5-carboxylate,
탄산일칼륨,Potassium carbonate,
N-(6-메톡시-3-피리디닐)사이클로프로판 카복사미드,N- (6-methoxy-3-pyridinyl) cyclopropane carboxamide,
N-부틸-8-(1,1-디메틸에틸)-1-옥사스피로[4.5]데칸-3-아민,N-butyl-8- (1,1-dimethylethyl) -1-oxaspiro [4.5] decan-3-amine,
소듐 테트라티오카보네이트, 및Sodium tetrathiocarbonate, and
구리 염 및 제제, 예를 들어 보르도(Bordeaux) 혼합물, 수산화 구리, 구리 나프테네이트, 옥시염화구리, 황산구리, 쿠프라네브, 산화구리, 만코퍼, 옥신-구리.Copper salts and preparations, such as Bordeaux mixtures, copper hydroxide, copper naphthenate, copper oxychloride, copper sulfate, cupraneb, copper oxide, mancopper, auxin-copper.
살균제: disinfectant:
브로노폴, 디클로로펜, 니트라피린, 니켈 디메틸디티오카바메이트, 카수가마이신, 옥틸리논, 푸란카복실산, 옥시테트라사이클린, 프로베나졸, 스트렙토마이신, 테클로프탈람, 황산구리 및 다른 구리 제제.Bronopol, dichlorophene, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octylinone, furancarboxylic acid, oxytetracycline, probenazole, streptomycin, teclophthalam, copper sulfate and other copper agents.
살충제 / 살비제 / 살선충제:Pesticides / Acaricides / Nematicides:
1. 아세틸콜린 에스테라제(AChE) 저해제.1. Acetylcholine esterase (AChE) inhibitors.
1.1 카바메이트, 예를 들어1.1 carbamate, for example
알라니카브, 알디카브, 알독시카브, 알릭시카브, 아미노카브, 아자메티포스, 벤디오카브, 벤푸라카브, 부펜카브, 부타카브, 부토카복심, 부톡시카복심, 카바릴, 카보푸란, 카보설판, 클로에토카브, 쿠마포스, 시아노펜포스, 시아노포스, 디메틸란, 에티오펜카브, 페노부카브, 페노티오카브, 포르메타네이트, 푸라티오카브, 이소프로카브, 메탐-소듐, 메티오카브, 메토밀, 메톨카브, 옥사밀, 피리미카브, 프로메카브, 프로폭수르, 티오디카브, 티오파녹스, 트리아자메이트, 트리메타카브, XMC, 크실릴카브,Alanicarb, Aldicarb, Aldoxicarb, Alixicarb, Aminocarb, Azametifoss, Bendiocarb, Benfuracarb, Buppencarb, Butacarb, Butokkasimsim, Butoxycarbsim, Cabaril, Cabofuran, Cabo Sulfan, cloetocarb, coomafoss, cyanofenfoss, cyanofoss, dimethyllan, ethiophencarb, phenobucarb, phenothiocarb, formmethate, furathiocarb, isoprocarb, metham-sodium, methiocarb , Metomil, metholcarb, oxamyl, pyrimikab, promecarb, propoxur, thiodicarb, thiophanox, triamate, trimethcarb, XMC, xylylcarb,
1.2 유기 포스페이트, 예를 들어1.2 organic phosphates, for example
아세페이트, 아자메티포스, 아진포스(-메틸, -에틸), 브로모포스-에틸, 브롬펜빈포스(-메틸), 부타티오포스, 카두사포스, 카보페노티온, 클로르에톡시포스, 클로르펜빈포스, 클로르메포스, 클로르피리포스(-메틸, -에틸), 쿠마포스, 시아노펜 포스, 시아노포스, 클로르펜빈포스, 데메톤-S-메틸, 데메톤-S-메틸설폰, 디알리포스, 디아지논, 디클로펜빈티온, 디클로르보스/DDVP, 디크로토포스, 디메토에이트, 디메틸빈포스, 디옥사벤조포스, 디설포톤, EPN, 에티온, 에토프로포스, 에트림포스, 팜푸르, 펜아미포스, 페니트로티온, 펜설포티온, 펜티온, 플루피라조포스, 포노포스, 포르모티온, 포스메틸란, 포스티아제이트, 헵테노포스, 이오도펜포스, 이프로벤포스, 이사조포스, 이소펜포스, 이소프로필 O-살리실레이트, 이속사티온, 말라티온, 메카르밤, 메타크리포스, 메타미도포스, 메티다티온, 메빈포스, 모노크로토포스, 날레드, 오메토에이트, 옥시데메톤-메틸, 파라티온(-메틸, -에틸), 펜토에이트, 포레이트, 포살론, 포스메트, 포스파미돈, 포스포카브, 폭심, 피리미포스(-메틸, -에틸), 프로페노포스, 프로파포스, 프로페탐포스, 프로티오포스, 프로토에이트, 피라클로포스, 피리다펜티온, 피리다티온, 퀴날포스, 세부포스, 설포텝, 설프로포스, 테부피림포스, 테메포스, 테르부포스, 테트라클로르빈포스, 티오메톤, 트리아조포스, 트리클로르폰, 바미도티온,Acetate, Azametifoss, Ajinfoss (-methyl, -ethyl), Bromophos-ethyl, Brompfenbinfoss (-methyl), Butadithiofoss, Cardusafoss, Carbophenothione, Chloethoxyfoss, Chlor Penvinforce, Chlormephos, Chlorpyriphos (-methyl, -ethyl), Coomaphos, Cyanophene Force, Cyanophos, Chlorfenbinphos, Demethone-S-methyl, Demethone-S-methylsulfone, Diali Phos, diazinon, diclofenvinthion, dichlorbos / DDVP, dicrotophos, dimethoate, dimethylbinfos, dioxabenzophos, disulfotone, EPN, ethion, etoprophos, etrimpos, Pampur, Penamifoss, Phenythrothione, Pensulfothione, Pention, Flupyrazophos, Phonophos, Formomolion, Phosmethyllan, Phosthiazate, Heptenophos, Iodofenfoss, Iprobenfoss , Isazofos, isofenfoss, isopropyl O-salicylate, isoxation, malathion, mecarbam, methacrypo , Metamidofos, metidathione, mevinfoss, monocrotophos, naled, ometoate, oxydemethone-methyl, parathion (-methyl, -ethyl), pentoate, forate, posalon, posmet, Phosphomidone, Phosphocarb, Bombide, Pyrimiphos (-methyl, -ethyl), Propenophos, Propaphos, Propetafoss, Prothiophos, Protoate, Pycloclofos, Pyridapentione, Pyri Dation, Quinal Force, Cebu Force, Sulpotep, Sulprophos, Tebupyrimphos, Temephos, Terbufoss, Tetrachlorbinfos, Tiomethone, Triazophos, Trichlorpon, Bamidothione,
2. 소듐 채널 조절제/전압-의존성 소듐 채널 봉쇄제2. Sodium Channel Regulators / Voltage-Dependent Sodium Channel Blockers
2.1 피레트로이드, 예를 들어2.1 pyrethroids, for example
아크리나트린, 알레트린(d-시스-트랜스, d-트랜스), 베타-사이플루트린, 비펜트린, 비오알레트린, 비오알레트린-S-사이클로펜틸-이성체, 비오에타노메트린, 비오퍼메트린, 비오레스메트린, 클로바포트린, 시스-사이퍼메트린, 시스-레스메트린, 시스-퍼메트린, 클로사이트린, 사이클로프로트린, 사이플루트린, 사이할로트린, 사이퍼메트린(알파-, 베타-, 테타-, 제타-), 사이페노트린, DDT, 델타메트린, 엠펜트린(1R-이성체), 에스펜발레레이트, 에토펜프록스, 펜플루트린, 펜프로파트린, 펜피리트린, 펜발레레이트, 플루브로사이트리네이트, 플루사이트리네이트, 플루펜프록스, 플루메트린, 플루발리네이트, 푸브펜프록스, 감마-사이할로트린, 이미프로트린, 카데트린, 람마-사이할로트린, 메토플루트린, 퍼메트린(시스-, 트랜스-), 페노트린(1R-트랜스 이성체), 프랄레트린, 프로플루트린, 프로트리펜부트, 피레스메트린, 레스메트린, RU 15525, 실라플루오펜, 타우-플루발리네이트, 테플루트린, 트랄레트린, 테트라메트린(1R-이성체), 트랄로메트린, 트랜스플루트린, ZXI 8901, 피레트린(피레트럼),Acrinatrin, alletrin (d-cis-trans, d-trans), beta-cyfluthrin, bifenthrin, bioaletrin, bioaletrin-S-cyclopentyl-isomer, bioethanomethrin, bio Permethrin, bioresmethrin, clovapotrin, cis-cypermethrin, cis-resmethrin, cis-permethrin, clocitrin, cycloprotrin, cyfluthrin, cyhalothrin, cypermethrin (alpha-, beta- , Theta-, zeta-), cyphenothrin, DDT, deltamethrin, empentrin (1R-isomer), espen valerate, etofenprox, fenfluthrin, phenpropatrine, phenpytrin, Penvalerate, flubrocithinate, flucitrinate, flufenprox, flumethrin, fluvalinate, fufenfenrox, gamma-cyhalothrin, imiprotrin, cathetrin, ramma-cyhalo Tririne, metofluthrin, permethrin (cis-, trans-), phenothrin (1R-trans isomer), Lalettrin, profluthrin, protrifenbut, pyresmethrin, resmetrin, RU 15525, silafluorene, tau-fluvalinate, tefluthrin, traletrine, tetramethrin (1R-isomer), Tralomethrin, transflutrin, ZXI 8901, pyrethrin (pyrethrum),
2.2 옥사디아진, 예를 들어 인독사카브,2.2 oxadiazines such as indoxacarb,
3. 아세틸콜린 수용체 작용제/길항제3. Acetylcholine Receptor Agonists / antagonists
3.1 클로로니코티닐/네오니코티노이드, 예를 들어3.1 chloronicotinyl / neicotinoids, for example
아세트아미프리드, 클로티아니딘, 디노테푸란, 이미다클로프리드, 니텐피람, 니티아진, 티아클로프리드, 티아메톡삼,Acetamiprid, clothianidine, dinotefuran, imidacloprid, nitenpyram, nithiazine, tiacloprid, thiamethoxam,
3.2 니코틴, 벤설탑, 카탑,3.2 nicotine, bensultap, katap,
4. 아세틸콜린 수용체 조절제4. Acetylcholine Receptor Modulator
4.1 스피노신, 예를 들어 스피노사드4.1 Spinosine, for example spinosad
5. GABA-조절 클로라이드 채널 길항제5. GABA-Regulating Chloride Channel Antagonists
5.1 사이클로디엔 유기 염소, 예를 들어5.1 cyclodiene organic chlorine, for example
캄페클로르, 클로로단, 엔도설판, 감마-HCH, HCH, 헵타클로르, 린단, 메톡시클로르,Campechlor, chlorodan, endosulfan, gamma-HCH, HCH, heptachlor, lindane, methoxycyclo,
5.2 피프롤, 예를 들어5.2 fiprole, for example
아세토프롤, 에티프롤, 피프로닐, 바닐리프롤,Acetoprole, etiprole, fipronil, vaniliprole,
6. 클로라이드 채널 활성제6. Chloride Channel Activator
6.1 멕틴, 예를 들어6.1 mectin, for example
아바멕틴, 아버멕틴, 에마멕틴, 에마멕틴 벤조에이트, 이버멕틴, 밀베멕틴, 밀베마이신,Abamectin, Avermectin, Emamectin, Emamectin Benzoate, Ivermectin, Milvemectin, Milbemycin,
7. 유충 호르몬 모방체, 예를 들어7. Larva hormone mimetics, eg
디오페놀란, 에포페노난, 페녹시카브, 하이드로프렌, 키노프렌, 메토프렌, 피리프록시펜, 트리프렌,Diphenols, epopenonane, phenoxycarb, hydroprene, quinoprene, metoprene, pyriproxyfen, triprene,
8. 에크디손 작용제/교란물질8. Ecdyson agonists / disruptors
8.1 디아실히드라진, 예를 들어8.1 diacylhydrazines, for example
크로마페노자이드, 할로페노자이드, 메톡시페노자이드, 테부페노자이드, Chromafenozide, halofenozide, methoxyfenozide, tebufenozide,
9. 키틴 생합성 억제제9. Chitin Biosynthesis Inhibitors
9.1 벤조일우레아, 예를 들어9.1 benzoylurea, for example
비스트리플루론, 클로플루아주론, 디플루벤주론, 플루아주론, 플루사이클록수론, 플루페녹수론, 헥사플루무론, 루페누론, 노발루론, 노비플루무론, 펜플루론, 테플루벤주론, 트리플루무론,Bistrifluron, Clofluazuron, Diflubenzuron, Fluazuron, Flucycloloxone, Flufenoxlon, Hexaflumuron, Lufenuron, Novaluron, Nobifluuron, Fenfluron, Tflubenzuron , Triple lumuron,
9.2 부프로페진9.2 Buprofezin
9.3 사이로마진,9.3 Cyclo Margin,
10. 산화 포스포릴화 억제제, ATP 교란물질10. Oxidative phosphorylation inhibitors, ATP disruptors
10.1 디아펜티우론,10.1 diafenthiuron,
10.2 유기 주석, 예를 들어 아조사이클로틴, 사이헥사틴, 펜부타틴 옥사이드,10.2 organic tin, for example azocyclotin, cyhexatin, fenbutatin oxide,
11. H-양성자 구배 차단에 의한 산화 포스포릴화 작용 해제제,11. oxidative phosphorylation inhibitors by blocking H-proton gradients,
11.1 피롤, 예를 들어 클로르페나피르,11.1 pyrrole, for example chlorfenapyr,
11.2 디니트로페놀, 예를 들어 비나파크릴, 디노부톤, 디노캅, DNOC,11.2 dinitrophenols such as vinapacryl, dinobutone, dinocap, DNOC,
12. I-측 전자 전달 억제제12. I-side electron transfer inhibitor
12.1 METIs, 예를 들어 펜아자퀸, 펜피록시메이트, 피리미디펜, 피리다벤, 테부펜피라드, 톨펜피라드, 12.1 METIs, for example penazaquine, penpyroximate, pyrimidipene, pyridaben, tebufenpyrad, tolfenpyrad,
12.2 히드라메틸논,12.2 hydramethylnon,
12.3 디코폴,12.3 decopol,
13. II-측 전자 전달 억제제13. II-Side Electron Transfer Inhibitor
13.1 로테논,13.1 rotenone,
14. III-측 전자 전달 억제제14. III-Side Electron Transfer Inhibitor
14.1 아세퀴노실, 플루아크리피림,14.1 acequinosyl, fluacrypyrim,
15. 곤충 장막 미생물 붕괴제15. Insect Vesicle Microbial Disintegrant
바실러스 투링기엔시스(Bacillus thuringiensis) 균주(strains), Bacillus thuringiensis strains,
16. 지방 합성 억제제,16. fat synthesis inhibitors,
16.1 테트론산, 예를 들어 스피로디클로펜, 스피로메시펜,16.1 tetronic acid, for example spirodiclofen, spiromesifen,
16.2 테트람산, 예를 들어 3-(2,5-디메틸페닐)-8-메톡시-2-옥소-1-아자스피 로[4.5]데-3-센-4-일 에틸 카보네이트(일명 카본산, 3-(2,5-디메틸페닐)-8-메톡시-2-옥소-1-아자스피로[4.5]데-3-센-4-일 에틸 에스테르, CAS-Reg.-No.: 382608-10-8) 및 카본산, 시스-3-(2,5-디메틸페닐)-8-메톡시-2-옥소-1-아자스피로[4.5]데-3-센-4-일 에틸 에스테르, CAS-Reg.-No.: 203313-25-1),16.2 Tetramic acid, for example 3- (2,5-dimethylphenyl) -8-methoxy-2-oxo-1-azaspiro [4.5] de-3-sen-4-yl ethyl carbonate (aka carboxylic acid , 3- (2,5-dimethylphenyl) -8-methoxy-2-oxo-1-azaspiro [4.5] de-3-sen-4-yl ethyl ester, CAS-Reg.-No .: 382608- 10-8) and carboxylic acid, cis-3- (2,5-dimethylphenyl) -8-methoxy-2-oxo-1-azaspiro [4.5] de-3-sen-4-yl ethyl ester, CAS -Reg.-No .: 203313-25-1),
17, 카복사미드, 예를 들어 플로니카미드,17, carboxamides, for example flornicamid,
18. 옥토파미너직 작용제(octopaminergic agonist), 예를 들어 아미트라즈,18. octopaminergic agonist, for example amitraz,
19, 마그네슘-촉진 ATPase 억제제, 예를 들어 프로파기트,19, magnesium-promoting ATPase inhibitors such as propargite,
20. 프탈아미드, 예를 들어 N2-[1,1-디메틸-2-(메틸설포닐)에틸]-3-요오도-N1-[2-메틸-4-[1,2,2,2-테트라플루오로-1-(트리플루오로메틸)에틸]페닐]-1,2-벤젠디카복사미드(CAS-Reg.-No.: 272451-65-7),20. phthalamide, for example N 2 - [1,1- dimethyl-2- (methylsulfonyl) ethyl] -3-iodo -N 1 - [2- methyl-4- [1,2,2, 2-tetrafluoro-1- (trifluoromethyl) ethyl] phenyl] -1,2-benzenedicarboxamide (CAS-Reg.-No .: 272451-65-7),
21. 네레이스톡신 유사체, 예를 들어 티오사이클람 하이드로겐 옥살레이트, 티오설탑-소듐,21. Neracetoxin analogues such as thiocyclam hydrogen oxalate, thiosulfato-sodium,
22. 생물학적 약제, 호르몬 또는 페로몬, 예를 들어22. Biological agents, hormones or pheromones, eg
아자디라크틴, 바실러스 종, 뷰베리아 종, 코들몬, 메타리지움 종, 파에실로마이세스 종, 투링기엔신, 버티실리움 종,Azadirachtin, Bacillus species, Burberry species, Codmon species, Metadium species, Paesilomyces species, Turingienxins, Verticillium species,
23. 작용 기전이 알려지지 않았거나 비특이적인 활성 물질,23. Active substances of unknown or nonspecific mechanism of action,
23.1 훈증제, 예를 들어 알루미늄 포스파이드, 메틸 브로마이드, 설러릴 플루오라이드,23.1 fumigants such as aluminum phosphide, methyl bromide, sulryl fluoride,
23.2 선택적 먹이섭취 방지제, 예를 들어 크리오라이트, 플로니카미드, 피메 트로진,23.2 Selective food intake inhibitors such as cryolite, floricamid, pimetrozin,
23.3 응애 성장 억제제, 예를 들어 클로펜테진, 에톡사졸, 헥시티아족스,23.3 mite growth inhibitors, for example clofentezin, ethoxazole, hexiaxox,
23.4 아미도플루메트, 벤클로티아즈, 벤족시메이트, 비페나제이트, 브로모프로필레이트, 부프로페진, 퀴노메티오네이트, 클로르디메포름, 클로로벤질레이트, 클로로피크린, 클로티아조벤, 사이클로프렌, 사이플루메토펜, 디사이클라닐, 페녹사크림, 펜트리파닐, 플루벤지민, 플루페네림, 플루텐진, 고시플루레, 하이드라메틸논, 자포닐루레, 메톡사디아존, 석유, 피페로닐 부톡사이드, 포타슘 올레에이트, 피리달릴, 피리프롤, 설플루라미드, 테트라디폰, 테트라설, 트라아라텐, 버부틴,23.4 Amidoflumet, benclothiaz, benzoxmate, bifenazate, bromopropylate, buprofezin, quinomethionate, chlordimeform, chlorobenzylate, chloropicrine, clothiazobene, cycloprene , Cyflumetophene, dicyclanyl, phenoxa cream, phentrifanyl, flubenzimine, flufenerim, flutenzin, gosiflure, hydrammethylnon, japonilure, methoxadione, petroleum, Piperonyl butoxide, potassium oleate, pyridalyl, pyriprolol, sulfluramid, tetradipon, tetrasul, traarate, verbutin,
화합물 3-메틸페닐 프로필카바메이트(추마사이드 Z),Compound 3-methylphenyl propylcarbamate (chumaside Z),
화합물 3-(5-클로로-3-피리디닐)-8-(2,2,2-트리플루오로에틸)-8-아자비사이클로[3.2.1]옥탄-3-카보니트릴(CAS Reg. No. 185982-80-3) 및 대응 3-엔도-이성체 (CAS Reg. No. 185984-60-5)(참조: WO-96/37494, WO-98/25923),Compound 3- (5-chloro-3-pyridinyl) -8- (2,2,2-trifluoroethyl) -8-azabicyclo [3.2.1] octane-3-carbonitrile (CAS Reg. 185982-80-3) and the corresponding 3-endo-isomer (CAS Reg. No. 185984-60-5) (WO-96 / 37494, WO-98 / 25923),
및 살충성 식물 추출물, 선충, 진균 또는 바이러스를 함유하는 제제.And formulations containing insecticidal plant extracts, nematodes, fungi or viruses.
제초제와 같은 기타 공지된 활성 성분, 비료, 성장조절제, 약해완화제 또는 신호물질과 혼합하는 것이 또한 가능하다.It is also possible to mix it with other known active ingredients such as herbicides, fertilizers, growth regulators, anti-mitigating agents or signaling substances.
본 발명에 따른 화학식 (I)의 화합물은 또한 매우 우수한 항균 효과를 나타낸다. 이들은 특히 피부진균(dermatophyte) 및 효모, 사상균 및 이상 진균(예를 들어 칸디다 알비칸스(Candida albicans), 칸디다 글라브라타(Candida glabrata)와 같은 칸디다 종(Candida species)) 및 에피더모파이톤 플로코숨 (Epidermophyton floccosum), 아스퍼질러스 니거(Aspergillus noger) 및 아스퍼질러스 푸미가투 스(Aspergillus fumigatus)와 같은 아스퍼질러스 종(Aspergillus species), 트리코파이톤 멘타그로파이트(Trichophyton mentagrophyte)와 같은 트리코파이톤 종(Trichophyton species), 마이크로스포론 카니스(Microsporon canis) 및 아우도우이니(audouinii)와 같은 마이크로스포론 종(Microsporon species))에 대해 매우 광범위한 항균 작용 스펙트럼을 가진다. 이들 진균 리스트는 기록가능한 항균 스텍트럼을 조금도 한정하지 않으며 단지 설명만을 목적으로 한다.The compounds of formula (I) according to the invention also show very good antibacterial effects. These particular skin fungi (dermatophyte) and yeasts, molds and more fungi (e.g. Candida albicans (Candida albicans), Candida glabrata (Candida species (Candida species), such as Candida glabrata)) and epi Dermo python flow kosum ( Aspergillus species such as Epidermophyton floccosum , Aspergillus noger and Aspergillus fumigatus , and Trichophyton species such as Trichophyton mentagrophyte Trichophyton species , Microsporon canis and Microsporon species such as audouinii have a very broad spectrum of antimicrobial action. These fungal lists do not limit the recordable antimicrobial spectrum in any way, but are for illustrative purposes only.
활성 물질은 그 자체로, 그의 제제 형태로, 또는 즉시 사용형 용액, 현탁제, 수화성 산제, 페이스트, 가용성 산제, 분제 및 과립제와 같이 이들로부터 제조된 실시 형태로 사용될 수 있다. 이는 통상의 방식, 예를 들어 붓기, 분무, 샤워링, 산포, 연무, 포밍(foaming), 살포 등에 의해 적용된다. 또한, 활성 물질을 극소 용적 방법에 의해 적용하거나, 활성 물질 제제 또는 활성 성분 자체를 토양에 주입할 수 있다. 식물의 종자가 처리될 수 있다.The active substances can be used on their own, in the form of their preparations, or in embodiments prepared from them such as ready-to-use solutions, suspensions, hydrating powders, pastes, soluble powders, powders and granules. This applies by conventional means, for example by pouring, spraying, showering, spraying, misting, foaming, spraying and the like. In addition, the active substance can be applied by a microvolume method or the active substance preparation or the active ingredient itself can be injected into the soil. Seeds of plants can be treated.
본 발명에 따른 활성 물질을 살진균제로 사용하는 경우, 적용량은 적용 형태에 따라 넓은 범위내에서 변할 수 있다. 식물 부분을 처리하는 경우, 활성 물질의 적용 비율은 일반적으로 0.1 내지 10,000 g/㏊, 바람직하게는 10 내지 1,000 g/㏊이다. 종자를 처리하는 경우, 활성 물질의 적용량은 일반적으로 종자 1 kg 당 0.001 내지 50 g, 바람직하게는 0.01 내지 10 g 이다. 토양을 처리하는 경우, 활성 물질의 사용량은 일반적으로 0.1 내지 내지 10,000 g/㏊, 바람직하게는 1 내지 5,000 g/㏊ 이다.When the active substance according to the invention is used as a fungicide, the application amount may vary within a wide range depending on the application form. When treating plant parts, the application rate of the active substance is generally from 0.1 to 10,000 g / dL, preferably from 10 to 1,000 g / dL. When treating seed, the application amount of the active substance is generally from 0.001 to 50 g, preferably from 0.01 to 10 g per kg of seed. When treating the soil, the amount of active substance used is generally 0.1 to 10,000 g / dL, preferably 1 to 5,000 g / dL.
상기 언급된 바와 같이, 본 발명에 따라 모든 식물 및 이들 부분이 처리될 수 있다. 바람직한 구체예로, 자연 발생 식물 타입 및 품종 및 이들 부분과 통상적인 생물학적 육종법, 예를 들어 교잡육종 또는 원형체 유합(protoplast fusion)에 의해 얻어진 것 들이 처리된다. 또 다른 바람직한 구체예로, 적합하다면 통상적인 방법과 함께 유전자공학적으로 얻어진 형질전환 식물 및 식물 타입(유전자 변형 유기체) 및 이들 부분이 처리된다. 용어 "부분", "식물의 일부" 또는 "식물 부분"은 상기 설명되었다.As mentioned above, all plants and their parts can be treated according to the invention. In a preferred embodiment, naturally occurring plant types and varieties and those parts and those obtained by conventional biological breeding methods such as hybrid breeding or protoplast fusion are treated. In another preferred embodiment, genetically engineered transgenic plants and plant types (genetically modified organisms) and these parts are treated with conventional methods, where appropriate. The terms "part", "part of the plant" or "plant part" have been described above.
각 경우에 시판중이거나 사용중인 식물 타입의 식물이 본 발명에 따라 특히 바람직하게 처리된다. 용어 "식물 타입"이라는 것은 통상적인 육종 기술, 돌연변이형성 또는 재조합 DNA 기술에 의해 얻어질 수 있는 새로운 특성을 갖는 식물로 이해되어야 한다. 이들은 타입, 육종(breed), 생리형(biotype) 또는 유전자형(genotype)일 수 있다.In each case plants of the plant type which are commercially available or in use are particularly preferably treated according to the invention. The term "plant type" is to be understood as a plant having new properties that can be obtained by conventional breeding techniques, mutagenesis or recombinant DNA techniques. They may be of type, breed, biotype or genotype.
식물 품종 또는 타입, 이들의 장소 및 성장 조건(토양, 기후, 생장 기간, 영양분)에 따라, 본 발명에 따라 처리함으로써 또한 상가("상승")적 효과가 나타날 수 있다. 따라서, 예를 들어 본 발명에 따라 사용될 수 있는 물질 및 제제의 적용비율의 감소 및/또는 활성 스펙트럼의 확대 및/또는 활성 증가, 식물 성장성 향상, 고온 또는 저온 내성 증가, 가뭄, 또는 물 또는 토양 염분에 대한 내성 증가, 개화량 증가, 수확 용이성, 성숙성 촉진, 작화량 증가, 수확 산물의 품질 향상 및/또는 영양가 증대, 및 수확 산물의 저장성 및/또는 처리성 향상과 같은 효과가 실제 기대되는 것 이상으로 나타날 수 있다.Depending on the plant variety or type, their location and growing conditions (soil, climate, growth period, nutrients), an additive ("raising") effect may also be produced by treatment according to the present invention. Thus, for example, reduction in the application rate of substances and preparations which can be used according to the invention and / or broadening the activity spectrum and / or increasing activity, improving plant growth, increasing hot or cold resistance, drought, or water or soil salinity Expected effects such as increased resistance to, increased flowering, increased harvesting, increased maturity, increased crop yields, improved quality and / or nutritional value of harvested products, and improved shelf life and / or treatability of harvested products. It may appear abnormal.
본 발명에 따라 바람직하게 처리되는 형질전환 식물 또는 식물 타입(즉, 유 전자공학적으로 얻어진 것)은 유전자 변형시에 이들 식물에 특히 유리한 유용한 성질("특성")을 부여하는 유전자 물질을 수용하는 모든 식물을 포함한다. 이러한 성질의 예로는 식물 성장성 향상, 고온 또는 저온 내성 증가, 가뭄, 또는 물 또는 토양 염분에 대한 내성 증가, 개화량 증가, 수확 용이성, 성숙성 촉진, 작화량 증가, 수확 산물의 품질 향상 및/또는 영양가 증대, 및 수확 산물의 저장성 및/또는 처리성 증대가 포함된다. 추가적으로 특히 언급할만한 상기 특성의 예로 동물 및 미생물 해충, 예를 들어 곤충, 응애, 식물병원성 진균, 박테리아 및/또는 바이러스에 대한 식물의 방어력 증가 및 또한 특정 제초 활성 물질에 대한 식물의 내약성 증가가 있다. 형질전환 식물의 예로 중요한 작황 식물, 예를 들어 곡물(밀, 쌀), 옥수수, 대두, 감자, 목화, 담배, 유지종자 및 또한 과수 식물(사과, 배, 감귤 및 포도 과일이 열리는)이 언급될 수 있으며, 옥수수, 대두, 감자, 목화, 담배 및 유지종자가 특히 강조된다. 강조되는 특성은 특히 식물에 형성된 독소, 특히 바실러스 투린기엔시스(Bacillus thuringiensis)로부터 얻은 유전자 물질(예를 들어 유전자 CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA, CryIIIB2, Cry9c, Cry2Ab, Cry3Bb 및 CryIF 및 이들 조합)에 의해 식물(이후 "Bt 식물"로 언급)에 형성된 독소로 인한 곤충, 거미류, 선충 및 달팽이에 대한 식물의 방어력 증가이다. 또한, 특히 강조되는 특성은 전신적으로 획득한 내성(SAR), 시스테민, 피토알렉신, 엘리시터 및 내성 유전자 및 상응하게 발현된 단백질 및 독소로 인한 진균, 박테리아 및 바이러스에 대한 식물의 방어력 증가이다. 그밖에 특히 강조되는 특성은 또한 특정 제초 활성 물질, 예를 들어 이미다졸리논, 설포닐우레아, 글리포세이트 또는 포스피노트리신(예를 들어 "PAT" 유전자)에 대한 식물의 내약성 증가다. 각 경우에 목적하는 해당 특성을 부여하는 유전자가 또한 형질전환 식물에 상호 조합으로 존재할 수 있다. "Bt 식물"의 예로 YIELD GARD®(예: 옥수수, 목화, 대두), KnockOut®(예: 옥수수), StarLink®(예: 옥수수), Bollgard®(예: 목화), Nucotn®(예: 목화) 및 NewLeaf®(예: 감자) 상품명으로 시판되고 있는 옥수수 품종, 목화 품종, 대두 품종 및 감자 품종이 언급될 수 있다. 제초제-내약성 식물의 예로 Roundup Ready®(글리포세이트 내약성, 예: 옥수수, 목화, 대두), Liberty Link®(포스피노트리신 내약성, 예: 유지종자 평지), IMI®(이미다졸리논 내약성) 및 STS®(설포닐우레아 내약성, 예: 옥수수) 상품명으로 시판되고 있는 옥수수 품종, 목화 품종 및 대두 품종이 언급될 수 있다. 제초제-내약성 식물(제초제 내약성을 위해 통상적인 방법으로 육종된 식물)의 예로 Clearfield® 명으로 시판되고 있는 품종(예: 옥수수)이 또한 언급될 수 있다. 물론, 상기 설명은 또한 미래에 개발되고/되거나 시장화될 식물로, 상술된 유전적 특성을 지니거나 여전히 개발될 여지가 남아 있는 식물 품종에도 적용된다.Transgenic plants or plant types (ie those obtained genetically) which are preferably treated according to the invention are those which accept genetic material that confers useful properties (“characteristics”) that are particularly advantageous to these plants at the time of genetic modification. Contains plants. Examples of such properties include improved plant growth, increased high or low temperature resistance, drought, or increased resistance to water or soil salts, increased flowering, ease of harvest, increased maturity, increased crop yields, improved quality of harvested products, and / or Increased nutritional value, and increased shelf life and / or processability of harvested products. Further particular mention of such properties is an increase in the plant's defense against animal and microbial pests such as insects, mites, phytopathogenic fungi, bacteria and / or viruses and also an increase in the plant's tolerability against certain herbicidally active substances. Examples of transgenic plants may include important crop plants, for example cereals (wheat, rice), corn, soybeans, potatoes, cotton, tobacco, oilseeds, and also fruit plants (opening apples, pears, citrus fruits and grape fruits). Corn, soybeans, potatoes, cotton, tobacco and oilseeds. Highlighted properties are in particular genetic material derived from toxins formed in plants, in particular Bacillus thuringiensis (eg genes CryIA (a), CryIA (b), CryIA (c), CryIIA, CryIIIA, CryIIIB2, Cry9c) , Increased protection of plants against insects, arachnids, nematodes and snails due to toxins formed in plants (hereinafter referred to as "Bt plants") by Cry2Ab, Cry3Bb and CryIF and combinations thereof. Also of particular emphasis is the increased defense of plants against fungi, bacteria and viruses due to systemically acquired resistance (SAR), cystemine, phytoalexin, eliminator and resistance genes and correspondingly expressed proteins and toxins. . Another particularly highlighted property is also the increased plant resistance to certain herbicidally active substances, for example imidazolinone, sulfonylurea, glyphosate or phosphinothricin (eg the "PAT" gene). In each case genes conferring the desired properties of interest can also be present in transgenic plants in mutual combinations. Examples of "Bt plants" include YIELD GARD ® (e.g. corn, cotton, soybean), KnockOut ® (e.g. corn), StarLink ® (e.g. corn), Bollgard ® (e.g. cotton), Nucotn ® (e.g. cotton) And corn varieties, cotton varieties, soybean varieties and potato varieties which are commercially available under the NewLeaf ® (eg potato) brand name. Examples of herbicide-tolerant plants include Roundup Ready ® (glyphosate tolerant, eg corn, cotton, soybean), Liberty Link ® (phosphinothricin tolerant, e.g. oilseed rape), IMI ® (imidazolinone tolerant) And corn varieties, cotton varieties and soybean varieties available under the trade name STS ® (sulfonylurea tolerant such as corn). Examples of herbicide-tolerant plants (plants bred by conventional methods for herbicide tolerability) may also be mentioned varieties sold under the name Clearfield ® (eg corn). Of course, the above description also applies to plant varieties which have the above-described genetic properties or which remain to be developed, with plants to be developed and / or marketed in the future.
상기 열거된 식물들이 본 발명에 따라 본 발명에 따른 화학식 (I)의 화합물 또는 활성 성분의 혼합물로 특히 유리하게 처리될 수 있다. 활성 물질에 대해 상기 언급된 바람직한 범위가 또한 이들 식물의 처리에도 적용된다. 본 명세서에 구 체적으로 언급된 화합물 또는 혼합물로 식물을 처리하는 것이 특히 강조된다.The plants listed above can be treated particularly advantageously according to the invention with a compound of formula (I) or a mixture of active ingredients according to the invention. The preferred ranges mentioned above for the active substances also apply to the treatment of these plants. Particular emphasis is given to the treatment of plants with the compounds or mixtures specifically mentioned herein.
이하, 본 발명에 따른 활성 물질의 제조 및 용도가 실시예로 설명된다.Hereinafter, the preparation and use of the active substances according to the invention are described by way of examples.
합성 실시예Synthetic Example
40 번 화합물의 합성Synthesis of Compound No. 40
5 ml 디클로로메탄중의 0.27 g(1.5 mmol)의 2-[1-(이소프로필아미노)에틸]아닐린 (III-4) 및 0.42 ml(3.0 mmol)의 트리에틸아민의 용액에 10 디클로로메탄중의 0.27 g(1.5 mmol)의 5-플루오로-1,3-디메틸-lH-피라졸-4-카보닐 클로라이드 용액을 적가하였다. 반응 혼합물을 50 ℃에서 2 시간동안 교반한 후, 실온에서 16 시간동안 교반하였다. 반응 혼합물을 물에 첨가한 후, 유기상을 황산마그네슘상에서 건조시킨 후, 진공 농축하여 후처리하였다. 칼럼 크로마토그래피(헥산/아세톤 4:1)에 의해 0.27 g(이론치의 56%)의 5-플루오로-N-{2-[1-(이소프로필아미노)에틸]페닐}-1,3-디메틸-1H 피라졸-4-카복사미드[log P (pH 2.3) = 0.58]를 수득하였다.To a solution of 0.27 g (1.5 mmol) 2- [1- (isopropylamino) ethyl] aniline (III-4) and 0.42 ml (3.0 mmol) triethylamine in 5 ml dichloromethane in 10 dichloromethane 0.27 g (1.5 mmol) of 5-fluoro-1,3-dimethyl-lH-pyrazole-4-carbonyl chloride solution was added dropwise. The reaction mixture was stirred at 50 ° C. for 2 hours and then at room temperature for 16 hours. After the reaction mixture was added to water, the organic phase was dried over magnesium sulfate and then concentrated in vacuo to work up. 0.27 g (56% of theory) of 5-fluoro-N- {2- [1- (isopropylamino) ethyl] phenyl} -1,3-dimethyl by column chromatography (hexane / acetone 4: 1) -1H pyrazole-4-carboxamide [log P (pH 2.3) = 0.58] was obtained.
60 번 화합물의 합성Synthesis of Compound No. 60
오일중 60% 수소화나트륨 156.0 mg(3.9 mmol)을 실온에서 2 ml 디메틸 포름아미드중의 897.8 mg(3.0 mmol)의 N-[2-(하이드록시메틸)페닐]-1-메틸-3-(트리플루오로메틸)-1H-피라졸-4-카복사미드(IV-1)의 용액에 첨가하였다. 30 분후, 0.6 ml(6.0 mmol)의 2-요오도프로판을 첨가하였다. 반응 혼합물을 100 ℃에서 6 시간동안 교반한 후, 실온에서 16 시간동안 교반하였다. 이어서, 혼합물을 1 ml의 메탄올로 희석하여 물에 첨가하고, 에틸 아세테이트로 추출하였다; 유기상을 황산마그네슘상에서 건조시킨 후, 건조제를 여과하고, 진공 농축하였다. 칼럼 크로마토그래피(사이클로헥산/에틸 아세테이트 3:1)에 의해 100.0 mg(이론치의 9.7%)의 N-[2-(이소프로폭시메틸)페닐]-1-메틸-3-(트리플루오로메틸)-lH-피라졸-4-카복사미드[logP(pH 2.3)= 2.85]를 수득하였다.156.0 mg (3.9 mmol) of 60% sodium hydride in oil was added to 897.8 mg (3.0 mmol) N- [2- (hydroxymethyl) phenyl] -1-methyl-3- (trifluoro) in 2 ml dimethyl formamide at room temperature. To a solution of rhomethyl) -1H-pyrazole-4-carboxamide (IV-1). After 30 minutes, 0.6 ml (6.0 mmol) of 2-iodopropane were added. The reaction mixture was stirred at 100 ° C. for 6 hours and then at room temperature for 16 hours. The mixture was then diluted with 1 ml of methanol, added to water and extracted with ethyl acetate; After drying the organic phase over magnesium sulfate, the desiccant was filtered and concentrated in vacuo. 100.0 mg (9.7% of theory) of N- [2- (isopropoxymethyl) phenyl] -1-methyl-3- (trifluoromethyl) by column chromatography (cyclohexane / ethyl acetate 3: 1) -lH-pyrazole-4-carboxamide [logP (pH 2.3) = 2.85] was obtained.
실시예 1 및 2와 유사하게, 그리고 본 발명의 합성 방법 (a) 내지 (m)의 일반적인 설명에 따라, 하기 표 1에 열거된 화학식 (I)의 화합물을 또한 수득하였다.Similarly to Examples 1 and 2 and in accordance with the general description of the synthetic methods (a) to (m) of the present invention, compounds of formula (I) listed in Table 1 below were also obtained.
표 1Table 1
a) ("*")로 표시된 결합은 아미드에 결합된다. a ) The bond represented by ( "*" ) is attached to the amide.
화학식 (III)의 출발물질의 합성Synthesis of Starting Material of Formula (III)
실시예 (III-1)Example (III-1)
44 g(0.188 mol)의 1-[1-(이소프로필티오)에틸]-2-니트로벤젠(VII-1)을 250 ml의 에탄올에 용해시키고, 3 g의 라니 니켈과 혼합한 후, 오토클레이브에서 6 시간동안 3 바의 수소로 실온에서 수소화하였다. 6 시간후, 3 g의 라니 니켈을 첨가하고, 실온에서 3 바의 수소로 16 시간동안 더 수소화를 계속하였다. 그후, 촉매를 여과 제거하고, 용매를 진공하에 제거하였다. 조 생성물을 칼럼 크로마토그래피(실리카겔, 헥산/메틸 t-부틸 에테르 3:1)에 의해 정제하였다. 32 g(HPLC에 의한 순도 97.3%, 이론치의 84.4%)의 2-[1-(이소프로필티오)에틸]아닐린을 황색 오일[logP (pH 2.3) = 2.45]로 수득하였다.44 g (0.188 mol) of 1- [1- (isopropylthio) ethyl] -2-nitrobenzene (VII-1) are dissolved in 250 ml of ethanol and mixed with 3 g of Raney nickel, followed by autoclave Hydrogenated at room temperature with 3 bars of hydrogen for 6 hours at. After 6 hours, 3 g Raney nickel was added and hydrogenation continued for 3 hours at 3 bar hydrogen at room temperature. The catalyst is then filtered off and the solvent is removed in vacuo. The crude product was purified by column chromatography (silica gel, hexane / methyl t-butyl ether 3: 1). 32 g (97.3% purity by HPLC, 84.4% of theory) of 2- [1- (isopropylthio) ethyl] aniline were obtained as a yellow oil [logP (pH 2.3) = 2.45].
실시예 (III-2)Example (III-2)
교반기 및 온도계가 장착된 500 ml 삼구 플라스크에 메탄올 160 ml중의 16.2 g(60.5 mmol)의 1-[1-(이소프로필설포닐)에틸]-2-니트로벤젠(VII-4)을 도입하고, 160 ml의 농염산과 교반하면서 혼합한 후, 31.5 g의 분말화 주석(265.2 mmol)을 20-40 ℃에서 조금씩 첨가하였다. 혼합물을 40 ℃에서 약 1 시간정도 교반하였다. 반응물을 냉각하고, 여과한 후, 1575 ml의 빙냉각 10% 수산화나트륨 수용액과 혼합하였다. 그후, 디클로로메탄으로 2회 추출하고, 황산나트륨상에서 건조시킨 후, 용매를 진공하에 제거하였다. 13.3 g(HPLC에 의한 순도 95.8%, 이론치의 92.6%)의 2-[1-(이소프로필설포닐)에틸]아닐린[logP (pH 2.3) = 1.28]을 수득하였다.Into a 500 ml three-necked flask equipped with a stirrer and a thermometer was introduced 16.2 g (60.5 mmol) of 1- [1- (isopropylsulfonyl) ethyl] -2-nitrobenzene (VII-4) in 160 ml of methanol, and 160 After stirring with ml of concentrated hydrochloric acid, 31.5 g of powdered tin (265.2 mmol) was added in portions at 20-40 ° C. The mixture was stirred at 40 ° C. for about 1 hour. The reaction was cooled, filtered and then mixed with 1575 ml ice-cold 10% aqueous sodium hydroxide solution. Then extracted twice with dichloromethane, dried over sodium sulfate and then the solvent was removed in vacuo. 13.3 g (95.8% purity by HPLC, 92.6% of theory) of 2- [1- (isopropylsulfonyl) ethyl] aniline [logP (pH 2.3) = 1.28] were obtained.
실시예 (III-3)Example (III-3)
교반기 및 온도계가 장착된 500 ml 삼구 플라스크에 메탄올 150 ml중의 11.8 g(55.6 mmol)의 1-[1-(이소프로필티오)메틸]-2-니트로벤젠(VII-2)을 도입하고, 150 ml의 농염산과 교반하면서 혼합한 후, 17.6 g의 분말화 주석(148.5 mmol)을 20-40 ℃에서 조금씩 첨가하였다. 혼합물을 40 ℃에서 약 1 시간정도 교반하였다. 반응물을 냉각하고, 여과한 후, 1300 ml의 빙냉각 10% 수산화나트륨 수용액과 혼합하였다. 그후, 디클로로메탄으로 2회 추출하고, 황산나트륨상에서 건조시킨 후, 용매를 진공하에 제거하였다. 조 생성물을 실리카겔상에서 3:1 헥산/메틸 t-부틸 에테르로 정제하였다. 4.6 g(HPLC에 의한 순도 94.6%, 이론치의 43.2%)의 2-[1-(이소프로필티오)메틸]아닐린[logP (pH 2.3) = 1.94]을 황색 오일로 수득하였다.Into a 500 ml three-necked flask equipped with a stirrer and a thermometer was introduced 11.8 g (55.6 mmol) of 1- [1- (isopropylthio) methyl] -2-nitrobenzene (VII-2) in 150 ml of methanol and 150 ml After stirring with concentrated hydrochloric acid, 17.6 g of powdered tin (148.5 mmol) was added little by little at 20-40 ° C. The mixture was stirred at 40 ° C. for about 1 hour. The reaction was cooled, filtered and mixed with 1300 ml of ice cooled 10% aqueous sodium hydroxide solution. Then extracted twice with dichloromethane, dried over sodium sulfate and then the solvent was removed in vacuo. The crude product was purified on 3: 1 hexanes / methyl t-butyl ether on silica gel. 4.6 g (94.6% purity by HPLC, 43.2% of theory) of 2- [1- (isopropylthio) methyl] aniline [logP (pH 2.3) = 1.94] were obtained as a yellow oil.
실시예 (III-4)Example (III-4)
30 ml 메탄올중의 5 g의 N-[1-(2-니트로페닐)에틸]프로판-2-아민(VII-5)(24 mmol) 용액을 0.5 g 라니 니켈과 혼합하고, 오토클레이브에서 5 시간동안 50 바의 수소로 50 ℃에서 수소화하였다. 냉각후, 촉매를 여과 제거하고, 용매를 진공하에 제거하였다. 2.8 g(HPLC에 의한 순도 98.1%, 이론치의 64.2%)의 2-[1-(이소프로필아미노)에틸]아닐린[logP (pH 2.3) = 0.05]을 수득하였다.A solution of 5 g N- [1- (2-nitrophenyl) ethyl] propan-2-amine (VII-5) (24 mmol) in 30 ml methanol is mixed with 0.5 g Raney nickel and 5 hours in an autoclave Hydrogenated at 50 ° C. with 50 bar of hydrogen. After cooling, the catalyst was filtered off and the solvent was removed in vacuo. 2.8 g (purity 98.1% by HPLC, 64.2% of theory) of 2- [1- (isopropylamino) ethyl] aniline [logP (pH 2.3) = 0.05] were obtained.
화학식 (IV)의 출발물질의 합성Synthesis of Starting Material of Formula (IV)
실시예 (IV-1)Example (IV-1)
50 ml 테트라하이드로푸란중의 34.5 g(0.16 mol)의 1-메틸-3-트리플루오로메틸-1H-피라졸-4-카보닐 클로라이드 용액을 실온에서 250 ml 테트라하이드로푸란중의 20.0 g(0.16 mol)의 2-아미노페닐메탄올 및 36 ml(0.26 mol)의 트리에틸아민의 용액에 적가하였다. 발열반응이 가라앉은 후, 반응물을 6 시간동안 환류시킨 후, 실온에서 48 시간동안 더 교반하였다. 반응 혼합물을 약 250 ml의 물에 첨가하고, 에틸 아세테이트로 추출한 후, 2N 염산으로 세척하여 황산마그네슘상에서 건조시킨 다음, 진공하에 농축하였다. 칼럼 크로마토그래피(구배: 사이클로헥산/에틸 아세테이트)에 의해 33.8 g(이론치의 69%)의 N-[2-(하이드록시메틸)페닐]-메틸-3-(트리플루오로메틸)-1H-피라졸-4-카복사미드[logP (pH 2.3)= 1.55]를 수득하였다.A solution of 34.5 g (0.16 mol) of 1-methyl-3-trifluoromethyl-1H-pyrazole-4-carbonyl chloride in 50 ml tetrahydrofuran at room temperature was 20.0 g (0.16) in 250 ml tetrahydrofuran. mol) of 2-aminophenylmethanol and 36 ml (0.26 mol) of triethylamine were added dropwise. After the exothermic reaction had settled, the reaction was refluxed for 6 hours and then further stirred at room temperature for 48 hours. The reaction mixture was added to about 250 ml of water, extracted with ethyl acetate, washed with 2N hydrochloric acid, dried over magnesium sulfate and then concentrated in vacuo. 33.8 g (69% of theory) of N- [2- (hydroxymethyl) phenyl] -methyl-3- (trifluoromethyl) -1H-pyra by column chromatography (gradient: cyclohexane / ethyl acetate) Sol-4-carboxamide [logP (pH 2.3) = 1.55] was obtained.
화학식 (VII)의 출발물질의 합성Synthesis of Starting Material of Formula (VII)
실시예 (VII-1)Example (VII-1)
교반기, 적가 깔때기 및 온도계가 장착된 1 ℓ 삼구 플라스크에서 20 ml 아세토니트릴중의 63 g의 1-(1-클로로에틸)-2-니트로벤젠(VIII-l)(순도 99.4%, 0.337 mol)을 30-40 ℃에서 450 ml 아세토니트릴중의 34.8 g(0.354 mol)의 소듐 2-프로판티올레이트에 적가하였다. 현탁액을 40 ℃에서 16 시간동안 더 교반한 후, 냉각하고, 용매를 진공하에 제거하였다. 잔류 잔사를 디클로로메탄에 용해시키고, 세척한 후, 황산나트륨상에서 건조시키고, 용매를 진공하에 제거하였다. 조 생성물을 칼럼 크로마토그래피(실리카겔, 29:1 헥산/아세톤)에 의해 정제하여 48 g(HPLC에 의한 순도 98.8%, 이론치의 62.4%)의 1-[1-(이소프로필티오)에틸]-2-니트로벤젠을 황색 오일[logP(pH 2.3) = 3.89]로 수득하였다.In a 1 L three-necked flask equipped with a stirrer, dropping funnel and thermometer, 63 g of 1- (1-chloroethyl) -2-nitrobenzene (VIII-l) (purity 99.4%, 0.337 mol) in 20 ml acetonitrile was added. Add dropwise to 34.8 g (0.354 mol) sodium 2-propanethiolate in 450 ml acetonitrile at 30-40 ° C. The suspension is further stirred at 40 ° C. for 16 h, then cooled and the solvent is removed in vacuo. The residual residue was dissolved in dichloromethane, washed, dried over sodium sulfate and the solvent removed in vacuo. The crude product was purified by column chromatography (silica gel, 29: 1 hexanes / acetone) to give 48 g (98.8% purity by HPLC, 62.4% of theory) of 1- [1- (isopropylthio) ethyl] -2 Nitrobenzene was obtained as a yellow oil [logP (pH 2.3) = 3.89].
실시예 (VII-2)Example (VII-2)
교반기, 적가 깔때기 및 온도계가 장착된 250 ml 삼구 플라스크에서 20 ml 아세토니트릴중의 17.2 g(0.1 mol)의 2-니트로벤질 클로라이드를 냉각하에 온도를 30-40 ℃로 유지하면서 75 ml 아세토니트릴중의 10.3 g(0.105 mol)의 소듐 2-프로판티올레이트에 적가하였다. 현탁액을 40-50 ℃에서 16 시간동안 더 교반하였다. 반응을 완결하기 위하여, 6 g(0.061 mol)의 소듐 2-프로판티올레이트를 추가한 후, 40-50 ℃에서 24 시간동안 더 교반하였다. 반응물을 냉각하고, 용매를 진공하에 제거하였다. 잔사를 메틸 t-부틸 에테르에 용해시키고, 세척한 후, 황산나트륨상에서 건조시켰다. 황산나트륨을 여과에 의해 제거하고, 용액을 진공하에 농축하였다. 조 생성물을 칼럼 크로마토그래피(실리카겔, 50:1 사이클로헥산/에틸 아세테이트)에 의해 정제하여 11.8 g(HPLC에 의한 순도 92%, 이론치의 51.2%)의 1-[1-(이소프로필티오)메틸]-2-니트로벤젠을 갈색 오일[logP (pH 2.3) = 3.28]로 수득하였다.In a 250 ml three-necked flask equipped with a stirrer, a dropping funnel and a thermometer, 17.2 g (0.1 mol) of 2-nitrobenzyl chloride in 20 ml acetonitrile was cooled in 75 ml acetonitrile while maintaining the temperature at 30-40 ° C. 10.3 g (0.105 mol) of sodium 2-propanethiolate was added dropwise. The suspension was further stirred at 40-50 ° C. for 16 h. To complete the reaction, 6 g (0.061 mol) of sodium 2-propanethiolate was added and then further stirred at 40-50 ° C. for 24 hours. The reaction was cooled and the solvent removed in vacuo. The residue was dissolved in methyl t-butyl ether, washed and dried over sodium sulfate. Sodium sulfate was removed by filtration and the solution was concentrated in vacuo. The crude product was purified by column chromatography (silica gel, 50: 1 cyclohexane / ethyl acetate) to give 11.8 g (92% purity by HPLC, 51.2% of theory) of 1- [1- (isopropylthio) methyl] 2-nitrobenzene was obtained as a brown oil [logP (pH 2.3) = 3.28].
실시예 (VII-3)Example (VII-3)
교반기, 적가 깔때기 및 온도계가 장착된 1 ℓ 삼구 플라스크에 465 ml 디클로로메탄중의 32.8 g 1-[1-(이소프로필티오)메틸]-2-니트로벤젠(VII-2)(0.155 mol)을 도입하고, 14.3 g의 포름산(0.31 mol) 및 1.6 g의 암모늄 몰리브데이트를 교반하면서 차례로 첨가하였다. 45.3 g(0.466 mol)의 35% 과산수소 수용액을 실온에서 급속 교반하면서 적가하였다. 혼합물을 16 시간동안 더 교반하였다. 그후, 유기상을 제거하고, 묽은 소듐 하이드로젠 설파이트 용액으로 1회, 물로 1회 세척한 다음, 유기 용액을 황산나트륨상에서 건조시켰다. 용매를 진공하에 증류시키고, 잔사를 디에틸 에테르와 교반한 후, 침전 생성물을 여과하고, 건조시켰다. 30.5 g(HPLC에 의한 순도 99%, 이론치의 80%)의 1-[(이소프로필설포닐)메틸]-2-니트로벤젠을 황색 고체[logP (pH 2.3)= 1.63]로 수득하였다.Into a 1 L three-neck flask equipped with a stirrer, dropping funnel and thermometer was introduced 32.8 g 1- [1- (isopropylthio) methyl] -2-nitrobenzene (VII-2) (0.155 mol) in 465 ml dichloromethane. 14.3 g of formic acid (0.31 mol) and 1.6 g of ammonium molybdate were then added with stirring. 45.3 g (0.466 mol) of 35% aqueous hydrogen peroxide solution was added dropwise with rapid stirring at room temperature. The mixture was further stirred for 16 hours. The organic phase was then removed, washed once with dilute sodium hydrogen sulfite solution and once with water, then the organic solution was dried over sodium sulfate. The solvent was distilled under vacuum and the residue was stirred with diethyl ether, then the precipitated product was filtered off and dried. 30.5 g (99% purity by HPLC, 80% of theory) of 1-[(isopropylsulfonyl) methyl] -2-nitrobenzene were obtained as a yellow solid [logP (pH 2.3) = 1.63].
실시예 (VII-4)Example (VII-4)
교반기, 적가 깔때기 및 온도계가 장착된 1 ℓ 삼구 플라스크에 390 ml 아세토니트릴중의 18.9 g(77.7 mmol)의 1-[(이소프로필설포닐)메틸]-2-니트로벤젠(VII-3)을 도입하고, 90.1 g(652 mnmol)의 탄산칼륨, 0.26 g의 18-크라운-6 및 12.1g(85.5 mmol)의 요오도메탄을 차례로 첨가하였다. 반응물을 환류하에 4 시간동안 교반한 후, 2.5 g의 요오도메탄(17.6 mmol)을 추가한 후, 환류하에 4 시간동 안 더 교반하였다. 반응물을 냉각하고, 진공하에 농축하였다. 잔사를 에틸 아세테이트에 용해시키고, 물로 세척한 후, 황산나트륨상에서 건조시켰다. 용매를 제거한 후, 조 생성물을 칼럼 크로마토그래피(실리카겔, 7:3 헥산/아세톤)에 의해 정제하였다. 16.2 g(HPLC에 의한 순도 96.1%, 이론치의 77.9%)의 1-[1-이소프로필설포닐)에틸]-2-니트로벤젠[logP (pH 2.3)= 1.99]을 수득하였다.Into a 1 L three-neck flask equipped with a stirrer, dropping funnel and thermometer was introduced 18.9 g (77.7 mmol) of 1-[(isopropylsulfonyl) methyl] -2-nitrobenzene (VII-3) in 390 ml acetonitrile. 90.1 g (652 mnmol) of potassium carbonate, 0.26 g of 18-crown-6 and 12.1 g (85.5 mmol) of iodomethane were added sequentially. The reaction was stirred at reflux for 4 h, then 2.5 g of iodomethane (17.6 mmol) was added and then further stirred at reflux for 4 h. The reaction was cooled and concentrated in vacuo. The residue was dissolved in ethyl acetate, washed with water and then dried over sodium sulfate. After removing the solvent, the crude product was purified by column chromatography (silica gel, 7: 3 hexanes / acetone). 16.2 g (purity 96.1% by HPLC, 77.9% of theory) of 1- [1-isopropylsulfonyl) ethyl] -2-nitrobenzene [logP (pH 2.3) = 1.99] was obtained.
실시예 (VII-5)Example (VII-5)
13.8 g의 1-(1-클로로에틸)-2-니트로벤젠(VIII-1)(순도 98.3%, 73.1 mol) 및 43.2 g(731 mmol)의 이소프로필아민을 오토클레이브중에 60 ℃ 및 고유압에서 24 시간동안 교반하였다. 반응 혼합물을 냉각한 후, 과량의 이소프로필아민을 진공하에 제거하고, 조 생성물을 실리카겔상에서 4:1 사이클로헥산/에틸 아세테이트로 정제하였다. 5 g(순도 94.4%, 이론치의 31%)의 N-[1-(2-니트로페닐)에틸]프로판-2-아민을 오일[logP (pH 2.3)= 0.55]로 수득하였다.13.8 g of 1- (1-chloroethyl) -2-nitrobenzene (VIII-1) (purity 98.3%, 73.1 mol) and 43.2 g (731 mmol) of isopropylamine at 60 ° C. and high pressure in an autoclave Stir for 24 hours. After cooling the reaction mixture, excess isopropylamine was removed in vacuo and the crude product was purified on 4: 1 cyclohexane / ethyl acetate on silica gel. 5 g (purity 94.4%, 31% of theory) of N- [1- (2-nitrophenyl) ethyl] propan-2-amine were obtained as an oil [logP (pH 2.3) = 0.55].
화학식 (VIII)의 출발물질의 합성Synthesis of Starting Material of Formula (VIII)
실시예 (VIII-1)Example (VIII-1)
교반기, 적가 깔때기 및 온도계가 장착된 6 ℓ 삼구 플라스크에서 311 g의 1-(2-니트로페닐)에탄올(XI-1)(순도 95.8%, 1.78 mol)을 3000 ml 디메틸 포름아미드에 용해시켰다. 921.4 g(7.13 mol)의 디이소프로필에틸아민을 한번에 첨가하고, 5 분동안 교반한 후, 612.5 g(5.35 mol)의 메탄설포닐 클로라이드를 20 내지 35 ℃에서 적당히 냉각하면서 적가하였다. 반응 종료후, 실온에서 90 시간동안 교반한 후, 용매를 진공하에 제거하였다. 잔사를 에틸 아세테이트에 용해시키고, 물로 3회 세척한 후, 황산나트륨상에서 건조시키고, 용매를 진공하에 제거하였다. 조 생성물을 칼럼 크로마토그래피(실리카겔, 9:1 헥산/아세톤)에 의해 정제하였다. 219 g(HPLC에 의한 순도 100%, 이론치의 66.2%)의 1-(1-클로로에틸)-2-니트로벤젠을 갈색 오일[logP (pH 2.3)= 2.87]로 수득하였다.In a 6 L three-necked flask equipped with a stirrer, dropping funnel and thermometer, 311 g of 1- (2-nitrophenyl) ethanol (XI-1) (purity 95.8%, 1.78 mol) was dissolved in 3000 ml dimethyl formamide. 921.4 g (7.13 mol) of diisopropylethylamine were added in one portion, stirred for 5 minutes, and then 612.5 g (5.35 mol) of methanesulfonyl chloride were added dropwise with moderate cooling at 20 to 35 ° C. After the reaction was completed, the mixture was stirred at room temperature for 90 hours, and then the solvent was removed in vacuo. The residue was dissolved in ethyl acetate, washed three times with water, dried over sodium sulfate and the solvent was removed in vacuo. The crude product was purified by column chromatography (silica gel, 9: 1 hexanes / acetone). 219 g (100% purity by HPLC, 66.2% of theory) of 1- (1-chloroethyl) -2-nitrobenzene were obtained as a brown oil [logP (pH 2.3) = 2.87].
화학식 (XI)의 출발물질의 합성Synthesis of Starting Material of Formula (XI)
실시예 (XI-1)Example (XI-1)
3200 ml 메탄올중의 320 g(1.938 mol)의 2-니트로아세토페논을 교반기, 적가 깔때기, 온도계 및 버블 카운터가 장착된 6 ℓ 삼구 플라스크에 도입하고, 288 ml 물중의 73.3 g(1.938 mol)의 소듐 보로하이드라이드를 30-40 ℃에서 적당히 냉각하면서 적가하였다. 반응 종료후, 실온에서 16 시간동안 더 교반하였다. 반응물을 묽은 염산으로 중화시키고, 용매를 회전 증발기상에서 제거하여 후처리하였다. 잔사를 디클로로메탄에 용해시키고, 물로 세척한 후, 황산나트륨상에서 건조시키고, 용매를 진공하에 제거하였다. 311 g(HPLC에 의한 순도 95.1%, 이론치의 91.3%)의 1-(2-니트로페닐)에탄올[logP (pH 2.3) = 1.49]을 옅은색 오일로 수득하였다.320 g (1.938 mol) of 2-nitroacetophenone in 3200 ml methanol were introduced into a 6 L three-necked flask equipped with a stirrer, dropping funnel, thermometer and bubble counter, and 73.3 g (1.938 mol) of sodium in 288 ml water. Borohydride was added dropwise with moderate cooling at 30-40 ° C. After the reaction was completed, the mixture was further stirred at room temperature for 16 hours. The reaction was neutralized with dilute hydrochloric acid and the solvent was worked up by removal on a rotary evaporator. The residue was dissolved in dichloromethane, washed with water, dried over sodium sulfate and the solvent removed in vacuo. 311 g (95.1% pure by HPLC, 91.3% of theory) of 1- (2-nitrophenyl) ethanol [logP (pH 2.3) = 1.49] were obtained as a pale oil.
주어진 logP 값은 EEC Directive 79/831 Annex V.A8 에 따라 역상 칼럼(C 18)을 사용하여 HPLC(고성능 액체 크로마토그래피)에 의해 측정되었다. 온도: 43 ℃.The logP values given were determined by HPLC (high performance liquid chromatography) using a reversed phase column (C 18) according to EEC Directive 79/831 Annex V.A8. Temperature: 43 ° C.
산성 범위(pH 2.3)에서의 측정을 위한 용리제: 0.1% 수성 인산, 아세토니트릴; 10% 아세토니트릴에서 90% 아세토니트릴로 선형 구배.Eluent for determination in acidic range (pH 2.3): 0.1% aqueous phosphoric acid, acetonitrile; Linear gradient from 10% acetonitrile to 90% acetonitrile.
logP 값이 공지된(두 개의 연속한 알카논 사이의 선형보간을 이용하여 체류 시간으로 logP 값 측정) 비측쇄 알칸-2-온(탄소 원자수 3 내지 16)을 사용하여 보정을 수행하였다.The calibration was performed using unbranched alkan-2-ones (3-16 carbon atoms) with known logP values (measured logP values by residence time using linear interpolation between two consecutive alkanones).
200 내지 400㎚의 UV 스펙트럼을 사용하여 크로마토그래피 시그널의 최대치로서 람다 max 값을 결정하였다.UV spectra of 200-400 nm were used to determine the lambda max value as the maximum of the chromatographic signal.
적용 실시예Application Example
실시예 AExample A
포도스파에라 시험(사과)/보호성Grape Spaera Test (Apple) / Protection
용 매 : 아세톤 24.5 중량부Solvent: 24.5 parts by weight of acetone
디메틸아세트아미드 24.5 중량부 24.5 parts by weight of dimethylacetamide
유화제 : 알킬아릴 폴리글리콜 에테르 1 중량부Emulsifier: 1 part by weight of alkylaryl polyglycol ether
활성 물질 1 중량부를 상기 언급된 양의 용매 및 유화제와 혼합하고, 농축물을 목적 농도가 되도록 물로 희석하여 활성 성분의 적합한 제제를 제조하였다.1 part by weight of the active substance is mixed with the aforementioned amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration to prepare a suitable formulation of the active ingredient.
보호 활성을 시험하기 위해, 어린 식물에 활성 물질 제제를 지정된 적용 비율로 분무하였다. 분무 코팅의 건조후, 식물에 사과 백분병 원인균인 포도스파에라 류코트리차(Podosphaera leucotricha)의 수성 포자 현탁액을 접종하였다. 그후, 식물을 약 23 ℃ 및 약 70% 상대 대기습도의 온실에 놓아 두었다.To test for protective activity, young plants were sprayed with the active substance formulation at the specified application rate. After drying of the spray coating, the plants were inoculated with an aqueous spore suspension of Podosphaera leucotricha , an apple powdery mildew causative agent. The plants were then placed in a greenhouse at about 23 ° C. and about 70% relative atmospheric humidity.
접종 10 일 후에 평가를 실시하였다. 0%란 대조군에 상응하는 유효도를 의미하고, 유효도가 100%란 감염이 전혀 관찰되지 않았음을 의미한다.Evaluation was carried out 10 days after the inoculation. 0% means efficacy corresponding to the control, and 100% effectiveness means that no infection was observed.
표 ATable A
포도스파에라 시험(사과)/보호성Grape Spaera Test (Apple) / Protection
실시예 BExample B
벤투리아 시험(사과)/보호성Venturi Test (Apple) / Protection
용 매 : 아세톤 24.5 중량부Solvent: 24.5 parts by weight of acetone
디메틸아세트아미드 24.5 중량부 24.5 parts by weight of dimethylacetamide
유화제 : 알킬아릴 폴리글리콜 에테르 1.0 중량부Emulsifier: 1.0 parts by weight of alkylaryl polyglycol ether
활성 물질 1 중량부를 상기 언급된 양의 용매 및 유화제와 혼합하고, 농축물을 목적 농도가 되도록 물로 희석하여 활성 성분의 적합한 제제를 제조하였다.1 part by weight of the active substance is mixed with the aforementioned amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration to prepare a suitable formulation of the active ingredient.
보호 활성을 시험하기 위해, 어린 식물에 활성 물질의 제제를 지정된 적용 비율로 분무하였다. 분무 코팅의 건조후, 식물을 사과 더뎅이병 원인균(벤투리아 이내쿠알리스(Venturia inaequalis))의 수성 분생자 현탁액으로 접종한 후, 약 20 ℃ 및 100% 상대 대기습도의 배양실에 하루동안 놓아 두었다.To test for protective activity, young plants were sprayed with a formulation of the active substance at the specified application rate. After drying of the spray coating, the plants were inoculated with an aqueous conidia suspension of the apple strains ( Venturia inaequalis ) and then placed in a culture room at about 20 ° C. and 100% relative atmospheric humidity for one day.
그후, 식물을 약 21 ℃ 및 약 90% 상대 대기습도의 온실에 놓아 두었다.The plants were then placed in a greenhouse at about 21 ° C. and about 90% relative atmospheric humidity.
접종 10 일 후에 평가를 실시하였다. 0%란 대조군에 상응하는 유효도를 의미하고, 유효도가 100%란 감염이 전혀 관찰되지 않았음을 의미한다.Evaluation was carried out 10 days after the inoculation. 0% means efficacy corresponding to the control, and 100% effectiveness means that no infection was observed.
표 BTABLE B
벤투리아 시험(사과)/보호성Venturi Test (Apple) / Protection
실시예 CExample C
보트리티스 시험(콩)/보호성Botrytis Test (Bean) / Protection
용 매 : 아세톤 24.5 중량부Solvent: 24.5 parts by weight of acetone
디메틸아세트아미드 24.5 중량부 24.5 parts by weight of dimethylacetamide
유화제 : 알킬아릴 폴리글리콜 에테르 1 중량부Emulsifier: 1 part by weight of alkylaryl polyglycol ether
활성 성분 1 중량부를 상기 언급된 양의 용매 및 유화제와 혼합하고, 농축물을 목적 농도가 되도록 물로 희석하여 유효한 활성 성분 제제를 제조하였다.An effective active ingredient formulation is prepared by mixing 1 part by weight of the active ingredient with the solvents and emulsifiers in the amounts mentioned above and diluting the concentrate with water to the desired concentration.
보호 활성을 시험하기 위해, 어린 식물에 활성 성분의 제제를 지정된 양으로 분무하였다. 분무 코팅의 건조후, 보트리티스 시네레아로 군집을 형성하고 있는 작은 아가 두 조각을 각 잎위에 놓았다. 접종 식물을 약 20 ℃ 및 100% 상대 대기습도의 암실에 놓아 두었다.To test for protective activity, young plants are sprayed with the formulations of the active ingredient in the indicated amounts. After drying of the spray coating, two pieces of small agar, clustered with Botrytis cinerea, were placed on each leaf. Inoculated plants were placed in the dark at about 20 ° C. and 100% relative atmospheric humidity.
접종 이틀후, 잎위의 병변 영역 크기를 평가하였다. 0%란 대조군에 상응하는 유효도를 의미하고, 유효도 100%란 감염이 전혀 관찰되지 않았음을 의미한다.Two days after inoculation, the lesion area size on the leaves was evaluated. 0% means efficacy corresponding to the control, and 100% efficacy means that no infection was observed.
표 CTable C
보트리티스 시험(콩)/보호성Botrytis Test (Bean) / Protection
실시예 DExample D
푸키니아 시험(밀)/보호성Pukenia Test (Wheat) / Protection
용 매: N,N-디메틸아세트아미드 50 중량부Solvent: 50 parts by weight of N, N-dimethylacetamide
유화제: 알킬아릴 폴리글리콜 에테르 1 중량부Emulsifier: 1 part by weight of alkylaryl polyglycol ether
활성 물질 1 중량부를 상기 언급된 양의 용매 및 유화제와 혼합하고, 농축물을 목적 농도가 되도록 물로 희석하여 활성 성분의 적합한 제제를 제조하였다.1 part by weight of the active substance is mixed with the aforementioned amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration to prepare a suitable formulation of the active ingredient.
보호 활성을 시험하기 위해, 어린 식물에 활성 물질 제제를 지정된 적용 비율로 분무하였다. 분무 코팅의 건조후, 식물에 푸키니아 레콘디타(Puccinia recondita)의 분생자 현탁액을 분무하였다. 그후, 식물을 20 ℃ 및 100% 상대 대기습도의 배양실에 48 시간동안 놓아 두었다.To test for protective activity, young plants were sprayed with the active substance formulation at the specified application rate. After drying of the spray coating, the plants were sprayed with a conidia suspension of Puccinia recondita . The plants were then left for 48 hours in a culture chamber at 20 ° C. and 100% relative atmospheric humidity.
이어서, 식물을 약 20 ℃ 및 80% 상대 대기습도의 온실에 놓아 두어 녹병 발포가 퍼지는 것을 촉진하였다.The plants were then placed in a greenhouse at about 20 ° C. and 80% relative atmospheric humidity to facilitate the spread of rust foam.
접종 10일 후에 평가를 실시하였다. 0%란 대조군에 상응하는 유효도를 의미하고, 유효도가 100%란 감염이 전혀 관찰되지 않았음을 의미한다.Evaluation was performed 10 days after the inoculation. 0% means efficacy corresponding to the control, and 100% effectiveness means that no infection was observed.
표 DTable D
푸키니아 시험(밀)/보호성Pukenia Test (Wheat) / Protection
표 D - 계속Table D-continued
푸키니아 시험(밀)/보호성Pukenia Test (Wheat) / Protection
표 D - 계속Table D-continued
푸키니아 시험(밀)/보호성Pukenia Test (Wheat) / Protection
실시예 EExample E
알터나리아 시험(토마토)/보호성Alternaria test (tomato) / protection
용 매: N,N-디메틸아세트아미드 49 중량부Solvent: 49 parts by weight of N, N-dimethylacetamide
유화제: 알킬아릴 폴리글리콜 에테르 1 중량부Emulsifier: 1 part by weight of alkylaryl polyglycol ether
활성 물질 1 중량부를 상기 언급된 양의 용매 및 유화제와 혼합하고, 농축물을 목적 농도가 되도록 물로 희석하여 활성 성분의 적합한 제제를 제조하였다.1 part by weight of the active substance is mixed with the aforementioned amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration to prepare a suitable formulation of the active ingredient.
보호 활성을 시험하기 위해, 어린 토마토 식물에 활성 물질 제제를 지정된 적용 비율로 분무하였다. 식물 처리 하루후, 식물에 알터나리아 솔라니(Alternaria solani)의 포자 현탁액을 분무하였다. 그후, 식물을 20 ℃ 및 96% 상대 대기습도의 온실에 놓아 두었다.To test for protective activity, young tomato plants were sprayed with the active substance formulation at the specified application rate. One day after plant treatment, the plants were sprayed with a spore suspension of Alternaria solani . The plants were then placed in a greenhouse at 20 ° C. and 96% relative atmospheric humidity.
접종 7일 후에 평가를 실시하였다. 0%란 대조군에 상응하는 유효도를 의미하고, 유효도가 100%란 감염이 전혀 관찰되지 않았음을 의미한다.Evaluation was carried out 7 days after the inoculation. 0% means efficacy corresponding to the control, and 100% effectiveness means that no infection was observed.
표 ETable E
알터나리아 시험(토마토)/보호성Alternaria test (tomato) / protection
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004005787.7 | 2004-02-06 | ||
DE102004005787A DE102004005787A1 (en) | 2004-02-06 | 2004-02-06 | carboxamides |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070000489A KR20070000489A (en) | 2007-01-02 |
KR20060136459A true KR20060136459A (en) | 2007-01-02 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1942431B (en) | Haloalkyl carboxamides for preventing micro-organisms | |
US7842710B2 (en) | Carboxamides | |
KR20070050958A (en) | Biphenyl thiazole carboxamides | |
KR101025742B1 (en) | Phenyl benzamides | |
KR20070009579A (en) | 2-halofuryl/thienyl-3-carboxamides | |
KR20070053275A (en) | Biphenyl-thiazolo-carboxamides | |
KR20060009917A (en) | Iodopyrazolyl carboxanilides | |
KR20050094886A (en) | Pyrazolyl carboxanilides for controlling unwanted microorganisms | |
KR20070053158A (en) | Silylated carboxamides | |
KR20070089940A (en) | 2-alkyl-cycloalk(en)yl-carboxamides | |
KR20060120118A (en) | 1,3-dimethylbutyl carboxanilides for controlling undersirable micro-organisms | |
KR20060070573A (en) | Hexyl carboxanilides and their use for controlling undersirable micro-organisms | |
JP2007515444A (en) | Substituted heterocyclic amides with bactericidal effects | |
KR20050056210A (en) | Thiazol-(bi)cycloalkyl-carboxanilides | |
KR20060126713A (en) | Optically active carboxamids and use thereof to combat undersirable microorganisms | |
KR20060120176A (en) | Silylated carboxamides | |
KR20070052234A (en) | N-substituted pyrazolyl carboxanilides | |
KR20060017605A (en) | Difluoromethylbenzanilides and use thereof for combating micro-organisms, intermediate products and use thereof | |
KR20060126685A (en) | Pyrazolopyrimidines | |
JP2007516249A (en) | 7-amino-5-halopyrazolopyrimidines having fungicidal action | |
JP2007513908A (en) | Pyrazolopyrimidines as bactericidal active ingredients | |
KR20060103543A (en) | Pyrazolopyrimidines | |
KR20060136459A (en) | N-(2-(Hydroxymethyl)phenyl)-1H-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials | |
KR20060132650A (en) | Triazolopyrimidines with fungicidal properties | |
KR20060121278A (en) | Pyrazolopyrimidines |